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SUMMARY
The hepatic monooxygenase system is responsible for the 
metabolism of xenobiotics and steroids ( Kuntzman et al 1964 ) .
In vivo studies in rats have shewn that the activities of the 
constituent enzymes of the hepatic monooxygenase system are not 
constant but are under the control of the endocrine system and the 
hormones which have been found to influence enzyme activity are 
(a) testosterone ( Yates et.al. 1958 ) , (b) oestrogen (Einarsson 
et al 1973 ) , (c) growth hormone ( Wilson and Frohman 1974 ; 
Wilson and Spelsberg, 1976 ; Vockentanz and Virgo 1985 ) , (d) 
thyroxine ( Kato and Gillette 1965a ; Kato et al 1970 ) , (e) 
insulin ( Kato et al 1971 ; Weiner et al 1972a ; Reinke et al 1978 
; Past and Cook 1983 ) , (f) glucocorticosteroids ( Kato and 
Gillette 1965a ; Kato et al 1971 ) , (g) glucagon ( Weiner et al 
1972a ) and (h) catecholamines ( Fouts 1962 ; Dixon et al 1964 ; 
Kato and Gillette 1965a ) .
The intracellular mechanisms by which these hormones produce 
their effects , however , have been little studied and 
extrapolation from in vivo data is complicated by the fact that 
hormones appear to have different effects in male and female rats. 
One of the mechanisms by which hormones are known to produce 
their intracellular effects is by altering turnover of cyclic AMP 
and it has been reported that hormones which , when administered 
in vivo , increase intracellular cyclic AMP levels by a variety of 
mechanisms e.g. thyroxine ( Muller and Seitz 1987 ) , adrenaline 
(Exton et al,1971; Studer and Borle 1984 ; Kunos et al 1984 ;
Kunos and Ishac 1987 ) tend to inhibit hepatic monooxygenase 
activity in the male rat but not in the female rat . Insulin ,
however , which decreases intracellular cyclic AMP levels by a
variety of mechanisms ( Heyworth et al 1985 ; O'Brien et al 1987 ) 
, stimulates hepatic monooxygenase activity when added to isolated 
rat hepatocytes ( Hussin and Skett 1987 ) . In addition , in vivo
administration of the cyclic AMP analogue , dibutyryl cyclic AMP ,
to male rats has also been reported to inhibit hepatic 
monooxygenase activity ( Weiner et al 1972a ; Ross et al 1973 ) 
which provides more direct evidence for a role of cyclic AMP in 
hormonally-mediated inhibition of hepatic monooxygenase activity 
in the male rat . This effect , however , does not occur in the 
female rat .
It has recently been demonstrated that , in a reconstituted 
microsomal membrane system , the catalytic subunit of cyclic 
AMP-dependent protein kinase ( PKa ) can phosphorylate cytochrome 
P450 , the terminal oxidase in many hepatic monooxygenases (
Pyerin et al 1983 , Pyerin et al 1986a ; Pyerin et al 1987 ) , 
resulting in its conversion to the inactive cytochrane P420 ( 
Taniguchi et al 1985 ) with a concomitant inhibition of enzyme 
activity ( Pyerin et al 1984 ) .
It is conceivable , therefore , that cyclic AMP , by 
activating PKa , phosphorylates cytochrome P450 and inhibits 
hepatic monooxygenase activity in the male rat but not in the 
female rat .
In contradiction to the above findings it has been reported 
that the induction of hepatic monooxygenases by Arochlor-1254
(Costa et al 1976 ) , phenobarbitone and 3-methylcholanthrene 
(Byus et al 1976 ) are accompanied by large increase in 
intracellular cyclic AMP levels and activation of PKa. PKa may be 
producing its effects by turning on gene expression ( Teng et al 
1971 ; Dokas and Kleinsmith 1971 ) .
The purpose of this present study was to attempt to elucidate 
the previously contradictory implications for a role of cyclic AMP 
in the regulation of hepatic monooxygenase activity and to examine 
the mechanisms by which cyclic AMP produces its effects .
The major problem of extrapolating frcm in vivo data is that 
the hormone may not necessarily be acting at the level of the 
liver but may be producing its effects by altering the synthesis 
or release of other hormones . Similarly the findings of in vitro 
studies may not be representative of the physiological situation . 
For the purpose of this study , therefore , we chose as our model 
the isolated rat hepatocyte which overcomes the major problems of 
in vivo and in vitro models . Cyclic AMP levels were elevated 
either indirectly using 8-brcmo-cyclic AMP , adrenaline , 
isobutylmethylxanthine ( IEMX ) or forskolin in hepatocytes 
isolated frcm male or female ( 8-brcmo-cyclic AMP only ) rats , or 
directly by the addition of different concentrations of cyclic AMP 
to electropermeabilised hepatocytes isolated frcm male rats and 
subsequent effects upon the metabolism of the endogenous steroid , 
4-androstene-3,17-dione , were determined after various periods of 
time .
We were able to shew that elevation of intracellular cyclic 
AMP levels by both direct and indirect mechanisms had a time- and
concentration-dependent biphasic effect upon steroid-metabolising 
enzymes .
At lew ( physiological ) concentrations of cyclic AMP produced 
indirectly by adrenaline , IEMX and the canbination of adrenaline 
with IEMX , directly by 5 x 10" 5 M cyclic AMP and mimicked by the 
cyclic AMP analogue 8-brano-cyclic AMP ( 10" 4M ) , non-specific 
inhibition of enzyme activity occurred in hepatocytes isolated 
frcm both male and female rats . The non-specific , non-sex 
dependent nature of the inhibition was thought to indicate that 
the in vivo hormonally-mediated maintenance of sex differentiation 
and refractoriness of female monooxygenases were due to complex 
interactions between components of the endocrine system and due to 
seme hormonal influence which does not mediate intracellular 
effects by alteration of cyclic AMP levels .
At intermediate concentrations of cyclic AMP produced 
indirectly by forskolin and directly by 5 x 10" 4M cyclic AMP , the 
inhibitory effects upon enzyme activity were diminished and slight 
stimulation of enzyme activity occurred following inhibition .
At high ( supraphysiological ) concentrations of cyclic AMP 
produced indirectly by the combination of forskolin and IEMX and 
directly by 5 x 10"3M cyclic AMP , only very slight inhibition of 
enzyme activity occurred and this was followed by marked 
stimulation of enzyme activity at the later time point .
Using cycloheximide we were able to shew that the stimulation 
of enzyme activity was due to increase in protein synthesis and 
that recovery from enzyme inhibition at lew concentrations of 
cyclic AMP was also due to weak stimulatory effects upon protein
synthesis . It was also apparent that at high concentrations of 
cyclic AMP marked inhibition occurred which was masked by the 
predominant stimulation and so it was concluded that inhibition 
and protein synthesis-dependent stimulation of enzyme activity 
occurred at all concentrations of cyclic AMP but the relative 
magnitudes of the effects and their changes with time resulted in 
apparent time- and concentration-dependent biphasic effects . 
Using the protein kinase inhibitors , KT5720 ( specifically 
inhibits PKa ) and K-252b ( specifically inhibits protein kinase 
c (PKc) ) ( Kase et al 1986 ; Nakanishi et al 1986 ; Yasazawa et 
al 1986 ; Kase et al 1987 ) we were able to show that both 
inhibition and stimulation of enzyme activity were produced as a 
result of cyclic AMP activation of PKa . At lew concentrations of 
cyclic AMP , however , PKa appeared to have no direct inhibitory 
effects upon enzyme activity but inhibition appeared to be 
mediated by secondary activation of PKc by PKa . At high 
concentrations of cyclic AMP , PKa did appear to have seme direct 
inhibitory effects and the overall inhibition was due to a 
canbination of the effects of PKa and PKc . Stimulation appeared 
to be due to a direct action of PKa at both lew and high 
concentrations of cyclic AMP hcwever at high concentrations of 
cyclic AMP the PKa-mediated stimulation of enzyme activity was too 
transient to account for the secondary stimulation of high 
concentrations of cyclic AMP and it was concluded that the 
PKa-mediated stimulation of enzyme activity may be prematurely 
terminated in the absence of PKc perhaps indicating that PKc 
activation is necessary for sustained stimulation to occur .
We also examined the effects of direct and indirect elevation 
of cyclic AMP upon whole cell cytochrane P450 levels and by using 
cycloheximide and K-252b to separate the components proposed to 
mediate the overall effects of cyclic AMP , we were able to shew 
that the effects of lew concentrations of cyclic AMP were not 
mediated by changes in the levels of whole cell cytochrane P450 
levels . The overall effects and the constituent components of the 
effects of high concentrations of cyclic AMP , hcwever , all 
reflected changes in whole cell cytochrane P450 content . The 
mechanisms by which high concentrations of cyclic AMP may produce 
these effects were not elucidated by this study .
To examine the possibility that the effects of physiological 
concentrations of cyclic AMP were due to reversible 
phosphorylation of cytochrane P450 , as has been implicated by "in 
vitro" studies ( Pyerin et al 1987 ) , we examined the cyclic 
AMP-stimulated incorporation of (32P) into cytochrane P450 
isozymes in hepatocytes . We were unable to detect any 
incorporation of (32P) into irrmunoprecipitated cytochrane P450 
PB-2a ( a constitutive isozyme which is male specific and thought 
to metabolise up to 90% of the hydroxylation of androstenedione at 
the 16a position ( Waxman 1984 ) ) , cytochrane P450 PB-3a ( the 
major phenobarbitone-inducible isozyme ) or cytochrane P450 MC-lb 
( the major 3-methylcholanthrene-inducible isozyme ) following 
incubation with 5 x 10"5 M cyclic AMP and it is suggested that 
phosphorylation of cytochrane P450 may not be a physiological 
effect of cyclic AMP . The mechanism by which physiological 
concentrations of cyclic AMP mediate inhibition of enzyme activity
, therefore , has not been elucidated by this study .
Fran this study we have concluded that lew concentrations of 
cyclic AMP mediate predominant inhibition of steroid-metabolising 
enzymes and these concentrations may correlate with those 
generated by hormones which have an inhibitory effect upon hepatic 
monooxygenase activity in vivo . High concentrations of cyclic AMP 
, however , mediate predominant stimulation of steroid- 
metabolising enzymes which we have shewn to be due to induction 
of cytochrome P450 and the inductive effects of phenobarbitone ,
3-methylcholanthrene and Arochlor-1254 in vivo may be mediated , 
at least in part , by elevation of cyclic AMP levels . It is 
proposed , therefore , that elevation of cyclic AMP may have a 
role in both hormonally-mediated inhibition of hepatic 
monooxygenases and in the actions of xenobiotics in hepatic 
monooxygenase induction .
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INTRODUCTION
1 INTRODUCTION
1.1 HISTORICAL BACKGROUND .
1.1(a) Discovery of hepatic metabolism .
It has been known for over a century that injested foreign 
compounds undergo a process of transformation or metabolism in the 
body prior to their excretion in the urine or faeces . The first 
of these biotransformaticns to be discovered was the formation of 
hippuric acid fran injested benzoic acid which was subsequently 
excreted via the kidneys ( Keller 1842 ) . In 1876 Bauman observed 
that the products excreted were less toxic than the injested 
compounds and twenty years later the proposal was put forward that 
the biotransformation process served as a chemical defence 
mechanism against toxicity ( Lang 1894 ; Neumeister 1895). It is 
new accepted that metabolism and particularly hepatic metabolism , 
is essential for the excretion of lipid soluble compounds from the 
body ( Brodie et al 1958 ) . The original work upon the body's 
biotransformation system was concerned with the detoxification of 
in jested compounds , however it has subsequently been demonstrated 
that testosterone is also metabolised in the liver ( Ccnney and 
Klutch 1963 ) and in 1964 Kuntzman et al postulated that the same 
enzymes were responsible for both endogenous steroid metabolism 
and the metabolism of exogenous compounds ( xenbbiotics ) . It 
would appear , therefore , that the biotransformation of exogenous 
substrates occurs incidentally to the physiological role of these
enzymes
1.1(b) Phase 1 and Phase 2 metabolism .
Hie process of metabolism occurs in two phases as classified 
by Williams ( 1959 ) . The first phase ( phase 1 ) involves sane 
alteration of the compound such as oxidation , reduction , 
hydration or hydrolysis whereas the second phase ( phase 2 ) 
involves the combination of the transformed compound with a 
hydrophilic endogenous molecule such as sulphate , glucuronide or 
glutathione in a process known as conjugation . It is generally 
assumed that the transformation of the parent compound by phase 1 
results in the production or the unmasking of a functional group 
which is essential for conjugation to occur ( Caldwell 1982 ) and 
so the two processes must be thought of as two steps in a 
functionally single event .
The work undertaken and discussed in this thesis deals only 
with the mechanism of regulation of phase 1 metabolism . Reviews 
of phase 2 conjugation reactions , however , are listed in the 
reference section ( Williams 1967 ; Caldwell 1982 ) .
1.1(c) Discovery of Hepatic Microsomal Metabolism .
Hcmogenisation and differential centrifugation of rat liver 
yields particles known as microscmes . These have been shewn to be 
made up of small vesicles composed of pieces of the endoplasmic
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reticulum ( Porter et al 1945 ) and they retain the essential 
properties of the intact endoplasmic reticulum . In 1949 Mueller 
and Miller discovered that the microsomal fraction of rat liver 
could metabolise aminoazo dyes by reductive cleavage . In 1953 
Moeller and Miller observed that the same dye could also be 
metabolised by N-demethylaticn by hepatic microscmes and that 
molecular oxygen , reduced nicotinamide adenine dinucleotide 
phosphate ( NADFH ) and reduced nicotinamide adenine dinucleotide 
( NAEH ) were required by the system for the reaction to occur at 
the optimum rate . This work was extended by Brodie and co workers 
who , working with rabbit liver microscmes , were able to shew 
that the microsomal system was capable of metabolising a wide 
range of differing compounds ( Brodie et al 1955 ) . In 1955 two 
independent groups showed that during oxidation of a compound one 
atom of molecular oxygen is transferred to the substrate and the 
other atom undergoes reduction to water ( Mason 1957 ; Hayaishi 
1964 ) . The oxidising enzymes were therefore given the name mixed 
function oxidases by one group ( Mason 1957 ) and monooxygenases 
by the other group ( Hayaishi 1964 ) . The proposal that the 
oxygen utilised in the metabolic biotransformation of the 
substrate was of molecular origin rather than derived from 
cellular water was later confirmed by Posner et al ( 1961 ) .
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1.1(d) Discovery of cytochrome P450
In 1958 Klinkenberg discovered a pigment in rat hepatic 
microscmes which , when treated with carbon monoxide , absorbed 
light of an unusually long wavelength of 450 nm and postulated 
that the chranophore of the pigment contained a heavy metal ion as 
an integral component . In 1962 Ctnura and Sato showed that this 
carbon monoxide binding pigment was a cytochrane and in 1964 they 
presented evidence that the integral heavy metal was iron ( Ctnura 
and Sato 1964a ) . They subsequently named the pigment cytochrane 
P450 ( pigment 450 ) . Although first discovered in hepatic 
microscmes , cytochrane P450 is also present in adrenocortical 
microscmes where it is involved in steroidogenesis ( Ball 1987 ) 
and many of the first studies made to attempt to elucidate the 
function of cytochrane P450 were carried out upon adrenocortical , 
as opposed to hepatic , microscmes . In this manner a role for 
cytochrane P450 was implicated in the 21-hydroxylation of
17-hydroxyprogestercne in adrenocortical microscmes ( Cooper et al 
1963 ) and this was later followed by the recognition of a role 
for cytochrane P450 in the oxidation of acetanilide , 
benzo-a-pyrene , codeine and 3-methylaminoantipyrine by hepatic 
microscmes ( Cooper et al 1965 ; Cooper et al 1977 ) .
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1.2 CXTOCHRCME P450 MUNOOXYGENASES
1.2(a) Structure of cytochrome P450 .
Cytochrane P450 is a unique haernqprotein which contains iron 
protoporphyrin IX ( haem ) as a prosthetic group ( Maines and 
Anders 1973a ) . The haem moiety is contained within a hydrophobic 
cleft in the polypeptide chain of the apoprotein and it differs 
frcm other baemoprotein ( eg haemoglobin and myoglobin ) in that 
the haem is not covalently bound to the protein ( Hall 1987 ) but 
the iron of the prosthetic group is thought to be ligated at its 
fifth coordinate position to a sulphur atan contributed by a 
cysteine residue on the polypeptide chain of the cytochrane P450 
apoprotein ( Mason 1965 ; Waterman and Masai 1972 ) . Pour of the 
six coordinate positions of the iron of the prosthetic group are 
ligated to pyrolle nitrogen but the nature of the sixth ligand has 
yet to be elucidated although both oxygen ( in the form of water )
( Griffin and Petersen 1975 ) and nitrogen ( in the form of 
histidyl imidazole ) ( Sligar and Gunsalus 1979 ) have been 
implicated as the sixth ligand . The cytochrane P450 is 
associated with the smooth endoplasmic reticulum ( Pouts 1962 ) 
and is anchored to the lipid bilayer by two NHg-terminal 
transmembrane segments or signal peptides cn the apoprotein which 
are strongly hydrophobic in nature ( Szczesna-Skorupa et al 1988 ; 
Nelson and Strobel 1988 ) . The hydrophobic cleft containing the 
haem prosthetic group is on the membrane side of the cytochrane 
P450 with the haem positioned parallel to the membrane ( Nelson
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and Strdbel 1988 )
1.2(b) Spectra .
In a similar manner to other haemoproteins , the haem readily 
carbines with carbon monoxide in its reduced state and this 
complex has a unique absorption spectrum in that it absorbs at an 
unusually long wavelength of about 450nm ( Qnura and Sato 1964a). 
In addition the haem has a natural absorption spectrum which is 
produced in the absence of carbon monoxide . This is dependent 
upon the arrangement of the electrons in the d orbited of the 
iron. The d orbital electrons of the iron can exist in two 
configurations namely low spin ( one unpaired electron ) or high 
spin ( five unpaired electrons ) and at any given time a 
cytochrome P450 molecule exists in either the high or the lew spin 
state . The overall spin state of the cytochrane P450 is dependent 
upon the sum of the effects of all of the individual cytochrome 
P450 molecules . Thus at no time does the cytochrane P450 exist in 
a state of 100% high spin configuration or 100% lew spin 
configuration but the system exists in a state of dynamic 
equilibrium favouring a predominance of one state or the other . 
The equilibrium is determined by the conformation of the haem 
within the hydrophobic cleft of the protein and in the absence of 
a substrate the equilibrium favours a lew spin conformation of 
electrons . This produces a major absorption peak ( the Sonet 
peak) at 420nm ( Ball 1987 ) .
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1.2(c) Function of cytochrane P450
Hepatic cytochrane P450 monooxygenase activity is restricted 
mainly , but not solely , to the parenchymal cells . Cytochrome 
P450-dependent activity has also been detected in the Kupffer 
cells and the reticuloendothelial cells but the ratios of the 
different enzyme activities may vary from those found in the 
parenchymal cells ( La Franconi et al 1987 ) . The term 
monooxygenase indicates that it oxidises the substrate by 
utilising one atom of molecular oxygen and the second atom 
undergoes two equivalent reduction steps to produce water as a 
bi-product of the oxidation process ( Mason 1957 ; Hayaishi 
1964). During this process two electrons are donated to the 
reaction by two molecules of NADFH and the overall 
biotransformation is as follows :
KH + 02 + 2H+ + 2e--------RGH + fyO
KH is the substrate and RGH is the oxidised product . The 
oxygen binds to the haem of the cytochrome P450 which is in its 
oxidised , ferric form and in oxidising the substrate the iron of 
the haem is reduced and is then reoxidised to complete the cycle.
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1.2(d) NADPH - cytochrane P450 reductase
The transfer of the two electrons frcm the NADPH to the 
cytochrane P450 does not occur directly but the electrons are 
passed first to an flavoprotein electron carrier and then frcm the 
carrier to the cytochrane P450 . This carrier is called NADPH 
-cytochrane P450 reductase and it contains two separate flavin 
moieties , namely : flavin adenine dinucleotide ( PAD ) and flavin 
mononucleotide ( FMN ) ( Iyanagi and Mascxi 1973 ) . The two flavin 
moieties appear to have separate functions in the transfer of 
electrons frcm NADPH to cytochrane P450 . EAD has been reported to 
act as the electron acceptor and , following the acceptance of 
electrons frcm NADPH , the electrons are passed to PMN and then 
transferred to the cytochrane P450 ( Iyanagi et al 1981 ;
Vermilion et al 1981 , Backes and Reker-Backes 1988 ) .
Analysis of the stoichicmetry of the microsanal membrane has 
revealed that there are approximately 20-30 molecules of 
cytochrane P450 to every molecule of NADPH-cytochrane P450 
reductase and the reductase , therefore , appears to act as an 
electron carrier for many molecules of cytochrane P450 . Two 
theories have been proposed for the organisation of these 
molecules in the endoplasmic reticulum . The "rigid arrangement" 
theory proposes that the reductase is surrounded by a cluster of 
cytochrane P450 molecules in a structurally organised formation 
(Peterson et al 1976 ) whereas the "fluid" model proposes that the 
reductase and the cytochrane P450 are both surrounded by a sheath 
of phospholipids and are able to move freely through the membrane
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in a lateral manner ( Yang et al 1977 ) . The criteria for both of 
these models have been proposed by Franklin and Estabrook ( 1971).
1.2(e) Sequence of events in cytochrane P450 dependent 
hydroxylaticn reactions .
Step 1 : Substrate binding .
Binding of the substrate occurs within the hydrophobic cleft 
which contains the haem prosthetic group ( active site )
( Schwarze et al 1988 ) . In 1967 , Schenkman et al divided 
substrates into three categories depending upon their mode of 
binding : type 1 ; type 2 and modified type 2 ( Schenkman et al 
1967a ) . In all of these cases substrate binding occurs when the 
haem is in its oxidised , ferric state .
Type 1 substrates are thought to bind to the polypeptide chain 
of the apoprotein and the hydrophobic amino acids at positions 
380-382 may have a role in this binding ( Schwarze et al 1988 ) . 
This binding results in the displacement of the sixth ligand from 
the haem and a subsequent conformational change in the positioning 
of the haem within the hydrophobic cleft ( White and Coon 1980 ) . 
This change alters the equilibrium position of the cytochrome P450 
to favours transition to a predominantly high spin electron 
configuration and this results in a characteristic shift in the 
Soret peak frcm 420nm to 390nm and measurement of the spectral 
change shows a maximum at 390nm and a minimum at 420nm .
Type 2 substrates bind directly to the iron of the haem at the
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sixth coordinate position ( Schenkman et al 1967a ) . This alters 
the equilibrium of the cytochrane P450 to favour a low spin 
electron configuration and measurement of the spectral change 
produced by the binding of a type 2 substrate produces a spectrum 
which is almost the mirror image of that produced by the binding 
of type 1 substrates i.e. maximum at 430nm and minimum at 395nm .
It is thought that modified type 2 ( reverse type 1 ) 
substrates act by displacing sane unknown endogenous compound 
which is bound to the cytochrane P450 at the type 1 substrate 
binding site or that they bind at the sixth coordinate position 
( Peterson et al 1971 ) . The spectral change which occurs with 
the binding of modified type 2 substrates is the exact reverse of 
that produced by the binding of type 1 substrates ( hence reverse 
type 1 ) i.e. maximum at 420nm and minimum at 390nm .
Type 1 substrates ( e.g. hexobarbitcne and aminopyrine ) and 
type 2 substrates ( e.g. aniline ) have been widely used in 
studies to determine the regulatory control of cytochrane P450 . 
The natural steroids are classified as type 1 substrates and so 
type 1 substrates can be considered to act in a more physiological 
manner than type 2 substrates .
Step 2 : Transfer of the first electron .
The first electron is passed frcm the reductase to the 
cytochrane P450 and is ultimately taken up by the iron which is 
reduced from the ferric to the ferrous form . This step is
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accelerated by the prior binding of a type 1 substrate in the 
active site . The binding of a type 2 substrate , hcwever , slews
the rate of reduction by NADPH and m y  Indicate that the oxidised
cytochrane P450/type 2 substrate canplex is reduced more slowly 
than the oxidised cytochrane P450 alone or that the transfer of 
the first electron occurs prior to the binding of a type 2 
substrate ( Gigon et al 1969 ) .
Step 3 : Binding of oxygen .
Following the reduction of iron to its ferrous form , 
molecular oxygen binds to the sixth coordinate position of the 
haem . This binding is promoted by the displacement of the sixth 
coordinate ligand by the binding of the substrate in step 1 . A 
threonine residue at position 302 on the apoprotein polypeptide 
chain m y  also be involved in stabilising the haem/oxygen canplex 
( Wolf et al 1988 ) .
Step 4 : Insertion of the second electron and oxygen 
"activation" .
Ihe second electron activates the oxygen to form a reactive 
species and internal rearrangement of the electrons re-oxidises 
the iron to its ferric form . Much work has been carried out to 
attempt to elucidate the nature of the reactive species of oxygen
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and the mechanisms of activation but the process is still poorly 
understood . The reactive species of oxygen is assumed to be an 
oxygen anion and is equivalent to a ferric ion/peroxide ion 
complex however the actual electron distribution and protonation 
states are unknown and the identity of the reactive species is the
subject of much debate as reviewed by White and Coon ( 1980 ) .
Subsequent steps in the cycle are poorly understood . The 
following sequence is a brief summary of the events which are 
thought to occur but the precise mechanism by which they occur is 
not presently known . More detailed discussion of the present 
theories concerning mechanisms are contained in a review by White 
and Coon ( 1980 ) .
Step 5 : Oxygen cleavage .
The activated oxygen cleaves and one atom combines with two 
hydrogen ions to form water whilst the second atom remains 
attached to the iron .
Step 6 : Oxygen insertion .
Hydrogen is removed from a carbon atom on the substrate . The 
hydrogen combines with the oxygen to form a hydroxyl radical and 
the loss of the hydrogen leaves a carbon radical on the
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substrate. The two radicals recanbine and the oxygen is thus 
transferred fran the haem to the substrate to form a hydroxylated 
product .
Step 7 : Dissociation of the product .
The hydroxylated product dissociates from the active site and 
the haem in its ferric form is now ready to repeat the cycle with 
new substrate .
The whole cycle is summarised diagranroatically in figure 1
1.2(f) Other phase 1 biotransfonnaticns mediated by the 
cytochrome P450 monooxygenase system .
In the scheme shown above the substrate is metabolised to 
yield a hydroxylated product . In addition to hydroxylation 
cytochrome P450 has been shown to be involved in a wide range of 
other types of oxidative metabolism e.g. deamination , 
dealkylation , oxidation and sulphoxidation . Although the 
resultant products differ markedly in their substitutions most of 
the reactions proceed via intermediate hydroxylation steps which 
are then broken down to yield the product . The mechanisms of 
these reactions , therefore , proceed , at least initially , by 
the same pathway as that shown in figure 1 ( Brodie et al 1958 ) .
-13-
ROH RH
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®
(Fe-0)3+ 
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h2o
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i
Figure 1 : Catalytic cycle of cytochrane P450
Two exceptions are epoxidaticn and N-oxidation which do not 
proceed via an intermediate hydroxylation step . Oxygen insertion 
occurs directly onto the nitrogen in the case of N-oxidation or 
across two carbon atoms in the case of epoxidaticn .
1.3 ADDITIONAL COMPONENTS OF THE CYTOCHRCME P450 M3N0QXYGENASE 
SYSTEM .
1.3(a) Lipids .
Lipids were first shown to be essential for the action of the 
cytochrome P450 mcnooxygenase system in 1968 when Lu and Coen 
demonstrated that a heat stable , lipid component was required for 
the optimal hydroxylation of fatty acids . In 1969 Lu et al 
extended this work to show that the same lipid component was 
required for the oxidative metabolism of both drugs and 
steroids. The lipid factor was postulated to be 
phosphatidylcholine by Strobel et al ( 1970 ) and Vore et al 
( 1974 ) found that organic extraction of lypophilised rat 
microscmes resulted in 75% removal of phospholipids from the 
membrane and 10-25% loss of cytochrome P450 and NADFH-cytochrcme 
P450 reductase . The enzymatic activity , however , was reduced to 
a much greater extent ( 30-50% of control ) than could be 
explained by loss of the enzymatic components alone and the 
activity was fully restored by the readdition of both total lipid
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extract and purified phosphatidylcholine . In similar manner , 
treatment of microscmes with phospholipase C resulted in 70% loss 
of total phospholipids and a substantial decrease in the 
metabolism of type 1 substrates ( Chaplin and Mannering 1970 ; 
Eling and Di Augustine 1971 ) . However , in contrast to the study 
made by Vore et al ( 1974 ) , these workers found that full 
activity of the enzymes could not be restored by 
phosphatidylcholine alone . The exact nature of the lipid 
component , therefore , is unclear but it would appear that 
phosphatidylcholine is an essential component.
The lipid factor is thought to be essential for the transfer 
of electrons between NADFH and cytochrome P450 ( Strobel et al 
1970 ) and may facilitate the binding of type 1 substrates to 
cytochrome P450 although it appears to have no effect upon the 
binding of type 2 substrates ( Chaplin and Mannering 1970 ; Eling 
and Di Augustine 1971 ) . The precise mechanism of its actions are 
unknown .
1.3(b) Cytochrome bg .
In the scheme outlined for cytochrome P450 catalysed 
oxidation, NADFH is assumed to be the source of both the first and 
the second electrons . The addition of NADH to an oxidising 
system, however , has a synergistic effect with NADFH ( Conney et 
al 1957). Mueller and Miller ( 1953 ) found that both NADFH and 
NADH were required for the optimal metabolism of aminoazo dyes .
The microsomal 9-desaturation of fatty acids is also dependent
-15-
upon either NADFH or NADH as an electron donor ( Holloway et al 
1963 ) and in a parallel system to cytochrane P450 , the 
desaturation of fatty acids is also a cytochrane-dependent 
process. Hie cytochrane involved is cytochrane bs and electrons 
are transferred from NADH to the cytochrane via NAEH-cytochrane 
reductase ( Strittmatter and Velick 1956 ) and in 1971 Hildebrandt 
and Estabrook attempted to explain the phenomenon of NADH 
stimulation of cytochrane P450 monooxygenase activity and 
postulated that cytochrane bg is a component of the hepatic 
cytochrane P450 mcnooxygenase system . Cytochrane bg is thought to 
be involved in the transfer of the second electron from NADH to 
cytochrome P450 . NADFH via NADFH-cytochrane P450 reductase can 
also supply the second electron but NADH is the preferential donor 
( Imai and Sato 1977 ) . It is generally accepted that NADH is 
unable to act as donor for the first electron since NADH alone 
cannot support drug oxidations ( Correia and Mannering 1973 ) . 
Under certain circumstances , however , cytochrane bg may 
substitute for NADFH-cytochrane-P450 reductase in the transfer of 
electrons from NADFH ( Vats is et al 1980 ) and may participate in 
the transfer of the first electron from this donor ( Golly et al 
1988 ) . Similarly NADFH-cytochrome P450 reductase can participate 
in NADH supported monooxygenaticns in place of NADH-cytochrcme 1% 
reductase at high concentrations of NADH ( Noshiro et al 1980 ) .
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1.4 MULTIPLICITY OF CYTOCHRCME P450
1.4(a) Discovery of multiple forms of cytochrane P450 .
Hie existence of multiple forms of cytochrane P450 in the 
liver has been recognised for over 20 years following the work of 
Ccnney et al ( 1959 ) who noted that benzo-a-pyrene administration 
increased the metabolism of benzo-a-pyrene and zoxazolamine , 
decreased the metabolism of pethidine and benadryl and had no 
effect upon the metabolism of chlorpranazine . In a similar 
manner, treatment of rats with either of the two classic inducing 
agents : phendbarbitone or 3-methylcholanthrene ( section 1.9(a) ) 
resulted in the induction of enzymes with different substrate 
specificities and reduced carbon monoxide absorption spectra 
( Alvares et al 1967 ; Kuntzman 1969 ; Sladek and Mannering 1969). 
In addition to studies examining the selective induction of 
cytochrane P450 by phendbarbitone and 3-methylcholanthrene and the 
properties of the enzymes induced by these agents , multiplicity 
has also been postulated on the grounds of different rates of 
turnover . Examination of the rates of haem synthesis has lead to 
the hypothesis that two forms of cytochrane P450 exist ; one with 
a fast rate of turnover and the other with a slew rate of turnover 
( Levin et al 1974 ) and studies using allylisoprcpylacetamide and 
furoxeme have suggested that the different cytochrane P450 
isozymes are synthesised at different rates ( Bradshaw et al 
1978).
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1.4(b) Purification of different cytochrane P450 isozymes
The isolation of different forms of cytochrane P450 fran 
phenabarbitcne or 3-methylcholanthrene treated rats was first 
achieved in 1973 when Ccmai and Gaylor physically separated 
cytochrane P450 isozymes fran phenabarbitcne- , 
3-methyl-cholanthrene-and ethanol-treated rats and showed that 
they differed in their cyanide binding ability . Simultaneously 
Fugita et al ( 1973) partially purified cytochrane P450 isozymes 
fran phenbbarbitcne-and 3 -metbylcbolanthrene-treated rats and 
shewed that they differed in substrate specificity . Since this 
time a multitude of cytochrane P450 isozymes have been purified 
fran induced and non-induced animals and these are listed in 
table 1 .
Evidence for distinct forms of cytochrane P450 has been 
presented based on the different properties of these purified 
isozymes :
(a) The isozymes have different mobilities on sodium dodecyl 
sulphate polyacrylamide gel electrophoresis ( SDS-PAGE ) .
(b) Hie isozymes have different but overlapping substrate 
specificities .
(c) Hie isozymes can be separated by imnunochemical techniques 
employing specific antibodies however cross reactivity
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Levin Waxman Guengerich Schenkman Wolf Ccrrments
a 3 UT-F - UT-1 Steroid 7 a-hydroxylase
b PB-4 PB-B FBKLM5 PB-3a Major phenobarbitone-inducible 
isozyme .
c BNF-B BNF-B - MC-lb Major 3-methylcholanthrene- 
inducible isozyme .
d ISF-G ISF-G — MC-la Major isosafrole-inducible 
isozyme also induced by 
methylcholanthrene .
e PB-5 PB-D PBRXM6 PB-3b Phenobarbitone- inducible .
f - - - - Constitutive isozyme , 
crossreactive with b
g - - REM3 - Constitutive isozyme . Male- 
specific , strain-dependent .
h 2c UT-A RLM5 PB-2a Male-specific isozyme. Steroid 
16a-hydroxylase .
i 2d UT-1 FRIM4 - Female isozyme.Steroid 
sulphate 15p-hydroxylase .
j - - KLM6 - Ethanol-inducible .
k PB-1 PB-C RLM5a PB-lb Phenobarbitone-inducible . 
Hormone-independent .
P PB-2a PCN-E Major Pregnenolone-16a- 
carbonitrile-inducible isozyme 
also induced by dexamethasone 
and triacetyloleandanycin .
2a Male-specific , steroid 6p- 
hydroxylase
Table 1 . Nomenclature of different rat hepatic cytochrane P450 isozymes 
characterised by different groups ( adapted from Waxman 1988 ) .
between different isozymes is carmen due to the 
conservation of many amino acid sequences in their 
structures .
(d) The isozymes can be distinguished fran one another by 
peptide mapping and analysis of the amino acid sequences 
of the apoprotein .
1.5 METABOLISM OF STEROIDS .
Steroids are metabolised by a complex system of enzymes both 
cytochrane P45 O-dependent and cytochrane P45 O-independent . Hie 
androgenic steroid : 4-androstene-3,17-dione will be used to 
illustrate the complexity of the system and is the substrate which 
we chose to represent the steroids in examining the regulation of 
steroid-metabolising enzymes throughout this project.
The metabolism of androstenedione is shewn in figure 2 . The 
parent molecule is hydroxylated at three positions : 16a , 60 and 
7a by cytochrane P450-containing monooxygenases .
Purification of the male specific cytochrane P450 ( P450 2c : 
see table 1 ) has shown that this cytochrane P450 isozyme 
catalyses up to 90% of the metabolism of androstenedione at the 
16a position ( Waxman 1984 ) and similarly hydroxylates 
testosterone at the 16a position to the same degree as assessed by 
purification studies ( Morgan et al 1985a ) and by assessing 
inhibition by specific monoclonal antibodies ( Waxman et al 1987). 
It also hydroxylates testosterone at the 2a position ( Waxman 1984
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Figure 2 : Hepatic metabolism of 4-androstene-3,17-dione
; Waxman et al 1983 ) but hydroxylation of androstenedione 
does not occur at this position .
Up to 85% of the hydroxylation of androstenedione at the 60 
position is thought to be catalysed by cytochrane P450 2a 
( table 1 ) ( Waxman et al 1985 ) although the cytochrane P450 
isozyme is deactivated during the course of microsomal 
solubilisation and so direct assessment of the activity of the 
purified enzyme has not , so far , been possible .
Hydroxylation of androstenedione at the la position has been 
reported to be catalysed almost exclusively by cytochrane P450 3 ( 
table 1 ) ( Waxman et al 1987 ; Nagata et al 1986 ) .
It appears , therefore , that in the uninduced liver the 
hydroxylation of androstenedione is catalysed by three separate 
and specific cytochrane P450 isozymes .
5a reductase is also a membrane-bound microsomal enzyme and 
although it does not contain cytochrane P450 as an integral 
component , reconstitution studies have shewn that it exists as 
part of a multi-component system which shews many similarities to 
the cytochrome P450 monooxygenase system . The electron transport 
chain is composed of three enzymes : steroid 5a reductase , 
coenzyme Q10 and NADFH-cytochrcme oxidoreductase . Coenzyme is 
a cytochrome and electrons are passed from NADFH to coenzyme Q10 
by NADFH-cytochrcme oxidoreductase and then from coenzyme Q10 to 
the steroid substrate by steroid 5a reductase where they are 
utilised in the reduction of the double bond ( Golf and Graef 
1978). The system also contains phosphatidylcholine as an integral 
canpcnent in an analogous manner to cytochrome P450 monoaxygenases
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and it may perform similar functions ( section 1.3(a) ) .
17 a/0 and 3 a/p hydroxysteroid dehydrogenases are also 
microsomal enzymes although details of their mode of action have 
been poorly documented . 3a hydraxysteroid dehydrogenase , however 
, has been the subject of a recent review by Penning et ad 
( 1987 ).
1.6 EXTRAHEPATIC FORMS OF CYIOCHRCME P450 .
Ihe best documented site of extrahepatic cytochrome P450 
monooxygenases is the adrenal gland where the enzymes are involved 
in the biosynthesis of steroid hormones from cholesterol. These 
enzymes have been reviewed in detail by Hall ( 1987 ) and four 
distinct forms of cytochrane P450 have been purified and 
characterised ( Waterman and Simpson 1985 ) . Cytochrome P450scc 
( cleaves the side chain of cholesterol to produce pregneneolcne) 
and cytochrome P450lip ( lip hydroxylation of 11-deoxycortisol to 
produce cortisol ) are mitochondrial enzymes and cytochrane 
P45017a ( 17a hydroxylation of progesterone ) and cytochrome 
P450C21 (21 hydroxylation of 17a hydroxyprogestenone to produce 
11-deoxycortisol ) are microsomal enzymes . The mitochondrial 
electron transport system differs from that of the liver and 
adrenal microsomal systems in that it utilises two carrier 
proteins in the transport of electrons from NADFH to the 
cytochrane P450 . The first carrier is a flavoprotein , 
NADFH-adrenodoxin reductase , and this then passes the electrons 
to an iron-sulphur protein , adrenodoxin , and then the electrons
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are passed fran adrenodoxin to the cytochrane P450 .
Extrahepatic steroidogenic forms of cytochrane P450 also exist 
in the testes and in the ovaries . In addition to cytochrane 
P450scc and cytochrane P45017a , the testes also contain 
cytochrane P450C17_C201 yase which catalyse the synthesis of 
androstenedione from 17a hydroxyprogestercne and the ovaries 
contain both cytochrane P450C17_C201 yase and cytochrane 
P450aromatase which catalyses the synthesis of oestradiol from 
androstenedione .
In addition to the liver and the steroidogenic organs , 
cytochrome P450 monooxygenases have also been reported in many 
other organs including the kidneys ( Orrenius et al 1973 ) , the 
lungs ( Bend et al 1973 ) and the brain ( Naslund et al 1987 ; 
Sugita et al 1987 ) .
1.7 SYNTHESIS OF CYTOCHRCME P450 .
IXie to the fact that cytochrane P450 consists of two 
components i.e. the apoprotein and the haem prosthetic group , the 
synthesis of the holoenzyme is a complex process .
The haem biosynthetic pathway , which is probably identical in 
all cells , is initiated by the condensation of glycine and 
succinyl coenzyme A in the presence of 6-aminolaevulinic acid 
synthase ( ALA-synthase ) and pyridoxyl phosphate to form 
aminolaevulinic acid ( ALA ) ( Granick and Urata 1963 ) . 
ALA-synthase is the rate limiting enzyme in the synthesis of haem
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and is located cn the matrix of the mitochondria ( McKay et al 
1969 ) . The ALA then passes out of the mitochondria into the 
cytosol and is converted to phosphbbilinogen in the presence of 
ALA-dehydratase . Phospbobilinogen is then converted to 
protoporphyrin IX by a series of uncharacterised enzyme steps and 
then the protoporphyrin IX passes back into the mitochondria and 
is converted to haem ( iron protoporphyrin IX ) by chelation with 
iron in the presence of protohaem ferrolyase ( ferrocheletase ) .
The apoprotein of the cytochrane P450 confers isozyme 
specificity and current evidence suggests that the genes encoding 
the amino acid sequences form a superfamily consisting of at least 
five gene families as classified by their susceptibility to 
different classes of Inducing agent . The apoprotein is 
synthesised from the specific genetic code for the isozyme and 
then the haem is incorporated to yield the holoenzyme . The 
incorporation of haem into the apoprotein occurs outside the 
mitochondria , however the site of haemcprotein production and the 
mechanism by which the haem passes out Into the cytosolic haem 
pool are unknown .
1.8 DEGRADATION OF CYTOCHRCME P450 .
1.8(a) Cytochrane P420 .
When micnoscmes are treated with a variety of solubilising 
agents e.g. lipases , proteases and detergents , cytochrane P450 
is converted to an inactive form and this is accompanied by a
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characteristic shift in the reduced carbon monoxide absorption 
peak from 450nm to 420nm . The absorption peak has led to it being 
named cytochrome P420 ( pigment-420 ) ( Onura and Sato 1964a ) .
In 1978 Dawson et al , in an attempt to elucidate the nature of 
the fifth coordinate haem ligand in cytochrome P450 , concluded 
that thiolate was the likely fifth ligand in cytochrome P450 but 
that this ligand was absent in cytochrome P420 . Thus cytochrome 
P420 may be formed from cytochrome P450 by loss or disruption of 
the fifth coordinate thiolate ( sulphur ) linkage between the haem 
and the apoprotein . The conversion of cytochrome P450 to 
cytochrome P420 is generally assumed to be a ncn-physiological 
transformation , however Taniguchi et al ( 1985 ) have postulated 
that this may be the underlying mechanism in the inhibition of 
monooxygenase activity mediated by the phosphorylation of 
cytochrome P450 and so may represent a physiological mechanism of 
degradation .
1.8(b) Haem oxygenase .
Haem oxygenase ( HD ) is a mixed function oxidase localised in 
microsomal membranes and it consists of two inraunologically 
distinguishable isozymes : HD-1 and HD-2 ( Maines et al 1986 ) . 
Both forms required NADFH , NADFH-cytochrcme P450 reductase and 
molecular oxygen in an analogous manner to cytochrome P450 but the 
two isozymes have different induction profiles in that only the 
HD-1 isozyme is inducible . Both isozymes cleave the iron
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protoporphyrin IX ( haem ) ring at the a meso bridge to form a 
linear a iscmer of biliverdin ( a tetrapyrolle ) ( Tenhunen et al 
1969 ; Maines et al 1986 ) . Biliverdin is then converted to 
bilirubin by reduction of the methane bridge of biliverdin by a 
cytosolic enzyme known as biliverdin reductase in the presence of 
NADH or NADFH to supply reducing equivalents ( Ellis-Bell and 
Maines 1988 ) . Of these two steps the cleavage of the iron 
protoporphyrin IX ring by haem oxygenase is rate limiting in the 
degradation of haem to bilirubin ( Tenhunen et al 1969 ) . One 
argument against a role of haem oxygenase-catalysed conversion of 
haem to bilirubin as a major route of cytochrane P450 degradation 
in the liver is that haem oxygenase is localised in the hepatic 
reticuloendothelial cells ( where it is responsible for the 
breakdown of haemoglobin derived haem ) and very little exists in 
the hepatic parenchymal cells ( Guengerich 1977 ) . Maines and 
Anders ( 1973b ) , however , proposed that the cytochrane 
holoenzyme is transported to the haem oxygenase by a transfer 
protein and both albumin and hemqpexin ( the two known plasma haem 
binding proteins ) may perform this function . They also found , 
however , that only cytochrane P420 and not cytochrane P450 could 
bind to these transfer proteins . Similarly , Kutty et al 
( 1988) found that a major phenobarbitone-inducible cytochrane 
P450 isozyme , cytochrane P450c was not susceptible to haem 
oxygenase-mediated degradation unless first converted to the 
analogous cytochrane P420 . This may indicate that the importance 
of haem oxygenase as a major route of cytochrome P450 degradation 
is dependent upon prior conversion of the cytochrome P450 to the
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analogous cytochrane P420 and may provide further implications for 
the physiological significance of this latter conversion .
1.8(c) Lipid peroxidation .
In the presence of NADFH and molecular oxygen , 
NADFH-cytochrane P450 reductase can degrade the haem of cytochrane 
P450 , cytochrane P420 and cytochrane bs ( Guengerich 1977 ) .
This has been shown to be due to the production of hydrogen 
peroxide or another oxygen derived species at the site of the haem 
which results in the production of lipid peroxides ( Schacter et 
al 1973 ) and the process overcomes two points which argue against 
haem oxygenase as a physiological mechanism of haem breakdown , 
namely (a) cytochrane P450 can be degraded without prior 
conversion to cytochrane P420 and (b) the cytochrane P450 is 
degraded at the site of the parenchymal cell endoplasmic reticulum 
and does not require transportation to the reticuloendothelial 
cells .
The major route of haem degradation in the untreated liver is 
unresolved and arguments have been offered for and against both 
haem oxygenase-mediated and lipid peroxide-mediated degradation . 
Both systems appear to have physiological significance and the 
ultimate effect is loss of haem which may increase the 
susceptibility of the apoprotein to proteolytic breakdown (Abraham
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et al 1988 ) .
1.9 XENCBIOTIC-MEDIATEID INDUCTION OF HEPATIC M3NOCK¥GENASES .
1.9(a) Inducing agents .
The ability of phendbarbitone to stimulate the metabolism of 
itself and other drugs has been known for many years and is a 
dose-dependent effect ( Tavolcni et al 1983 ) . One of the first 
studies upon the mechanism of phendbarbitone1 s actions was 
conducted in 1965 by Emster and Orrenius and it was reported that 
pretreatment with phenobarbitone increased drug metabolism and 
this was accompanied by concomitant induction of both cytochrome 
P450 and NADFH-cytochrcme P450 reductase . In 1975 Hutterer et 2d 
reported that , in addition to induction of cytochrome P450 , 
phenobarbitone also increased the size of the liver , the total 
microsomal protein content and the phospholipid content of the 
liver and the effects of phendbarbitone , therefore , are not 
confined to the cytochrome P450 monooxygenases tut it has a 
general proliferative effect upon, the liver . Despite this general 
proliferative effect phenobarbitone has a selective induction 
effect upon seme cytochrome P450 isozymes , minimal effect upon 
other isozymes and has also been reported to decrease the 
microsomal content of seme isozymes ( Waxman et al 1985 ;
Ioann ides and Parke 1987 ) . Other inducing agents have selective 
isozyme-induction profiles differing fran that of phendbarbitone 
and it is now recognised that three major classes of inducing
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agents exist and each mediates a characteristic induction profile.
Hie three major groups are (i) phendbarbitone-like ; (ii) 
polycyclic aromatic hydrocarbons and (iii) synthetic steroids .
(i) Phenobarbitone-like .
This group includes , in addition to phendbarbitone , 
chlordane ; SKF-525A ; trans stilbene oxide ; glutethimide and 
mephenytoin . All of these agents induce two major isozymes termed 
cytochromes P450b and P450e ( table 1 ) of which cytochrome P450b 
is the major phenobarbitone-inducible isozyme .
Phenoiba rbitone-like inducers also induce cytochrome P450a 
( table 1 ) which is responsible for steroid hormone 
7a-hydroxylase activity and cytochrome P450-PCN which is the major 
synthetic steroid-inducible isozyme ( Ioannides and Parke 1987 ) . 
It has also been reported to decrease the levels of the 
male-specific isozyme ( termed P450 h , P450 2c , P450 UT-A and 
P450 REM5 by differing groups : see table 1 ) ( Waxman et al 1985) 
but the overall hydroxylation of testosterone is increased 
( Kuntzman et al 1966 ) and this effect may be augmented by the 
ability of cytochrome P450b to compensate for the loss of 
testostercne-16a-hydroxylase activity attributable to decrease in 
the levels of the male-specific cytochrome P450 isozyme , by 
hydroxylating the steroid at the 16J3 position 
( Waxman et al 1983 ) .
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(ii) Polycycllc aranatic hydrocarbons
This group is usually represented by the prototype hydrocarbon 
: 3-methylcholanthrene but the group also includes 
p-naphtboflavcne , benzo-a-pyrene and 2,3,7,8-tetrachlonodibenzo 
-p-dioxin ( TCDD ) . These agents induce two major cytochrane P450 
isozymes termed cytochrome P450c and cytochrome P450d ( table 1 ) 
and these isozymes are also collectively known as cytochrome P448 
due to the fact that the reduced OO-absorpticn spectrum peak 
occurs at the slightly shorter wavelength of 448nm ( Ioannides and 
Parke 1987 ) . The major isozyme inducible by the polycyclic 
aromatic hydrocarbons is cytochrome P450c . In a similar manner to 
the phenbbarbitcne-like inducers , the polycyclic aromatic 
hydrocarbons also increase the levels of cytochrome P450a but to a 
lesser extent than cytochromes P450c and P450d ( Yeowell et al 
1987a ) and decrease the levels of the male-specific cytochrome 
P450 isozyme ( Yeowell et al 1987b ) . They also suppress the 
levels of cytochrome P450b and the other phenabarbitcne-specific 
isozymes in both untreated and phenobarbitone-treated rats (Dannan 
et al 1983 ; Yeowell et al 1985 ) .
Isosafrole also induces cytochromes P450c and P450d in a 
similar manner to the polycyclic aromatic hydrocarbons tut unlike 
these agents , cytochrome P450d is the major isosafrole-inducible 
isozyme and cytochrome P450c is induced to a lesser extent . 
Isosafrole also induces cytochrome P450a to a limited extent and
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unlike the polycyclic aromatic hydrocarbons , cytochrane P450b is 
also induced by isosafrole but to a lesser extent than its 
induction by phendbarbitone ( Levin et al 1980 ) . Isosafrole , 
therefore , appears to have a similar induction profile to the 
polycyclic aromatic hydrocarbons but shows characteristic 
differences and it has been suggested that isosafrole is a unique 
inducer of microsanal monooxygenases ( Dickens and Bridges 1978). 
It also differs from the other classes of Inducing agents in that 
Isosafrole-induced cytochrane P450d but not cytochromes P450a , 
P450b or P450c , is purified as an isosafrole metabolite 
/cytochrome P450 complex with the metabolite bound to the haem of 
the cytochrome ( Levin et al 1980 ) .
(iii) Synthetic steroids .
The prototype of this group is pregneneolcne-16a-carbcnitrile 
( FCN ) but dexametbascne is also thought to induce monooxygenases 
in an identical manner . PCN induces a cytochrome P450 isozyme 
which is distinct from those induced by either phenobarbitone or 
3-methylcholanthrene and which is called cytochrane P450-PCN 
( Elshourbagy and Guzelian 1980 ) . This isozyme can also be 
selectively induced by the macrolide antibiotic : 
triacetyloleandcmycin and has , therefore , also been called 
cytochrome P450-TAO ( Wrightcn et al 1985 ) .
Triacetyloleandcmycin also shows similarities to isosafrole in
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that its metabolite binds to the cytochrane P450 and forms a 
reversible complex ( Pessayre et al 1981 ) .
It has been proposed that inducing agents tend to induce the 
cytochrome P450 isozymes which metabolise them and induction , 
therefore , represents a form of homeostasis . The characteristics 
of phenobarbitone-inducible and 3-methylcholanthrene-inducible 
isozymes have been reviewed by Ioannides and Parke ( 1987 ) . The 
phenobarbitone-inducible isozymes tend to be induced by non 
planar, bulky molecules and substrates are similarly non planar, 
globular molecules . Endogenous steroids , therefore , are good 
substrates for the phenobarbitone- inducible isozymes . The 
oxidations catalysed by these cytochrome P450 isozymes produce 
good substrates for conjugation and these isozymes tend to be 
located in the centrildbular region of the liver which is also the 
region in which the conjugating enzymes are most prevalent . 
3-methylcholanthrene-inducible isozymes , however , are induced by 
rigid , planar molecules and their substrates similarly tend to be 
rigid and planar . Endogenous steroids , therefore , are poor 
substrates for the 3-methylcholanthrene-inducible isozymes . The 
oxidised products are poor substrates for conjugation and these 
isozymes are found in the periportal region of the liver which is 
lew in conjugating enzymes . Much of the work upon the 
structure/activity relationships of the phenobarbitone-like and 
3-methylcholanthrene-like inducers has utilised Arochlor-1254 
which is a mixture of polychlorinated biphenyls and is a mixed 
phenobarbitone-like and 3-methylcholanthrene-like inducer . The
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ability to induce phenobarbitone-inducible or 
3-methyl-cholanthrene-inducible isozymes has been found to be 
dependent upon the degree of substitution of the molecule and 
specifically at the position ortho to the biphenyl bridge . As the 
degree of substitution increases the molecule becomes more 
sterically hindered and therefore less planar and so the ability 
of the molecule to act as a 3-methylcholanthrene-like inducer 
decreases with a concomitant increase in its ability to act as a 
phencbarbitcne-like inducer ( Dannan et al 1983 ; Parkinson et al 
1983 ) .
1.9(b) Induction of apoprotein synthesis .
Hie mechanism of action of the inducing agents is , as yet , 
unknown and is an area of intensive research .
The major phenobarbitone- and 3-methylcholanthrene-inducible 
isozymes are induced in hepatocytes in a similar manner to the 
whole animal ( Daujat et al 1987 ; Hishinuma et al 1987 ) and so 
the effect of inducing agents upon specific isozymes appears to 
occur at the level of the liver cells .
Hie polycyclic aromatic hydrocarbons bind to a cytosolic 
receptor , an effect which may involve sulphydryl groups on the 
receptor , and binding of the ligand has been proposed to produce 
seme conformational change in the receptor which results in its 
activation ( Henry et al 1988 ) . The inducer/receptor complex 
then translocates into the nucleus where it associates with a
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regulatory gene as a complex with the inducer molecule 
( Fujisawa-Sehara et al 1987 ) . This leads to an increase in gene 
transduction and a subsequent increase in cytochrome P450 
messenger KNAs and , in cells which do not accumulate the 
inducer/receptor complex in the nucleus , these effects do not 
occur ( Israel and Whitlock 1984 ) .
No equivalent receptor has been discovered for phenobarbito- 
ne-like inducers and the mechanism of action of these agents is 
unknown . Itoey appear , however , to increase gene transcription 
in a similar manner to the polycyclic aromatic hydrocarbons 
(Pike et al 1985 ; Shephard et al 1987 ) . Iversen et al ( 1987 )
, however , reported that phendbarbitone and 3-methylcholanthrene 
synergistically superinduced the messenger RNAs for 
phenobarbitone-inducible isozymes but this superinducticn was not 
accompanied by a corresponding rise in the activity of the 
isozymes and so it was proposed that the regulatory step of 
induction occurred at a level beyond gene transcription .
Similarly the isosafrole-mediated induction of apo-cytochrane P450 
was found to occur with no detectable increase in gene 
transcription ( Shephard et al 1987 ) . It appears therefore that 
inducing agents induce the apoprotein of cytochrome P450 isozymes 
by increasing gene transcription and/or stabilising post- 
transcriptional events .
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1.9(c) Effects upon haan synthesis
Both pbenabarbitone and 3-methylcholanthrene have been 
reported to increase the activity of 6-aminolaevulinic acid 
synthase in chick embryo liver and this leads to a subsequent 
increase in the levels of haem ( Shedlofsky et al 1987 ; Lincoln 
et al 1988 ) . It has been postulated that this Increase in haem 
leads to an increase in the expression of cytochrome P450 genes as 
inhibitors of haem synthesis ( cobalt chloride and thioacetamide ) 
block the induction of the apoprotein of cytochrome P450 by 
pbenobarbitcne ( Dwafki et al 1987 ; Satyabhama et al 1986 ) and 
it has been proposed that haem is a general positive regulator of 
cytochrome P450 gene expression which may act by promoting ENA 
transcription and messenger RNA elongation ( Jayarama Bhat and 
Padmanaban 1988 ) but the inducing agent imparts isozyme 
specificity ( Ravishankar and Padmanaban 1985 ) . Elevation of 
haem in the haem pool , however , does not appear to be a 
necessary precedent for apo-cytochrome P450 gene transcription as 
increase in the gene transcription has been reported to occur at 
an earlier time point following administration of pbenobarbitcne 
than its effects upon haem synthesis ( Rajamanickam et al 1975 ; 
Correia and Meyer 1975 ) . Kumar et al ( 1980 ) , however , found 
that the administration of cobalt chloride in conjunction with 
pbenobarbitcne had no effect upon phenobarbitcne-mediated 
induction of messenger RNA levels but decreased the synthesis of 
apo-cytochrcme P450 and it was proposed , therefore , that the 
rate of apo-cytochrcme P450 synthesis is dependent upon the rate
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of endogenous haem synthesis and that haem produces its effects by 
acting at seme post-transcriptional site .
1.9(d) Effects upon cytochrome P450 degradation .
In addition to an increase in 6-aminolaevulinic acid synthase 
and gene transcription/messenger RNA stabilisation , both 
phenobarbitone and 3-methylcholanthrene have been reported to 
increase haem oxygenase in chick embryo liver and this is thought 
to occur secondary to the increase in aminolaevulinic acid 
synthase and an increase in haem levels ( Shedlovsky et al 1987 ; 
Lincoln et al 1988 ) . In addition , 3-methylcholanthrene has also 
been proposed to accelerate the degradation of haem by uncoupling 
the cytochrome P450 system which leads to an increase in the 
production of hydrogen peroxide ( De Mattheis 1988 ) . Obese 
effects may all contribute to the decrease in cytochrome P450 half 
life which has been shown to occur in phenobarbitone-and
3-methylcholanthrene-induced rat liver ( Sadano and Qnura 1983 ) . 
It has also been reported that phenobarbitone-induced membranes 
are rapidly removed from the cell following cessation of treatment 
and this is thought to be due to an increase in autophagic 
vacuoles induced by phenobarbitone and the increase in the levels 
of intracellular membranes . The autophagic vacuoles are thought 
to engulf the membrane and breakdown subsequently occurs via the 
action of proteolytic enzymes ( Bolender and Vfeibel 1973 ) .
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1.10 XENCBIOTIC-MEDIATED INHIBITICN OF HEPATIC MSNOCXYGENASES
Xendbiotic inhibition is a much more diverse subject than is 
induction and many xenobiotics have specific toxic actions upon 
the cytochrome P450 monooxygenases which are related to the 
specific mode of action of the individual drug . Such toxic 
actions are outside the subject of this thesis and will not be 
discussed .
1.10(a) Destruction of cytochrome P450 .
The best documented of the mechanisms of cytochrome P450 
destruction are those mediated by xenobiotics containing olefinic 
or acetylenic groups e.g. allylisopropylacetamide ( AIA ) and 
3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-l, 4-dihydropyridine 
(DEEP). Obese drugs are classified as "suicide substrates" as 
metabolism by cytochrome P450 is a necessary precedent for their 
degradative actions . These xenobiotics give rise to the formation 
of "green pigments" in the liver and these have been shewn to be 
alkylated-or substrate-haem fragments derived from the native 
prosthetic group of the cytochrome P450 ( Ortiz de Montellano et 
al 1981 ; De Matteis et al 1981 ) . The major site of action of 
these drugs has been proposed to be directly at the haem locus and 
the effects of AIA have been reported to be readily reversible by 
the administration of exogenous haem ( Bomheim et al 1987 ) . 
Cytochrome P450p ( table 1) , however , is refractory to the
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addition of haem and similarly the administration of DDEP has been 
reported to alkylate the haem at the active site of cytochrome 
P450p and then the subsequently produced alkylated-haem fragments 
bind to the apoprotein of the cytochrome and increase its 
susceptibility to proteolytic breakdown ( Correia et al 1987 ) . 
These agents , therefore , may have additional secondary 
degradative effects upon sane cytochrome P450 isozymes by 
increasing susceptibility to proteolytic enzymes .
1.10(b) Xenobiotics which form inactive complexes with 
cytochrome P450 .
These drugs include amphetamines , cimetidine , methadone and 
iscniazid and unlike the drugs in category (a) they do not appear 
to share any carmen structured reactive groups . They are similar 
to the drugs in category (a) , however , in that they require 
metabolism by cytochrome P450 to exert their full inhibitory 
effects and this metabolism is thought to yield an intermediate or 
product which forms an inactive complex with cytochrome P450 
(Testa and Jenner 1981 ) . They differ from the drugs in category 
(a) , however , in that the complexes thus formed are reversible 
and do not lead to degradation of cytochrome P450 . 
Triacetyloleadcmycin ( TAO ) and isosafrole also appear to form 
complexes with cytochrome P450 but in addition induce specific 
cytochrome P450 isozymes and , thus , isosafrole both induces and 
forms an inactive complex with cytochrome P450d ( Levin et al 
1980) and TAO both induces cytochrome P450-TAO and forms an
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inactive complex with this and other cytochrome P450 isozymes 
(Pessayre et al 1981 ) and so the overall effect of these inducing 
agents is time dependent inhibition of their specifically induced 
isozymes .
1.10(c) Xenobiotics which alter rates of haem synthesis and 
degradation .
The best documented of these agents is cobalt which both 
inhibits 6-aminolaevulinic acid synthase and induces haem 
oxygenase ( Drummond and Kappas 1982 ) whereas the well documented 
hepatotoxic effects of carbon tetrachloride are thought to be 
mediated by an increase in the formation of lipid peroxides 
(Davies et al 1985 ) . As stated in the previous sections the 
classic inducing agents , phenobarbitone and 3-methylcholanthrene 
also appear to induce haem oxygenase and/or uncouple the 
cytochrome P450 system leading to an increase in the production of 
hydrogen peroxide and this may contribute to the increase in 
turnover rates of the isozymes induced by these agents .
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1.11 PHYSIOLOGICAL REGULATION OF HEPATIC BICTRANSPORMATIQN
1.11(a) Hormonal control of hepatic enzyme activity
Hormonal fluctuation has been shown to be one of the major 
mechanisms by which the body can physiologically regulate hepatic 
enzyme activity . Steroids have been shown to be the natural 
substrates for the hepatic monooxygenases ( Kuntzman et al 1964 ) 
and this regulation , therefore , may constitute a major pathway 
of hormonal homeostasis . The major hormones which have been found 
to influence enzyme activity are : (1) the sex steroids : 
testosterone and oestrogen ; (2) the pituitary hormones acting 
both directly at the level of the liver or indirectly by 
stimulating other endocrine organs ; (3) thyroxine ; (4) insulin ; 
(5) glucocorticosteroids ; (6) glucagon and (7) catecholamines . 
The regulation of enzyme activity by each of these agents will be 
dealt with under separate headings .
The metabolism of type 1 substrates ( including steroids ) is 
sensitive to hormonal regulation by the above agents . The 
metabolism of type 11 substrates , however , is relatively 
refractory to hormonal changes .
1.11(b) Sexual differentiation of enzyme activity .
Short term fluctuation in the level of any particular hormone 
can occur in response to a number of physiological stimuli and 
constitutes an important mechanism of body homeostasis . In
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addition , hormone levels are subject to long term ( fixed ) 
variation which can occur in pathological states such as 
hyperthyroidism and diabetes and under physiological conditions is 
dependent upon the age and sex of the animal . It follows , 
therefore , that the hepatic monooxygenases , under the influence 
of these hormones , are also subject to fixed variation of their 
activities depending upon the age and sex of the animal . The 
onset of sexually differentiated enzyme activity occurs at puberty 
and this corresponds to sexual differentiation of pituitary 
hormone release . In the rat this sexual differentiation of enzyme 
activity is marked and has been well documented for both 
xenobiotics and steroids as shown in table 2 .
Type 1 substrates e.g. hexobarbitone and aminopyrine , have 
been found to be more susceptible to hormonal regulation than type 
2 substrates e.g. aniline and zoxazolamine , and it follows , 
therefore , that sexually differentiation in metabolism tends to 
occur with type 1 substrates under the influence of sexually 
differentiated hormone profiles whereas the metabolism of type 2 
substrates tends to occur independently of the age or sex of the 
animal .
In addition to the rat , sexual differentiation of hepatic 
monooxygenase activity also occurs in the mouse and in the hamster 
. Both of these species exhibit sex-dependent metabolism of 
steroids , however , in both cases , the sexual differentiation 
appears to be in the opposite direction to that seen in the rat in 
that steroid hydroxylases are more active in the female than in 
the male of the species ( Niedermayer and Shapiro 1988 ; Miura et
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Substrate Differentiation Reference
Xenobiotics
Hexobarbital oxidase
Aminopyrine-N-demethylase
Ethylirorphine-N-demethylase
Lignocaine-N-deethylase
]jnipramine-N-demethylase
Aniline hydroxylase
Zoxazolamine hydroxylase
male > female
male > female
male > female
male > female
male > female
male = female
male - female
Kuntzman et al 1964 
Schenkman et al 1967 
Rumbaugh et al 1984 
Skett et al 1980a 
Skett et al 1980a 
Kato and Gillette 1965b 
Kato and Gillette 1965b
Steroids
4-Androstene-3,17-dione/ 
testosterme :
(a) 5a-reductase
3 a-hydroxysteroid- 
dehydrogenase 
17 a-hydroxysteroid- 
dehydrogenase 
6p-hydroxylase 
16a-hydroxylase 
7 a-hydroxylase
(b)
(c)
(d)
(e)
(f)
5a-Androstane-3,17-diol :
(a) 2a-hydroxylase
(b) 7a-hydroxylase
(c) 18-hydroxylase
Steroid sulphate-15f3- 
hydroxylase
Cortisol 200-hydroxylase 
Cholesterol 7a-hydroxylase
male < female Gustafsson and Stenberg 1974a 
male = female 11 11
male > female 
male > female 
male > female 
male = female
male > female 
male > female 
male > female
male < female
male > female 
male = female
Gustafsson and Ingelman-
-Sundberg 1974 
Denef and De Moor 1968 
Einarsson et al 1973
Table 2 : Examples of substrates which are metabolised by the rat hepatic 
monooxygenase system and illustration of sex differentiation of the 
metabolism of seme xenobiotics and steroids .
al 1988 ) . Sex differences in metabolism also occur in the human 
and show similar differences to those seen in the rat although 
less marked ( Pfaffenberg and Homing 1977 ) .
The sex differences in hepatic monooxygenase activity in the 
rat have been postulated to be due to 3 factors (a) differences in 
the constitutive cytochrome P450 isozymes ( Kamataki et al 1983 );
(b) greater substrate affinity for cytochrome P450 in the male 
than in female ( Schenkman et al 1967b ) ; (c) slower turnover of 
cytochrome P450 in the male than in the female ( Levin et al 
1974). Recent reports have indicated that sex differences also 
exist in the lipid component of the hepatic monooxygenase system 
(section 1.3(a) ) . It has been shewn that the activity of a 
purified cytochrome P450 isozyme which catalyses N-demethylaticn 
of lignocaine and which is thought to correspond to the male- 
specific cytochrome P450 isozyme ( P450 2c , P450 OT-A , P450h , 
P450 RLM5 or P450 PB-2a : table 1 ) , is much higher when 
reconstituted in a system composed of male derived lipids than 
when reconstituted with female derived lipids ( Meftah and Skett 
1987 ) . This may indicate that differences in the lipid 
environment of the cytochrome P450 may be a fourth factor which 
contributes to the overall sexual differentiation of the hepatic 
monooxygenase system .
1.11(c) Imprinting .
The sexual differentiation of both hormone profiles and 
hepatic enzyme activity in the rat do not occur until puberty .
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Few sex differences exist in the genane except for the Y/X 
chranoscme , the major function of which is to determine 
testicular / ovarian differentiation , and it is the differences 
in the secretory products of the gonads which are responsible for 
sexual dimorphism ( Bardin and Catterall 1981 ) . Neonatal 
exposure to androgens imprints both the central nervous system 
( MacLusky and Naftolin 1981 ) and the metabolising enzymes of the 
liver ( Denef and De Moore 1968 ) to produce 1'maleness " in the 
postpubertal animal . Imprinting of the hypothalamus results in 
sexual differentiation of hormone release profiles fncm the 
pituitary and this results in sexual differentiation of hepatic 
enzyme activity .
The presence of oestrogen does not appear to imprint sexual 
dimorphism at this levels although an exception may be the 
difference in the secretory patterns of thyroxine ( which is under 
the direct control of the pituitary gland ) . The higher plasma 
levels of thyroxine in the female appear to be dependent upon 
oestrogen but this difference can be reversed , at least in part, 
by oestrogen administration to the adult male ( Dcnda et al 1987 ) 
and so does not appear to be due to imprinting of the pituitary 
gland/hypothalamus by neonatal oestrogen .
The full male pattern of postpubertal hepatic activity in the 
rat is determined by direct imprinting by neonatal testosterone at 
the level of the hypothalamus and maintenance of a male pattern 
hormone profile by postpubertal testosterone .
In addition it was found that neonatal testosterone was 
necessary for testosterone responsiveness in the postpubertal male
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rat ( Gustafsson and Stenberg 1974b ) and females were reported to 
be unresponsive to postpubertal increase in their testosterone 
levels ( Bitar and Shapiro 1987 ) . This further implies that 
imprinting of the hypothalamus by neonatal testosterone is 
necessary for postpubertal maintenance of the male hormone profile 
by testosterone . Powell-Jones et al ( 1981 ) and Sloop et al 
( 1983 ) , however , postulated that neonatal testosterone also 
had an imprinting effect upon the liver to permanently program 
higher levels of the oestrogen-binding protein HCEA ( also known 
as HASP or male SBP : section 1.11(e) ) in the postpubertal male 
rat than in the postpubertal female rat . It is conceivable , 
therefore , that neonatal testosterone imprints the male rat liver 
in a similar manner to that proposed for the oestrogen-binding 
protein , HCLA . The absence of hepatic androgen receptors , 
therefore , m y  be an alternative explanation for the lack of 
effect of testosterone in the postpubertal female rat ( Bitar and 
Shapiro 1987 ) and in the neonatally castrated , postpubertal male 
rat ( Gustafsson and Stenberg 1974b ) .
1.11(d) Testosterone .
The precise role of testosterone in the postpubertal 
regulation of hepatic monooxygenase activity is unclear . Although 
castration in the male rat leads to increase in the activity of 
hepatic steroid 5a reductase ( normally higher in the female ) and 
this effect can be reversed by testosterone ( Yates et al 1958 ) . 
Kramer et al ( 1975 ) reported that the masculinising effect of
-43-
testosterone upon ethylmorphine metabolism did not occur in the 
absence of the pituitary gland . Other workers , however , have 
reported that hypcphysectany is unable to mimic the abolition of 
the male pattern of steroid metabolism produced by castration 
( Lax et al 1974 ) . This may imply that testosterone has seme 
pituitary-independent effects at the levels of the liver . Skett 
( 1978 ) , however , found that although hypcphysectany had no 
effect upon steroid metabolism in the male rat , hypcphysectany of 
female rats resulted in masculinisaticn of steroid metabolism . It 
is new thought , therefore , that the effects of testosterone upon 
hepatic monooxygenase activity are due to inhibition of the 
synthesis or release of a pituitary "feminising factor" ( section 
1.11(f) ) and testosterone has little direct at the levels of the 
liver .
Androgen receptors , however , are present in the liver 
( Sarkar et al 1987 ) although their physiological significance is 
obscure . The levels of the hepatic androgen receptors are under 
the control of the Tfm locus . In mice deficient in the locus 
(Tfm/Y) the androgen receptor is absent fron the liver and 
testosterone administration fails to masculinise the metabolism of 
ethylmorphine ( Brown et al 1978 ) . Similarly the levels of a 
hepatic androgen-binding protein have been correlated to the 
ability of testosterone to produce a male pattern of xendbiotic 
metabolism in rats ( Rumbaugh et al 1984 ) . These findings imply 
that testosterone does have sane direct effects at the level of 
the liver in addition to suppressing the synthesis or release of 
sane pituitary factor .
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The sex differences in hepatic monooxygenase activity 
correlate with differences in the levels of the constitutive 
cytochrome P450 isozymes ( Kamataki et al 1983 ) . Sex differences 
also exist in the binding of type 1 substrates to cytochrome P450 
in that binding is twice as high in the male rat than in the 
female rat ( Schenkman et al 1967b ) and in the ratio of fast to 
slew turnover types of cytochrome P450 in that male rats have a 
higher ratio of slew turnover cytochrome P450 which contributes to 
the higher activities of the cytochrome P450 isozymes in the male 
than in the female ( Levin et al 1974 ) . The administration of 
testosterone increases the affinity of type 1 xenbbiotic 
substrates for their respective cytochrome P450 isozymes but has 
little effect upon cytochrome P450 levels ( Kato and Qnoda 1970 ). 
This may imply that a direct effect of testosterone at the level 
of the liver and mediated by the androgen receptor , is an 
increase in the affinity of the substrate for cytochrome P450 
whereas the indirect effects of testosterone via the pituitary 
gland , are necessary for the maintenance of the levels of 
constitutive cytochrome P450 isozymes and their turnover rates .
1.11(e) Oestrogen .
Physiological concentrations of oestrogen appear to have 
little direct effect at the level of the liver . Administration of 
oestrogens to male rats leads to feminisation of enzyme activity 
( Einarsscn et al 1973 ) . This effect , however , does not occur 
in the hypophysectcmised rat ( Gustafsson and Stenberg 1976 ) . It
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has been postulated , therefore , that the feminising effects of 
oestrogens in the male rat are due to an indirect effect at the 
level of the pituitary gland .
Oestrogen binding proteins , however , are present in the 
liver and appear to fall into two categories . Both male and 
female livers contain equal quantities of a classic oestrogen 
receptor ( Rumbaugh et al 1983 ) . In addition , a second 
oestrogen binding protein exists which is present at much higher 
concentrations in the male than in the female rat . This binding 
protein has been investigated by a number of workers and has been 
designated : HASP ( Lax 1987 ) ; HCLA ( Sloop et al 1983 ;
Pcwell-Jones et al 1981 ) and male SEP ( Powell-Jones 
et al 1980 ) . Another male-specific oestrogen binding protein , 
MEB may also be identical to the above but appears to differ from 
them in seme of its properties ( Rogerson and Eagon 1986 ) . These 
male-specific oestrogen binding proteins have been proposed to act 
as a sink for oestrogen by binding oestrogen and preventing its 
action at the oestrogen receptor ( Rumbaugh et al 1983 ) or 
alternatively may influence the translocation of the 
oestrogen/receptor complex into the nucleus ( Powell-Jcnes et al 
1980 ) . Little evidence exists , however , for a direct hepatic 
action of oestrogen , at physiological concentrations , in 
feminising hepatic monooxygenase activity and at physiological 
concentrations the receptors are thought to be non functioned 
( Lax 1987 ) . Inhibition of 30-bydroxysteroid dehydrogenase by 
oestrogen , however , can be blocked by tamoxifen which indicates 
that seme of the effects of oestrogen are mediated via an
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oestrogen receptor ( Lax et al 1980 ) . This study , however , did 
not indicate the site of the proposed oestrogen receptors . 
Oestrogen receptors are present in the pituitary and are thought 
to be involved in the oestrogen-mediated alteration of pituitary 
function ( Lax et al 1983 ) . This may be the mechanism , 
therefore , by which tamoxifen prevents the oestrogen-mediated 
inhibition of 30-hydroxysteroid dehydrogenase activity rather than 
by blocking hepatic oestrogen receptors . Pharmacological levels 
of oestrogen , however , do have a direct effect at the level of 
the liver , presumably via the oestrogen receptor , and produce 
masculinisaticn of steroid metabolism ( Lax 1987 ) .
1.11(f) Pituitary hormones .
Hie anterior pituitary gland is responsible for the synthesis 
and secretion of a number of hormones . Follicle-stimulating 
hormone (FSH) ; luteinising hormone (LH) ; thyroid stimulating 
hormone (TSH) and adrenocorticotrqphin (ACTH) all act on 
peripheral endocrine organs to cause the secondary release of 
their respective hormones . Growth hormone (GH) and prolactin 
(PEL) have direct effects upon target tissues . In addition , 
growth hormone may mediate indirect effects upon target tissues by 
stimulating the synthesis of sanatanedins ( section 1.16(e) ) .
The alteration of hepatic monooxygenase activity which accompanies 
hypcphysectany i.e. feminisation of hepatic monooxygenase activity 
in the male rat ( Skett et al 1980 ) and the masculinisaticn of 
hepatic monooxygenase activity in the female rat ( Skett 1978 )
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may be mediated by alteration in the levels of any one or a 
combination of the above or their respective peripheral hormones . 
The implantation of a pituitary gland under the kidney capsule in 
the hypcphysectcmised male or female rat was found to feminise 
hepatic monooxygenase activity regardless of the sex of the animal 
( Denef 1974 ) . In this model hypothalamic control of pituitary 
function is absent and so these results imply that the pituitary 
gland from either sex is capable of secreting a hormone ( or 
combination of hormones ) which feminises hepatic monoaxygenase 
activity however in the male rat the secretion of this pituitary 
fraction is suppressed by sane hypothalamic factor . This 
pituitary fraction was termed " the feminising factor " and the 
inhibitory male-specific hypothalamic factor as 11 feminostatin " . 
It has be postulated that a specific centre in the hypothalamus is 
irreversibly imprinted at birth by neonatal testosterone and at 
puberty this centre is " turned on 11 in the male only and secretes 
"feminostatin" under the influence of testosterone which inhibits 
the pituitary secretion of " feminising factor " . In the female 
the absence of " feminostatin " results in unopposed secretion of 
" feminising factor " ( Gustafsson et al 1979 ; Gustafsson et al 
1981 ) . Much work has been carried out to establish the hormonal 
nature of the " feminising factor " . Both IH and ESH increase 
ethylmorphine-N-demethylase activity in the castrated rat 
indicating a ncn-gonadal mode of action ( Schreifers et al 1975 ). 
This increase in ethylmorphine metabolism , however , 
represents masculinisation rather than feminisation and neither 
ESH or LH , therefore , is likely to be the feminising factor
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although a role in the pituitary control of hepatic metabolising 
enzyme activity cannot be ruled out . Implantation of a pituitary 
mairmotrophic tumour which secreted ACEH , GH and PEL inhibited 
xenbbiotic metabolism ( Wilson 1968 ) however treatment of rats 
with 2-brcmo-a-ergocriptine which inhibits the release of ERL from 
the pituitary gland , had no influence upon the feminising effects 
of an ectopic pituitary on steroid or xenobiotic metabolism 
( Skett et al 1978 ) . It seems unlikely , therefore , that PEL is 
the feminising factor . Injection of GH inhibited the metabolism 
of ethylmorphine and aminopyrine ( Wilson 1970 ) and a pituitary 
marrmotrophic tumour which secreted GH and PEL but very little ACTH 
had the same effect upon steroid metabolism as that secreting GH , 
PEL and A d H  ( Eneroth et al 1976 ) . In addition purification of 
the 11 feminising factor " from rat pituitary has lead to a product 
identical to GH ( Mode et al 1983 ) and so the identity of the 
11 feminising factor " is now assumed to by GH . Furthermore , the 
feminising effects of GH on both xenbbiotic and steroid metabolism 
has been confirmed by Kramer and Colby ( 1976 ) . Injection of 
ACTH , however , does result in a sex-dependent / GH-independent 
inhibition of the metabolism of hexbbarbitone and aminopyrine in 
the male rat ( Kato and Gillette 1965a ) and may augment the 
action of GH in feminising hepatic monooxygenase activity .
1.11(g) Growth hormone .
Although growth hormone is secreted by the pituitary in both 
males and females there is a sex difference in the secretory
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dynamics . In the female rat GH levels are constant whereas male 
rats exhibit large peaks in plasma levels with intervening 
undetectable levels of the hormone ( Eden 1979 ) . The pattern of 
GH secretion is now assumed to be the regulator of hepatic 
monooxygenase activity in the rat ( Mode et al 1982 ) and levels 
of steroid 16a hydroxylase have been directly correlated to 
changes in the diurnal pattern of GH secretion i.e. feminisaticn 
( decrease ) or masculinisaticn ( increase ) ( Morgan et al 
1985b). Similarly constant infusion of growth hormone ,
mimicking female secretory dynamics , results in complete
feminisaticn of 3a hydroxysteroid dehydrogenase and steroid 5a 
reductase activities in male rats ( Lax et al 1983 ) . The sex 
differences in the secretory dynamics are neonatally imprinted by 
testosterone ( Janssen et al 1984 ) and the resulting pulsatile 
release of GH in the male has be postulated to be due to 
interaction between two pituitary factors : growth hormone 
releasing hormone ( GHRH ) and growth hormone release-inhibiting
hormone (GHRIH or somatostatin ) (Weiss et al 1987 ) . In an in
vivo study , lesions of the paraventricular hypothalamus or an 
injection of somatostatin antiserum led to a drop in somatostatin 
release in the male and this resulted in a change of the GH 
secretory dynamics to a female pattern concomitant with 
feminisaticn of hepatic monooxygenase activity ( Gustafsson et al 
1983 ) . If (31 is assumed to be the 11 feminising factor 11 , 
therefore , somatostatin appears to correspond to " feminostatin".
The inhibitory effects of GH upon xenobiotic metabolism may be
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mediated by a reduction in the flow of reducing equivalents to 
cytochrome P450 ( Wilson and Frobman 1974 ) or by reducing levels 
of cytochrome P450 ( Wilson and Spelsberg 1976 ) . Later work , 
however , has shewn that the GH-mediated feminisaticn of the 
hepatic monooxygenase system was due to a specific decrease in the 
synthesis of the male specific cytochrome P450 probably regulated 
at the level of translation ( Vockentanz and Virgo 1985 ) and that 
the higher level of steroid 150 hydroxylase activity in the female 
than in the male was due to the selective induction of the 
female-specif ic cytochrome P450 by GH at a step which appears to 
precede translation ( MacGeoch et al 1987 ) . Thus it appears that 
the alteration of hepatic monooxygenase activity may reflect 
differential changes in the content of specific cytochrome P450 
isozymes .
Hie major problem which arises when studying the effects of 
GH in vivo are the complex interactions which exist between the 
components of the endocrine system . Diabetes is associated with 
elevation of somatostatin and suppression of GH release 
( Tannenbaum 1981 ) and thyroxine stimulates the synthesis of GH 
by a direct action at the level of the pituitary gland ( Mirell et 
al 1987 ; Santos et al 1987 ) . Similarly hypothyroidism , which 
may occur secondary to diabetes , leads to suppression of <31 
release ( Ortiz-Caro et al 1984 ; Shapiro 1983 ) . GH may also 
attenuate the effects of insulin by suppression of the affinity of 
hepatic insulin receptors ( Davidson and Melmed 1983 ) . When 
isolated hepatocytes were incubated with GH in an attempt to 
examine the direct effects of GH at the level of the liver ,
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steroid metabolism was unaffected ( P. Gulati : personal 
connunicaticn ) . This contrasts markedly with the feminising 
effects seen in vivo and indicates that feminisaticn of the 
hepatic roonooxygenases is a complex interactive process which may 
involve more than one component of the endocrine system .
1.11(h) Thyroxine
Thyroxine is subject to fixed , sexually differentiated 
variation in its secretion . Females have higher plasma levels of 
triiodothyronine ( the active form of thyroxine ) than do males 
and also have a higher number of pituitary triiodothyronine 
receptors ( through which triiodothyronine negatively regulates 
its own production by attenuating the production of TSH ) . This 
sexually differentiated secretory pattern may be due to higher 
oestrogen levels in females than in males as oestrogen 
administration to male rats elevates the number of pituitary 
triiodothyronine receptors ( Donda et al 1987 ) . The effects of 
thyroxine upon the activity of the hepatic monooxygenases are also 
sex dependent . Administration of thyroxine to male rats 
( hyperthyroidism ) impairs the metabolism of the type 1 
substrates , hexobarbitone and aminopyrine and slightly enhances 
the metabolism of the type 2 substrate , aniline ( Kato and 
Gillette 1965a ) . It also inhibits the hydroxylaticn of 
testosterone ( Kato et al 1970 ) . Inhibition of both type 1 
xenbbiotic metabolism and the hydroxylaticn of steroids is 
dependent upon sex and neither occur in the female rat . These
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effects , however , cannot be fully explained by the sexually 
differentiated secretory pattern of thyroxine and paradoxically 
thyroidectomy also inhibits the hydroxylation of testosterone 
( Kato et al 1970 ) . These heterologous effects upon hepatic 
mcnoaxygenase activity similarly cannot be adequately explained 
purely in terms of an alteration of the levels of gonadal or 
pituitary hormones although the inhibitory effects of thyroxine 
upon hepatic monooxygenase activity are abolished by castration 
( Kato and Gillette 1965a ) and thyroxine stimulates the release 
of IH ( Wang et al 1987 ) and the synthesis of GH ( Mirell et al 
1987 ; Santos et al 1987 ) in the pituitary gland . Thyroxine may, 
however , have a permissive effect upon the hepatic actions of 
testosterone ( section 1 .1 1(d) ) by altering the concentrations of 
the androgen receptor ( Lax et al 1979 ) and this may explain the 
lowering of the substrate affinity which accompanies the 
inhibition of hepatic monooxygenase activity in the 
thyroidectcmised rat ( Kato et al 1970 ) . One possible 
explanation for the heterologous effects of thyroxine i.e. 
inhibitory effects upon hepatic monooxygenase activity in both 
hyperthyroid and thyroidectcmised rats , is that physiological 
levels of thyroid hormones induce hepatic 6-aminolaevulinate 
synthase whereas higher concentrations of thyroxine induce haem 
oxygenase ( smith and Drummond 1988 ) . Inhibition of enzyme 
activity in the thyroidectcmised rat , therefore , may be due to a 
decrease in cytochrome P450 synthesis whereas inhibition in the 
hyperthyroid rat may be due to an increase in cytochrome P450 
degradation .
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In addition to any direct effects exerted at the level of the 
liver and effects produced by alteration of pituitary function , 
thyroxine may also produce effects upon enzyme activity by 
altering pancreatic function . Close correlation exists between 
pancreatic function and thyroxine secretion and thyroxine 
stimulates the release of glucagon from pancreatic a cells which 
then stimulates the pancreatic 0 cells and produces a secondary 
rise in insulin secretion ( Wolf and Eisenstein 1981 ) . 
Furthermore hypothyroidism attenuates the cellular response to 
insulin by reducing insulin binding and receptor number ( Sterman 
et al 1983 ) .
l.ll(i) Insulin .
Acute diabetes or starvation , both of which result in a 
lowering of plasma insulin have both a sex-dependent and a 
sex-independent effect upon hepatic monooxygenases .
The sexually differentiated enzymes which metabolise type 1 
substrates ( including steroids ) are inhibited in the male rat 
but stimulated in the female rat . This represents a loss of 
sexual differentiation ( Kato and Gillette 1965a ; Kato and 
Gillette 1965b ) and this effect can be reversed by insulin 
administration ( Weiner et al 1972a ; Reinke et al 1978 ) . The 
ncn-sexually differentiated enzymes which metabolise type 2 
substrates are stimulated to an equal extent in both male and 
female rats ( Past and Cook 1982 ; Past and Cook 1983 ) . 
Similarly steroid 7a hydroxylase activity is also stimulated by
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diabetes in the male rat and this effect can be reversed by 
insulin administration ( Reinke et al 1978 ) .
The increase in the metabolism of aniline ( a type 2 
substrate ) in both male and female rats has been correlated 
with the appearance of a diabetes-specific cytochrome P450 which 
metabolises aniline ( Past and Cook 1982 ; Past and Cook 1983 ; 
Eavreau et al 1987 ; Bellward et al 1988 ) . The decrease in the 
activity of steroid 16a hydroxylase activity in the male rat has 
been correlated with loss of the male-specific cytochrome P450 
(P450 2c , P450 UT-A , P450h , P450 RIM5 or P450 PB-2a : table 1 ) 
( Eavreau and Schenkman 1987 ) and it has been postulated that the 
changes in hepatic monooxygenase activity caused by diabetes 
reflect differential changes in the specific cytochrome P450 
isozyme levels ( Past and Cook 1980 ) . This may reflect a direct 
effect of insulin at the level of the hepatocyte and in the 
isolated rat hepatocyte it has been found that insulin does have a 
direct stimulatory effect upon steroid metabolism producing two 
peaks of activity at half an hour and 24 hours . These effects , 
however , do not appear to be due to protein synthesis as 
evaluated by measuring whole cell cytochrome P450 levels , but may 
indicate a direct effect at the level of the cytochrome P450 
( Hussin and Skett 1987 ) . The effects of insulin in hepatocytes, 
however , differ from those that would have been expected from 
the findings of previous in vivo studies in that the effects of 
insulin are not specific for particular isozymes and this may 
indicate that the effects of insulin in vivo are due , at least in 
part , to effects upon the release of hormones from other
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endocrine organs .
Insulin has many effects upon other hormones and similarly 
diabetes results in changes in the release patterns of many 
hormones in addition to a fall in insulin levels . The feminising 
effects of diabetes upon the activity of the hepatic 
monooxygenases in the male rat can be partially reversed by 
administration of testosterone ( Skett et al 1984 ) which implies 
that the effects of insulin are not mediated directly at the 
levels of the liver but are due to alterations in testosterone 
secretion . Testosterone secretion , however , is not consistently 
lowered in diabetes and diabetes , therefore , may be producing 
its effects by altering pituitary function ( Kato and Gillette 
1965a ; Skett et al 1984 ) . Diabetes does , however , result in a 
decrease in the spectral change associated with the binding of the 
substrate to cytochrome P450 which may represent impairment of an 
androgen-dependent regulatory mechanism for binding due to 
inhibition of testosterone secretion . Diabetes also suppresses 
plasma levels of thyroxine by inhibiting its secretion 
( Ortiz-Caro et al 1984 ) and the elevated levels of glucagon in 
diabetes leads to a secondary loss in hepatic triiodothyronine 
receptors ( Dillman et al 1978 ; Wiersinga et al 1982 ; Jolin 
1987 ) which further suppresses the effects of thyroxine .
Diabetes also suppresses pituitary release of GH which may occur 
secondary to a rise in somatostatin ( Tannenbaum 1981 ) or to 
suppression of thyroxine levels ( Ortiz-Caro et al 1984 ) and this 
is accompanied by a decrease in the ability of the liver to 
synthesise somatomedin c in response to GH ( Scott and Baxter
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1986 ) ( see section 1.16(e) ) . The in vivo effects of 
insulin/diabetes upon hepatic monooxygenase activity could , 
therefore , be mediated by the secondary alteration in the levels 
of these other hormones in addition to any direct effects of 
insulin at the level of the liver . In addition , Bellward et al 
( 1988 ) reported that the levels of a diabetes-induced cytochrome 
P450 isozyme which metabolises aniline , cytochrome P450j 
( table 1 ) , in spontaneously diabetic rats did not correlate 
with the plasma levels of insulin but did correlate with the 
levels of ketone bodies . The changes in hepatic monooxygenase 
activity in diabetes , therefore , may occur , at least in part , 
by impairment of cellular processes in addition to a fall in 
insulin levels and effects upon other endocrine organs .
Hie effects of acute diabetes upon hepatic monooxygenase 
activity are diminished in chronically diabetic rats ( Skett and 
Joels 1985 ) and , similarly , hepatocytes which have been 
isolated fron chronically diabetic rats are refractory to the 
direct stimulatory effects of insulin ( Hussin and Skett 1988 ) .
l.ll(j) Glucocorticosteroids .
Glucocorticosteroids are synthesised and released fron the 
adrenal cortex under the control of adrenocorticotrcphin ( ACTH ). 
Their effects upon hepatic monooxygenase activity are complex 
and in general the natural glucocorticosteroids inhibit drug 
metabolism whereas synthetic glucocorticosteroids induce 
metabolism . Dexamethasone has a similar enzyme induction profile
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to FCN ( see section 1.9(a) ) . This is not thought to be due to 
its steroidal properties ( Skett 1987 ) but it may be acting in a 
similar manner to the classic inducing agents as it has been shewn 
that the ENA fragments which are enhanced in their activity by the 
presence of 3-methylcholanthnene are similar in base structure to 
the fragments which respond to induction by glucocorticosteroids 
( Fujisawa-Sehara et al 1987 ) . Adrenalectomy also decreases the 
metabolism of type 1 substrates but has no effect upon the 
metabolism of type 2 substrates in the male rat . This represents 
a feminisaticn of metabolism in the male rat and adrenalectomy has 
no effect upon the metabolism of either type 1 or type 2 
substrates in the female rat ( Kato and Gillette 1965a ) . Hie 
decrease in the metabolism of type 1 substrates may be due to a 
decrease in the affinity of the substrate for cytochrome P450 
rather than a decrease in cytochrome P450 levels as adrenalectomy 
decreases the magnitude of the spectral change associated with the 
binding of type 1 substrates to the cytochrome P450 ( Kato et al 
1971 ) . Adrenalectomy also inhibits the activities of steroid 3a- 
hydroxysteroid dehydrogenase and 17p-hydroxysteroid dehydrogenase 
tut has no effect on the activity of 5a reductase . These enzymes 
do not contain cytochrome P450 as an integral component ( see 
section 1.4 ) and unlike the effects of adrenalectomy upon the 
metabolism of type 1 xenobiotics , these enzymes are inhibited to 
an equal extent in rats of both sexes ( Lax et al 1979 ) . One 
possible mechanism by which adrenalectomy might lead to a decrease 
in monooxygenase activity is by the induction of haem oxygenase as 
has been reported in the chick embryo liver ( Sassa et al 1980 ) .
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Glucxxx>rticosteroids reduce hepatic insulin binding and the 
number of hepatic insulin receptors ( Sterman et al 1983 ) and 
also stimulate the synthesis of GH in the pituitary gland ( Gick 
and Bancroft 1987 ) . Sane of the effects of glucocorticosteroids/ 
adrenalectany upon hepatic monooxygenase activity , therefore , 
may be produced by a secondary alterations in the levels of these 
other hormones .
l.ll(k) Glucagon .
In vivo administration of glucagon to rats increases the 
hexbbarbitcne sleeping time indicating that glucagon inhibits the 
activity of the hepatic mcnooxygenases ( Weiner et al 1972a ) . 
Addition of glucagon to isolated rat hepatocytes in culture 
inhibits the metabolism of androstenedicne in a nonspecific manner 
and does not appear to have a direct feminising effect upon 
steroid metabolism . This effect of glucagon is maximal at 
physiological concentrations of glucagon ( 10~8M ) but is lost at 
supraphysiological concentrations indicating that the inhibitory 
effects of glucagon upon hepatic monooxygenase activity are dose 
dependent ( Hussin et al 1988 ) . Glucagon has been reported to 
increase cell autophagy in the liver and thus one of its 
mechanisms may include changes in lysosomal fragility and increase 
in the proteolytic breakdown of the microsomal proteinaceous 
components ( Deter and DeDuve 1967 ) .
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1.11(1) Catecholamines
Multiple injections of noradrenaline into rats inhibit the 
metabolism of hexdbarbitone and aminopyrine ( Dixon et al 1964 ) 
and multiple injections of adrenaline inhibit the metabolism of 
bexobarbitcne and chlorpranazine ( Pouts 1962 ) . All of the 
substrates used in the above studies are type 1 substrates and the 
inhibitory effects of catecholamines appear to be specific for 
type 1 substrates . In vivo administration of catecholamines have 
no effect upon the metabolism of type 2 substrates ( Kato and 
Gillette 1965a ) . The inhibitory effects of the catecholamines 
appear to be sex-dependent and no inhibitory effects upon either 
type 1 or type 2 substrates have been noted in the female rat 
( Kato and Gillette 1965a ) .
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1.12 INTRACELLULAR SECOND MESSENGERS FOR H3RM3NAL TRANSDUCTION
The two major second messenger systems in target cells are 
(a) adenylate cyclase activation and cyclic adenosine 3 17 5' 
-monophosphate ( cyclic AMP ) generation and (b) phosphatidyl- 
inositol hydrolysis which leads to inositol 1,4,5-trisphosphate 
(IP3 ) and diacylglycerol ( DAG ) generation . The ultimate result 
of the generation of any of these second messengers is generally 
thought to be due to the activation of their respective protein 
kinases and the phosphorylation of intracellular proteins . 
Hydrolysis of inositol phospholipids also leads to an increase in 
the release of arachidonic acid and an increase in the 
concentration of another nucleotide second messenger , cyclic 
guanosine 3' ,5'-monGphospate ( cyclic Q4P ) which may also 
contribute to the intracellular effects of hormones which 
stimulate this pathway .
1.12(a) Cyclic AMP .
Cyclic AMP was first discovered by Sutherland and Rail in 
1960 and is produced within the cell from adenosine 
51-triphosphate ( ATP ) in the presence of magnesium ions by the 
action of the enzyme adenylate cyclase . Adenylate cyclase is 
located in the plasma membrane of the cell and was originally 
thought to be composed of two components , namely a receptor for 
the hormone located on the extracellular surface of the membrane 
and a catalytic unit located on the cytosolic side of the
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membrane, and it was proposed that the hormone receptor 
activated the catalytic unit by direct interaction ( Perkins 
1973). In 1971 , however , Rodbell et al found that guanosine 
triphosphate ( CTP ) was essential for the activation of the 
catalytic subunit by the receptor and , in 1975 , Rodbell and 
co-workers reported that hormone receptor binding enhanced this 
interaction . This led to the identification of a CTP binding 
protein as a component of adenylate cyclase in 1977 ( Pfeuffer 
1977 ) and it is now thought that the adenylate cyclase system 
consists of at least three separate canpcnents : the hormone 
receptor at the outer surface of the membrane , the catalytic 
subunit at the inner surface of the membrane and a CTP binding 
protein (N) which mediates the effects of hormones upon the 
catalytic subunit ( Rodbell 1980 ) . Later work has shewn that at 
least two different CTP binding proteins can act as transducers 
between the hormone receptor and the catalytic subunit . Ns is 
associated with hormone-induced stimulation of the catalytic 
subunit whereas Ni is associated with inhibition of the catalytic 
subunit ( Ross and Gilman 1980 ; Jakobs et al 1984 ) . Both of 
these proteins are composed of three non- identical subunits . Two 
of the subunits designated p and^appear to be identical in both Ns 
and Ni , however the a subunits vary in molecular size ( Houslay 
1984 ) .
In the resting state it is thought that the CTP binding 
proteins exist as aggregates with the receptors and are separated 
from the catalytic units ( Rodbell 1980 ) . When a stimulatory 
hormone binds to its receptor , CTP binds to the a subunit of Ns
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and causes it to dissociate f ran the p and # subunits . The a 
subunit of Ns bound to GTP then interacts with and activates the 
catalytic unit of adenylate cyclase ( Gilman 1984 ; Schramn and 
Selinger 1984 ) . Activity is terminated by the hydrolysis of the 
CTP to guanosine diphosphate ( GDP ) by an intrinsic GEPase 
(Jakobs et al 1984 ) .
The mechanism by which Ni mediates the effects of inhibitory 
hormones upon adenylate cyclase is less well understood . Hormone 
binding to the receptor results in the binding of CTP to the a 
subunit and its dissociation from the p and Y subunits as with Ns 
and Toro and Bimbaumer ( 1987 ) have proposed that in an 
analogous manner to Ns , the a subunit of Ni mediates the 
inhibitory effects of the hormone by interacting with the 
catalytic subunit . Other workers , however , have proposed that 
the p and # subunits of Ni and not the a subunit interact with the 
a subunit of Ns and thereby inhibit the catalytic subunit 
indirectly ( Cerione et al 1985 ; Hekman et al 1987 ) .
Cyclic AMP is thought to produce the majority of its effects 
in the cell by the activation of cyclic AMP-dependent protein 
kinase ( FKa ) . The elevation of cyclic AMP also activates a 
cyclic AMP phosphodiesterase ( Corbin et al 1985 ) , which then 
breaks down cyclic AMP to the inactive adenosine 51 -monophosphate 
( 5'-AMP ) and , therefore , terminates the signal . The sequence 
of events in the hormonally-stimulated generation of cyclic AMP 
and its subsequent degradation is shewn in figure 3 .
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Figure 3 : The sequence of events in hormonal stimulation of cyclic AMP 
generation and subsequent degradation , where s is the stimulatory hormone , 
i is the inhibitory hormone , Rs is the stimulatory hormone receptor and c 
is the catalytic subunit of adenylate cyclase . Other abbreviations are as 
follows : A3P ( adenosine 51 -triphosphate ) , cAMP ( adenosine 31,51 -cyclic 
monophosphate or cyclic AMP ) and 5'-AMP ( adenosine 51-monophosphate ) .
1.12(b) Cyclic AMP-dependent protein kinase
PKa is associated with the smooth and rough endoplasmic 
reticulum and also with ribosomes ( Jergil and Ohlsscn 1974 ) and 
it consists of two different types of subunit : a regulatory (R) 
subunit and a catalytic (C) subunit . It is activated by the 
dissociation of the two subunits and the release of the free C 
subunit ( Kumcn et al 1970 ) . The enzyme is not a single species 
but is a family of closely related enzymes with identical C groups 
but slightly differing R groups with regards to amino acid 
sequence ( Rbbinscn-Steiner et al 1984 ) . These enzymes are 
classified as either type 1 or type 2 depending upon their 
stability in the boloenzyme form . Type 1 enzymes are less stable 
as holoenzymes and dissociate in the presence of his tone or 
physiological concentrations of sodium chloride . They ,therefore, 
are less dependent upon cyclic AMP than are type 2 enzymes (Corbin 
et al 1975 ) . The liver contains both type 1 and type 2 protein 
kinases with a slightly greater proportion of type 1 .
The PKa holoenzyme exists as a quaternary aggregate composed 
of two R subunits and two C subunits ( Beavo et al 1975 ) and 
each of the two R subunits of the holoenzyme are able to bind two 
molecules of cyclic AMP ( four molecules bound in total ) at two 
distinct binding sites called site 1 and site 2 ( Beebe et al 
1986 ) . Both of the binding sites are found on the 
carboxy-terminal two thirds of the polypeptide chain and have 
differing cyclic AMP dissociation rates ( Doskeland 1978 ) . The 
binding of cyclic AMP to the two sites shews positive
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cocperativity ( Rbbinscn-Steiner and Corbin 1983 ) and this has 
been attributed to a tyrosine residue in site 2 , as substitution 
of this residue with phenylalanine leads to loss of the positive 
cooperativity ( Bubis et al 1988 ) . Binding of the C subunit to 
the R subunit in the holoenzyme occurs at a different site to the 
binding of cyclic AMP and it has been found that the R subunit is 
a substrate for the catalytic activity of the C subunit ( Corbin 
et al 1978 ) . First and Taylor ( 1988 ) reported that the 
phosphorylation of the serine residue at position 95 on the R 
subunit by the C subunit increases the affinity of the R subunit 
for the C subunit and postulated that this amino acid was the site 
of contact between the R and the C subunit and that the R subunit 
inhibits the catalytic activity of the C subunit in the holoenzyme 
by competing with the substrate for the active site of the C 
subunit . It has also been reported that the cysteine residues at 
position 97 in the R subunit and at position 199 in the C subunit 
form a disulphide linkage and that , as these positions coincide 
with the proposed linkage between the serine 95 and the active 
site of the C subunit , this disulphide bend may also contribute 
to the association of the two subunits in the holoenzyme ( First 
et al 1988 ) .
Cyclic AMP generated by the activation of adenylate cyclase , 
therefore , binds to the regulatory subunit of the PKa holoenzyme 
at four binding sites and induces seme conformational change 
which leads to the disruption of the bonds between the regulatory 
and the catalytic subunits and the dissociation of the holoenzyme 
to yield free catalytic subunits .
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1.12(c) Inositol phospholipid hydrolysis
The physiological role of inositol phospholipid hydrolysis in 
the intracellular transduction of hormones has only recently been 
realised . The ability of hormones to alter the composition 
of plasma membrane phosphoinos it ides , however , has been known 
for over twenty years following the work of Hokin and Hokin 
( 1953 ) who showed that acetylcholine was able to stimulate the 
rapid incorporation of (32P) into phosphatidylinositol ( PI ) and 
phosphatidic acid . It was not until 1975 , however , that 
Michell reported that this incorporation of (32P) was due to the 
hormonal stimulation of breakdown and resynthesis of inositol 
phospholipids ( PI turnover ) . This theory was later modified by 
Michell et al in 1981 when they reported that the breakdown of 
phosphatidylinositol 4,5-bisphosphate ( PIP2 ) was the 
primary event in hormonal effects and not PI breakdown and 
resynthesis and this was verified by Creba et al in 1983 . Two 
enzymes are known to mediate hydrolysis of PIP2 ( Irvine 1982a ) ; 
a phosphcmonoesterase cleaves the phosphate at position 5 to 
yield phosphatidylinositol 4-phosphate ( PIP ) and is important in 
the interconversion of phosphatidylinositols in the plasma 
membrane , the second is a phosphodiesterase known as 
phospholipase c which is activated by occupation of the hormone 
receptor . This enzyme hydrolyses PIP2 in the presence of calcium 
ions to produce two products : diacylglycerol ( DAG ) and inositol 
1,4,5, -trisphosphate ( rp3 ) which are thought to mediate the 
intracellular effects of hormone binding .
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Recent studies have shown that the activation of phospholipase 
c by hormone occupation of the receptor may be mediated via a CTP 
binding protein in a manner analogous to adenylate cyclase 
(Molski et al 1984 ; Qkajima and Ui 1984 ) and the presence of CTP 
analogues has been reported to lower the calcium requirement of 
phospholipase c and increase its activity at saturating 
concentrations of calcium ( Taylor and Exton 1987 ) . The nature 
of the postulated CTP binding protein is , however , unresolved 
and Bcnjanic et al ( 1987 ) have proposed that guanine nucleotide 
stimulation of PIP2 hydrolysis may be a nonspecific effect .
rP3 , produced by the hydrolysis of PIP2 , is released into 
the cytoplasm and is thought to mediate the mobilisation of 
intracellular calcium stores . DAG is insoluble in water and 
remains within the plasma membrane where it is thought to 
directly activate protein kinase c ( the mechanisms of each of 
these second messengers in producing their effects will be dealt 
with in greater detail under separate headings ) . rP3 is broken 
down to myo-inositol 1 ,4-bisphosphate by a specific 
phosphcmcnoesterase which exists predominantly in the plasma 
membrane ( Seyfred et al 1984 ) . Myo-inositol 1,4-bisphosphate is 
subsequently broken down to myo-inositol 1-phosphate and 
myo-inositol by two consecutive hydrolysis steps . DAG is 
metabolised to phosphatidic acid by the action of diacylglycerol 
kinase , the activity of which may by regulated by an endogenous 
inhibitor ( Jeng et al 1988 ) . This is then converted to PI in 
the endoplasmic reticulum by combination with inositol and is 
subsequently transported to the plasma membrane by a PI exchange
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protein . Resynthesis of PIP2 occurs by consecutive 
phosphorylation steps by the ATP-requiring enzymes : PI kinase and 
PIP kinase ( reviewed by Berridge 1981 ) . The sequence of events 
in hormonal stimulation of inositol phospholipid hydrolysis and 
subsequent resynthesis is shown in figure 4 .
1.12(d) Elevation of Intracellular free calcium .
The breakdown of inositol phospholipids has been linked to 
the elevation of intracellular free calcium from two main sources. 
An early effect is the mobilisation of calcium from intracellular 
calcium stores which appears to be mediated by IP3 . The main site 
of the calcium stores mobilised by IP3 is the endoplasmic 
reticulum ( Joseph and Williamson 1983 ; Burgess et al 1984 ; 
Joseph et al 1984 ; Thomas et al 1984 ) and a receptor for IP3 has 
been discovered in the permeabilised guinea pig hepatocyte which 
has been postulated to mediate the calcium icnophore-effects of 
TP3 ( Spat et al 1986 ) . This effect may also involve 
transduction via a CTP binding protein ( Mullaney et al 1987 ; 
Codina et al 1988 ) . Calcium can also be mobilised from the 
mitochondria ( Murphy et al 1980 ) and it has been proposed by 
Joseph and Williamson ( 1983 ) that , at lew calcium 
concentrations , calcium is mobilised predominantly from the 
endoplasmic reticulum whereas at high calcium concentrations it is 
mobilised predominantly from the mitochondria . Joseph and 
Williamson ( 1981 ) also reported that in addition to mobilisation 
of internal calcium stores from either the endoplasmic reticulum
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Figure 4 : The sequence of events in hormonal stimulation of inositol 
phospholipid hydrolysis and subsequent resynthesis , where s is the 
stimulatory hormone , and R is the hormone receptor . Other abbreviations 
are as follows : PLC ( phospholipase c ) , PIP2 ( phospatidylinositol 4,5- 
bisphosphate ) , PIP ( phosphatidylinositol 4-phosphate ) , PI 
( phosphatidylinositol ) , DAG ( diacyglycerol ) , IP3 ( inositol 1,4,5- 
trisphiosphate ) IP2 ( myo-inositol 1,4, -bisphosphate ) IP ( myo-inositol 
1-phosphate ) and PA ( phosphatidic acid ) .
or the mitochondria , inhibition of calcium efflux fran the cell 
by inhibition of the calcium efflux pump was another early event . 
The second major source of calcium is from the extracellular 
medium and influx of extracellular calcium occurs secondary to the 
mobilisation of calcium fran internal stores ( Mauger et al 1984). 
Hie precise mechanism of calcium influx is at present unknown 
tut it appears that increase in the permeability of the plasma 
membrane to calcium occurs independently of IP3 generation (
Joseph et al 1984 ) .
Sane workers have argued against a role of inositol 
phospholipid hydrolysis in elevation of intracellular calcium . In 
1982 , Prpic et al postulated that the breakdown of inositol 
phospholipids occurred too slowly to mediate the rapid elevation 
of intracellular free calcium and that inositol phospholipid 
hydrolysis may occur secondary to changes in intracellular 
calcium. Similarly the pborbol ester , pborbol myristate acetate 
( IMA ) was found to attenuate the effects of the calcium 
mobilising hormone , angiotensin II upon IP3 production tut to 
have no effects upon the calcium mobilising effects of the hormone 
(Johnson and Garrison 1987 ) . It has been calculated , however , 
that the increase in IP3 production necessary to elicit maximum 
cytosolic free calcium elevation is only 10-15% above control 
(Tbanas et al 1984 ) . Thus one explanation for the discrepancy 
noted above by Prpic et al (1982) is that although the maximum 
elevation of IP3 occurred at a later time point than calcium 
mobilisation , the increase in IP3 concentrations necessary to 
elicit maximum mobilisation of calcium i.e. 10-15% above basal
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levels was sufficiently rapid to account for calcium mobilisation. 
Similarly , although the angiotensin-mediated elevation of IP3 
concentrations was greatly attenuated by the presence of EMA in 
the study conducted by Johnson and Garrison (1987) , the levels of 
IP3 were still sufficient to elicit maximum mobilisation of 
calcium and it is now generally accepted that , although inositol 
phospholipid hydrolysis has a minimum requirement for calcium , it 
is not mediated by prior elevation of intracellular calcium and is 
a necessary prerequisite for calcium mobilisation to occur 
(Hxxnas et al 1983 ) although stimulation of calcium influx may be 
mediated by inositol phospholipid-independent mechanisms .
Following elevation of cytosolic free calcium the signal is 
terminated by the efflux of calcium fran the cell ( Williamson et 
al 1985 ) and by uptake into the mitochondria ( Nicchita and 
Williamson 1984 ) and the endoplasmic reticulum where its uptake 
and interned binding may be controlled in a similar manner to the 
uptake and binding of calcium to calciquestrin in the sarcoplasmic 
reticulum of muscle ( Damiano et al 1988 ) .
1.12(e) Calmodulin and calcium/calmodulin-dependent protein 
kinase .
Many of the effects of calcium in the cell occur following 
the binding of calcium to a calcium-binding protein known as 
calmodulin to form a calcium/calmodulin complex . In the absence 
of calcium , calmodulin is ccnformaticnally inactive . It is able 
to bind up to four calcium ions per molecule and this binding
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induces a conformational change in the molecule and allows it to 
interact with a number of intracellular receptor proteins ( Klee 
et al 1980 ) . A number of structural features of the receptor 
protein have been postulated to be necessary for the binding of 
the calcium/calmodulin complex , namely the ability to form an a 
helix ( Malencik and Anderson 1983 ) , clusters of basic residues 
and a hydrophobic region adjacent to the basic residues (Mallencik 
and Anderson 1982 ) . The first receptor protein discovered for 
the calcium/calmodulin complex was cyclic AMP phosphodiesterase 
(Cheung 1967 ) . The binding of the complex leads to activation of 
the enzyme and , since 1967 , calcium/calmodulin has been reported 
to activate many other cellular receptor proteins e.g. adenylate 
cyclase ( Katada et al 1987 ) . The activation of adenylate 
cyclase will lead indirectly to the activation of PKa by elevating 
cyclic AMP . The calcium/calmodulin complex has also been reported 
to directly activate a number of protein kinases . The first of 
these kinases to be discovered were myosin light chain kinase and 
phosphorylase kinase both of which have very narrow substrate 
specificities within the cell . Later work , however , has shown 
that calcium/calmodulin is able to activate a specific 
calcium/calmodulin-dependent protein kinase which has a much 
broader substrate specificity and is thought to mediate many of 
the actions of calcium within the cell ( Bennett et al 1983 ;
Naim et al 1985 ) .
Hie enzyme is present mainly in brain tissue but is also 
found in other organs and is composed of two different isozymes : 
a ( Mr 50.000) and p/p1 ( Mr 58,000-60,000 ) ( MoGuiness et al
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1985 ) . The amino acid sequences of both of these isozymes have 
been elucidated ( Hanley et al 1987 , Bennett and Kennedy 1987 ) 
and they have been reported to be very similar in structure and 
function .
The protein kinase isozymes appear to exist as aggregates of 
twelve kinase molecules consisting of 9 a isozymes and 3 p/p' 
isozymes ( Bennett et al 1983 ) arranged as two hexameric rings 
stacked one above the other ( Woodgett et al 1983 ) .
The calcium/calmodulin-dependent protein kinase differs from 
PKa in that the inhibition of the kinase in its ncn-activated 
state is intrinsic to the same molecule that contains the 
catalytic site and is not mediated by a separate regulatory 
protein ( Payne et al 1988 ) .
Calcium/calmodulin binding proteins are also found in the 
nucleus of hepatocytes and although not bound directly to ENA 
itself they are associated with active ENA and may regulate its 
function by seme mechanism which appears to result in the 
decrease of the phosphorylation of proteins in sane fractions but 
which is not thought to involve the activation of a protein 
phosphatase ( Bachs and Carafoli 1987 ) ( see section 1.15 ) .
1 .1 2(f) Diacylglycerol and protein kinase c .
Diacylglycerol ( DAG ) is water insoluble and is produced in 
the plasma membrane where it is retained within the lipid bilayer 
( Takai et al 1979 ) . In 1977 a proteolytically-activated 
protein kinase was identified and named protein kinase c ( PKc )
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( Takai et al 1977 ) . This protein kinase was later shown to be 
dependent upon calcium icns and a phospholipid for its activation 
( Nishizuka 1983 ) . DAG was shown to increase the affinity of 
the enzyme for calcium ions and produce full activation of the 
protein kinase without a net increase in calcium concentration 
( Kaibuchi et al 1983 ) . Later work has shown that FKc is not a 
single enzyme but is a family of subspecies with closely related 
structure , mode of activation , kinetic properties and substrate 
specificities ( Ido et al 1987 ; Sekiguchi et al 1987 ) .
One of the problems encountered when studying the activation 
of FKc by DAG is the inability of DAG to penetrate the plasma 
membrane . The tumour promoting pborbol esters , such as pborbol 
myristate acetate ( FMA ) , however , are structurally very 
similar to DAG and have been shown to activate FKC in vitro and in 
vivo ( Castagna et al 1982 ) . It is now generally accepted that 
the receptor for the pborbol ester is FKc ( Kikkawa et al 1983 ; 
Niedel et al 1983 ) and like DAG , pborbol esters activate FKC by 
increasing the affinity of the enzyme for calcium . Much of the 
work carried out upon the activation and the intracellular 
mechanisms of FKc , therefore , have utilised the FKc-activating 
properties of the pborbol esters . One problem with the use of the 
pborbol esters in the study of FKc activation and mechanisms is 
their stability to breakdown within the cell in contrast to DAG , 
which is present only transiently in membranes . The pborbol 
esters , therefore , may extend a phase of cellular response which 
is limited under physiological conditions . This , to seme extent, 
has been overcome by the development of synthetic
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diacylglycerols , such as 1-oleoyl- 2-acetylglycerol , which are 
able to penetrate the cell membrane and activate FKc in a manner 
analogous to hormonally-stimulated production of DAG and are 
metabolised rapidly to their corresponding phosphatidic acids and 
probably to inositol phospholipids ( Yamanishi et al 1983 ) . 
Activation of FKc by both FMA and hormones which stimulate the 
plasma membrane production of DAG has been shown to be associated 
with the translocation of FKc fran the cytosol to the plasma 
membrane ( Hemandez-Sotcmayor and Garcia-Sainz 1988 ) although 
the precise mode of activation is unknown . The enzyme is caiposed 
of a single polypeptide chain which contains both a hydrophobic 
domain , thought to be involved in the binding of the protein 
kinase to the plasma membrane , and a hydrophilic domain 
containing the active site ( Kikkawa et al 1982 ) . The membrane 
phospholipid composition also appears to be critical for 
activation . Phosphatidylserine has been shewn to be 
indispensible but phosphatidylethanolamine shews positive 
cooperativity with phosphatidylserine for kinase activation 
whereas phosphatidylcholine is inhibitory ( Kaituchi et fid 1981 ). 
Activation of FKc , therefore is favoured by assymetric 
distribution of phospholipids in the lipid bilayer .
1.12(g) Generation of free arachidcnic acid .
Most of the phosphatidylinositol found in mammalian tissues 
contain arachidcnic acid at position 2 and , thus , 
diacylglycerol and phosphatidylinositol may both liberate free
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arachidcnic acid directly by two differing routes ( Reviewed by 
Irvine 1982 ) . Phosphatidylinositol ( and other phospholipids 
such as phosphatidylethanolamine and phosphatidylcholine ) is 
cleaved at the sn-2-acyl bend to produce equimolar amounts of 
lysophospholipid and free fatty acids ( including arachidcnic 
acid ) by phospholipase Ag ( Chang et al 1987 ) . Diacylglycerol 
produced by hormonal stimulation of inositol phospholipid 
hydrolysis by phospholipase c can be further degraded by 
diacylglycerol lipase to yield glycerol and free fatty acids 
(including arachidcnic acid ) . Arachidcnic acid has been reported 
to mobilise intracellular calcium from internal stores in a 
manner similar to IP3 ( Chan and Turk 1987 ) and , as arachidcnic 
acid is the precursor for the production of prostaglandins , the 
elevation of prostaglandins may also contribute to the 
intracellular transduction of hormones which stimulate inositol 
phospholipid hydrolysis . Prostaglandins may also be produced 
indirectly as a consequence of FKc activation as has been 
reported in the 3T3 tumour cell line ( Butler-Gralla et al 1983 ).
1.12(h) Cyclic GMP .
Cyclic guanos ine 315'-monophosphate ( cyclic GMP ) is produced 
in the cell in an analogous manner to cyclic AMP by the activation 
of guanylate cyclase and it similarly activates a specific cyclic 
GMP-dependent protein kinase ( PKg ) . Guanylate cyclase can be 
activated by the binding of hormones to specific receptors linked 
to the enzyme e.g. hepatic muscarinic receptors ( Illiano et al
-75-
1973 ) and also by the hormonal stimulation of inositol 
phospholipid hydrolysis . The exact mechanism of elevation of 
cyclic GMP by PIP2 hydrolysis is unclear but it has been proposed 
that arachidonate peroxide and prostaglandin endcperoxides serve 
as activators of guanylate cyclase ( Graff et al 1978 ) . 
Elevation of cyclic GMP and the subsequent activation of FKg , 
therefore , may contribute to the intracellular effects of 
hormones which stimulate inositol phospholipid hydrolysis .
1.13 PROTEIN FH3SPH3RYLATICN AS A REGULATOR OF DTOAfKTI/ILAR 
ACTIVITY .
Activation of specific protein kinases by their corresponding 
ligands leads to the phosphorylation of intracellular proteins 
utilising the terminal phosphate of ATP in the presence of 
magnesium ions . Many key regulatory proteins can be 
phosphorylated on seryl , threonyl or occasionally tyrosyl 
residues and this leads to a conformational change occurring 
within the protein and subsequent alteration of its biological 
properties . The list of the intracellular phosphate-accepting 
proteins is extremely long and the proteins currently thought to 
be phosphorylated by PKc have been reviewed by Nishizuka ( 1986 ) 
and , similarly , Cohen ( 1985 ) has reviewed the enzymes which 
are phosphorylated by PKa and calcium/calmodulin-dependent protein 
kinases .
PKa , PKc and calcium/calmodulin frequently phosphorylate the
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same protein substrates and , in 1978 , Garrison reported that 
treatment of cells with cyclic AMP analogues increased the 
phosphorylation of 12 cytosolic proteins and that at least 10 of 
the same protein substrates could also be phosphorylated by 
hormones which stimulated inositol phospholipid hydrolysis . It 
was also reported that four of these proteins could also be 
phosphorylated by addition of the calcium icncphore , A23187 . In 
a separate study it was reported that 7 of the 10 proteins 
phosphorylated by stimulation of inositol phospholipid hydrolysis 
were also phosphorylated by addition of A23187 whereas the 
remaining 3 were phosphorylated by addition of IMA indicating that 
their phosphorylation was mediated by activation of PKc ( Garrison 
et al 1984 ) . Although phosphorylation may occur on the same 
protein substrates , the phosphorylation sites are usually , 
although not always , distinct and so the biological changes 
caused by phosphorylation , attributed to the different protein 
kinases , may not be identical . For example PKa , PKC and 
calcium/calmodulin all increase the phosphorylation of glycogen 
phosphorylase ( Cohen 1985 ; Nishizuka 1986 ) , an Important 
glycogenolytic enzyme . Phosphorylation by PKa and calcium/ 
calmodulin results in activation of the enzyme . PKc , however , 
has been reported to have no effect upon the activation of 
glycogen phosphorylase ( Garrison et al 1984 ) tut may have a 
synergistic effect upon the activation of this enzyme with calcium 
( Fain et al 1984 ) .
Extensive work has shown that the amino acid sequence in the 
vicinity of the phosphorylation site is a primary factor for
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substrate recognition ( Reviewed by Krebs and Beavo 1979 ) and 
phosphorylation of differing proteins or of differing sites cn the 
same protein may , therefore , be attributable to the different 
substrate recognition sites of the protein kinases . The best 
documented of the protein kinase recognition sites is that for PKa 
which is thought to require two or more adjacent basic residues 
amino-terminal to the phosphorylatable residue ( Cohen 1985 ) . 
Information about recognition sites for the other protein kinases 
, however , is limited .
1.14 THE ROLE OF PROTEIN PH0SFH3RYLATICN IN SECOND MESSENGER 
TRANSDUCTICN .
In addition to mediating the response of the cell to hormones 
and their corresponding second messenger systems , phosphorylation 
of proteins is also thought to be the underlying mechanism 
mediating the effects of second messengers upon their own 
transduction ( feedback ) and upon the transduction of other 
second messengers ( interaction or "cross-talk" ) .
1.14(a) Negative feedback systems .
Both PKa and PKc exert a negative feedback effect upon the 
pathways that generate them .
PKa is thought to phosphorylate and activate cyclic AMP 
phosphodiesterase ( Loten et al 1978 ; Heyworth et al 1983 ;
Corbin et al 1985 ) and phosphorylate and inhibit adenylate
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cyclase ( Ccnstantcpoulos and Najjar 1973 ) . The overall effect , 
therefore , will be the lowering of cyclic AMP levels . PKa m y  
also have an inhibitory or desensitising effect upon the 
transraembrane transduction of cyclic AMP-elevating hormones ( p 
adrenergic agonists/glucagon ) by phosphorylating the receptor 
(Sibley et al 1984 ) . This is thought to modulate the interaction 
between the receptor and Ns ( Heyworth and Houslay 1983a ;
Heyworth et al 1984a ; Bouvier et al 1987 ) and/or decrease 
agonist binding ( Refnes et al 1987 ) .
In similar manner to PKa , PKc is also thought to inhibit the 
hormonal stimulation of inositol phospholipid hydrolysis ( ax 
adrenergic agonists ) ( Garcia-Sainz et al 1985 ; Van de Werve et 
al 1985 ) and this has been reported to be due to down regulation 
of the receptor ( Cooper et al 1985 ; Corvera et al 1986 ) perhaps 
involving phosphorylation of the putative transducing CTP binding 
protein ( Blackmore and Exton 1986 ) and uncoupling of the 
receptor from phospholipase c ( Leeb-Lundberg et al 1985 ) .
Cyclic GMP produced as a result of PIP2 hydrolysis also appears to 
exert a negative feedback effect upon further hydrolysis of PIP2 
to DAG by stimulating the phosphorylation of two proteins ( Takai 
et al 1981 ) and this is thought to be a major route of negative 
feedback in platelets and smooth muscle ( Schultz et al 1977 ) . 
Its relevance in other tissues and mechanisms of action , however 
, are unclear .
-79-
1.14(b) Interactions between inositol phospholipid-degrading
and cyclic AMP-generating pathways .
Many workers have reported that cyclic AMP elevation leads to 
an increase in calcium influx ( Mauger et al 1985 ; Staddon and 
Hansford 1986 ) and this has been proposed to be due to the 
phosphorylation of a site near to or on the calcium gating 
channels ( Poggioli et al 1986 ) . Cyclic AMP may also increase 
the receptor binding of hormones which stimulate inositol 
phosphate hydrolysis ( ax adrenergic agonists ) ( Morgan et al
s
1984 ) although reports of the effects of cyclic AMP upon inositol 
phosphate hydrolysis directly , vary . In hepatocytes cyclic AMP 
has been reported to stimulate PIP2 hydrolysis by phosphorylation 
of a GEP binding protein ( Blackmore and Exton 1986 ) , inhibit PI 
turnover by inhibiting PI kinase ( see section 1.12(c) ) ( O'Shea 
et al 1987 ) , although this was thought to be a non-specific 
effect of adenine nucleotides , and to have no effect upon PIP2 
hydrolysis ( Kaibuchi et al 1982 ) , although the same study 
reported inhibition of PIP2 hydrolysis in lynphocytes . Cyclic AMP 
has also been reported to have an inhibitory effect upon the 
mobilisation of calcium from internal stores perhaps by 
stimulating mitochondrial uptake of calcium ( Morgan et al 1983a). 
Interaction also exists between PKa and the protein kinases 
activated as a result of inositol phospholipid hydrolysis . PKa 
inhibits the activation of PKc in skeletal muscle myoblasts 
( Narindrasorasak et al 1987 ) . In the GH4 pituitary cell tumour 
line , however , cyclic AMP has been postulated to produce seme of
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its nuclear effects by stimulating the activity of a 
calcium-dependent protein kinase although the exact nature of this 
protein kinase is unclear ( Waterman et al 1985 ) .
In rat hepatocytes , FKc ( activated by FMA ) inhibits the 
activation of adenylate cyclase ( Heyworth et al 1985 ) and the 
hormonal ( glucagon ) stimulation of cyclic AMP accumulation 
(Garcia-Sainz et al 1985 ) . This effect is thought to be mediated 
by disruption between the catalytic subunit of adenylate cyclase 
and Ns ( Heyworth et al 1984b ) . In turkey erythrocytes phorbol 
esters also desensitise the effects of stimulatory hormones 
(p-adrenergic agonists ) upon, adenylate cyclase by phosphorylation 
of the receptor ( Kelleher et al 1984 ) . Hydrolysis of PIP2 may 
also have an indirect negative effect upon hormonal stimulation of 
cyclic AMP accumulation by the secondary elevation of arachidcnic 
acid and prostaglandins ( Brcnstad and Christoffersen 1981 ; Brass 
et al 1987 ) although this is unlikely to represent a protein 
phosphorylation-mediated interaction between inositol phospholipid 
hydrolysis and cyclic AMP generation . Phorbol esters have also 
been reported to inhibit cyclic AMP phosphodiesterase in 
hepatocytes by phosphorylating the enzyme ( Irvine et al 1986 ) . 
This is in direct contrast to the effect of PKa-mediated 
phosphorylation upon the same enzyme , which has been reported to 
activate the phosphodiesterase (Corbin et al 1985 ) and so may be 
another example of dual control of an enzyme by phosphorylation at 
different sites . In contrast to the effects in hepatocytes , PKc 
activation by FMA has been reported to enhance the activation of 
adenylate cyclase in response to cyclic AMP-elevating hormones in
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S49 lymphcma cells perhaps by enhancing the interaction between Ns 
and the catalytic subunit ( Bell et al 1985 ) , and directly 
activate adenylate cyclase in adipocytes ( Naghshineh et al 1986).
1.15 PROTEIN HPSEHRTASES .
Hie role of protein phosphatases in cellular function has 
been reviewed by Cohen ( 1985 ) and Ingebritsen and Cohen ( 1983). 
In addition to phosphorylation of proteins by the activation 
of the protein kinases , the overall phosphorylation state of any 
protein in vivo is also controlled by the activation states of 
protein phosphatases which dephosphorylate the phosphcprotein .
In contrast to the large number of different protein kinases , 
relatively few protein phosphatases participate in cellular 
regulation and these , therefore , have broad substrate 
specificities . Pour protein phosphatases have been identified 
which are capable of depbospborylating seryl or threcnyl residues. 
These have been roughly divided into two groups namely protein 
phosphatase-1 ( PP-1 ) and protein phosphatase-2 ( FP-2 ) which 
is composed of three subspecies designated FP-2a , PP-2b and 
FP-2c . PP-1 , PP-2a and FP-2c account for nearly all of the 
protein phosphatase activity in the liver . PP-1 differs from the 
group 2 protein phosphatases in that it is a membrane bound 
enzyme whereas FP-2a and PP-2c are both cytosolic enzymes and 
also because it can be inhibited by two Inhibitor proteins termed 
inhibitor-1 and inhibitor-2 . Inhibitor-2 exhibits spontaneous 
inhibitory activity ( Goris et al 1978 ) but inhibitor-1 is
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inactive unless phosphorylated at specific threonine residues by 
PKa . Cyclic AMP , therefore , in addition to activating PKa , 
also activates an inhibitor of the membrane bound PP-1 which will 
further enhance the protein phosphorylation effects of PKa .
PP-2b ( also known as calcineurin ) appears to be active mainly 
in the dephosphorylation and subsequent inactivation of 
inhibitor-1 . PP-2b consists of a catalytic subunit and a calcium 
binding subunit which is structurally related to calmodulin 
( Aitkin et al 1984 ) and the binding of calcium is essential for 
the activation of PP-2b ( Tcnks and Cohen 1983 ) . Thus calcium 
antagonises the effects of PKa and other protein kinases upon 
protein phosphorylation by the activation of the membrane bound 
PP-1 . In addition to the indirect effects of PP-2b upon the 
activation of PP-1 , Yang et al ( 1987 ) have also reported the 
existence of a directly acting activator of PP-1 in the liver 
which has been csdled Fa and which has been found to be a 
membrane-bound protein kinase . This mechanism , therefore , may 
represent a form of negative feedback between activation of the 
kinase and termination of the phosphorylation effects by 
activation of the phosphatase . The exact nature of the 
endogenous ligand which activates Fa , however , was not apparent 
in this study .
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1.16 INTRACELLULAR TRANSDUCTION OF H3FM3NES
1.16(a) Hormonal action at target cells .
Hormones can be divided into three categories depending upon 
their mode of action in target cells .
(1) Hormones acting at a plasm membrane receptor . These 
hormones are unable to penetrate the plasma membrane and produce 
their effects by alteration of the synthesis , release or 
activation of intracellular second messengers stimulated by the 
binding of the hormone to a plasma membrane receptor . This 
category includes adrenaline , glucagon , insulin and the 
pituitary hormones including growth hormone .
(2) Hormones acting at an intracellular receptor and having 
no effect upon intracellular second messengers ._These hormones 
penetrate the plasma membrane and bind to a cytosolic/nuclear 
receptor and the intracellular effects are produced by the 
interaction between the hormone/receptor complex and ENA to induce 
( or inhibit ) the synthesis of intracellular proteins . This 
category includes testosterone and oestrogen and , in most target 
organs , glucocorticosteroids . The transduction of the hormones 
will not be discussed in detail but have been reviewed ( King 1987 
; Lax 1987 ; Eisenf eld and Aten 1987 ) .
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(3) Hormones acting at an intracellular receptor and having
additional effects upon second messenger responsiveness to plasma 
membrane hormones . These hormones have identical effects upon 
protein synthesis as listed in category (2 ) but , in addition , 
have indirect effects upon second messenger systems . Hormones in 
this category include glucocorticosteroids in the liver and 
thyroid hormones .
1.16(b) Catecholamines .
Three different types of receptor for the catechol amines 
exist on the plasma membrane of liver cells . p2_Adrener9ic 
receptors have a stimulatory effect upon the activity of 
adenylate cyclase via Ns and agonist binding , therefore , 
results in the elevation of intracellular cyclic AMP ( Exton et 
al 1971 ) . ax -Adrenergic receptors are linked to stimulation of 
inositol phospholipid hydrolysis and agonist binding , therefore, 
results in the subsequent mobilisation of calcium and 
activation of FKc ( Bimbaum and Fain 1977 ; Tolbert et al 1980 ; 
Studer and Borle 1982 ) . a2 -Adrenergic receptors have an 
inhibitory effect upon adenylate cyclase activity and subsequent 
cyclic AMP accumulation and act through the inhibitory GEP 
binding protein , Ni ( Jard et al 1981 ) . Adrenaline has agonist 
activity at each of these receptors and the overall effect upon 
second messenger systems is dependent upon the relative densities 
of each of the receptors on the plasma membrane and/or their 
sensitivities . Noradrenaline , however , is much more specific
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for cii -receptors and therefore produces its effects by 
stimulation of inositol phospholipid hydrolysis rather than by 
elevation of cyclic AMP ( Garrison and Wagner 1982 ) . Sex 
differences exist in the hepatic cyclic AMP-elevating effects of 
adrenaline ( Bitensky et al 1970 ) and this is thought to be due 
to differences in the relative densities of c^- and p2 -receptors 
on the hepatocyte plasma membrane in that females have a much 
higher ratio of p2 -receptors to ax -receptors than do males , or 
that the sensitivity of the hepatocyte p2-receptors is lower in 
the male than in the female ( Studer et al 1984 ) , and therefore 
the cyclic AMP accumulation produced by adrenaline is much higher 
in the female than in the male . Close links exist between the 
coupling of p2- and -receptors to their respective 
intracellular pathways and it has been reported that in 
calcium-depleted hepatocytes , dx -receptors become linked to the 
cyclic AMP-generating pathway ( Chan and Exton 1977 ) and this 
has been attributed to calcium-mediated inhibition of the 
coupling of d:-receptors to adenylate cyclase in calcium-replete 
cells . A similar effect has been reported in the aging male rat 
( Morgan et al 1983b ; Morgan et al 1983c ) and may be due to a 
drop in testosterone levels ( Bitensky et al 1970 ) . In these 
models , noradrenaline may elevate cyclic AMP via its actions at 
ox-receptors .
In 1971 Exton et al reported that in the perfused male rat 
liver , adrenaline mfld-iatfid a 4 fold increase in cyclic AMP 
levels after 1 minute which rapidly declined back to basal levels 
and they postulated that the stimulation of glycogenolysis by
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adrenaline was mediated via p2 receptors and a rise in cyclic AMP 
. It is new more generally accepted , however , that in the adult 
male rat adrenaline-mediated elevation of cyclic AMP is 
functionally unimportant for the stimulation of glycogenolysis 
( Bimbaum and Fain 1977 ; Studer and Borle 1982 ; Morgan et al 
1983b ; Studer et al 1984 ) . Elevation of cyclic AMP , however , 
is thought to mediate adrenaline-stimulated induction of 
ornithine decarboxylase and its associated messenger RNA 
( Evcniuk et al 1985 ) and adrenaline-stimulated phosphorylation 
and subsequent activation of fructose-1 ,6-biphosphatase 
( Nilsson-Ekdahl and Ekman 1987 ) .
1.16(c) Glucagon .
It is well established that one of the actions of glucagon is 
the stimulation of adenylate cyclase and elevation of cyclic AMP 
( Exton et al 1971 ) and in the isolated perfused male rat liver, 
glucagon ( 10" 8M ) was reported to increase the levels of 
cyclic AMP 11-fold after one minute and 60-fold after 5 minutes . 
Both the metabolic effects upon glycogen and glucagon-mediated 
induction of ornithine decarboxylase ( Evcniuk et al 1985 ) have 
been attributed to the cyclic AMP-elevating effects of glucagon.
More recently it has been shewn that glucagon also increases 
intracellular free calcium levels ( Studer et al 1984 ; Staddon 
and Hansford 1986 ) by both promoting its mobilisation from the 
endoplasmic reticulum ( Bond et al 1987 ) and also by stimulating 
the influx of extracellular calcium ( Mauger et al 1985 ; Boggioli
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et al 1986 ) . Glucagon may produce its effects upon intracellular 
calcium try either a cyclic AMP-dependent or a cyclic AMP- 
independent mechanism . It has been shown that the ability of 
glucagon to elevate intracellular calcium levels can been mimicked 
by forskolin ( which directly activates adenylate cyclase ) and by 
the cyclic AMP analogue , 8-brano-cyclic AMP ( Staddcn and 
Hansford 1986 ) . Angiotensin II acting at the Ag receptors 
( linked by Ni to the inhibition of adenylate cyclase ) blocks 
both the glucagon-mediated elevation of cyclic AMP and its effects 
upon calcium levels ( Morgan et al 1983d ) . Similarly the cyclic 
AMP antagonist : (Rp)-cAMP also blocks the effects of glucagon 
upon calcium levels ( Connelly et al 1987 ) and in 1983 Creba et 
al reported that glucagon had no effect upon the hydrolysis of the 
inositol phospholipids and thus appears to have no direct effects 
upon the pathway which would lead to the generation of IP3 . These 
findings imply that the glucagon-mediated elevation of calcium 
occurs secondary to elevation of cyclic AMP .
In contradiction to the above reports it has been suggested 
that the stimulation of glycogen phosphorylase activity by 
glucagon occurs at a lower concentration than that required to 
elevate cyclic AMP levels ( Bimbaum and Fain 1977 ) and it has 
also been reported that the activation of FKc by FMA inhibits the 
glucagon-mediated elevation of cyclic AMP but not its effects 
upon ureogenisis ( Garcia-Sainz et al 1985 ) . Similarly the 
glucagon analogue , (1-Na -trinitrophenylhistidine, 12- 
hanoarginine)glucagon ( TH-glucagon ) mimics the glucagon-mediated 
stimulation of glycogenolysis ( Corvera et al 1984 ) and
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inhibition of steroid metabolism ( Hussin et al 1988) but has no 
stimulatory effect upon, cyclic AMP levels . These finding imply 
that the calcium-mobilising effects of glucagon occur 
independently of its effects upon cyclic AMP levels and it has 
been proposed that two classes of plasma membrane receptor mediate 
the intracellular effects of glucagon , namely : GR-1 linked to 
inositol phospholipid hydrolysis and GR-2 linked to cyclic AMP 
generation ( Wake lam et al 1986 ) .
1.16(d) Insulin .
One of the short term effects of insulin is a lowering of 
intracellular cyclic AMP mediated by stimulation of cyclic AMP 
phosphodiesterase ( Loten et al 1978 ; Hayworth et al 1983 ; 
Heyworth et al 1984c ; Beebe et al 1985 ; Heyworth et al 1985 ) 
and inhibition of adenylate cyclase ( Heyworth and Houslay 1983b 
; O'Brien et al 1987 ) . Both of these effects are thought to be 
mediated via a GTP binding protein although they do not appear to 
share a carmen pathway ( Weber et al 1987 ) . Insulin also lowers 
the effects of cyclic AMP by inhibiting the effects of PKa 
( Marks and Parker-Botelho 1986 ; Malchoff et al 1987 ) and by 
activation of one or several protein phosphatases ( Thcmas et al 
1985 ) which oppose the cyclic AMP-mediated phosphorylation of 
proteins .
insulin also affects other intracellular transduction 
pathways in addition to attenuation of cyclic AMP levels . In the 
liver insulin increases the levels of cyclic GMP and this effect
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is not blocked by atropine which indicates that insulin-mediated 
elevation of cyclic GMP is not due to actions at the muscarinic 
receptor ( Illiano et al 1973 ) and sane of the effects of 
insulin in rat adipocytes have been proposed to be mediated by 
activation of FKc ( Cherqui et al 1987 ; Pershadsingh et al 1987 
; Snal and De Meyts 1987 ) . This is accompanied by activation of 
a phospbolipase c ( Koepker-Hobelsberger and Wieland 1984 ) . 
However , it has been reported that insulin does not itself 
stimulate inositol phospholipid degradation in adipocytes but may 
enhance the increase in PrP2 hydrolysis mediated by ax agonists 
by stimulating the de novo synthesis of PI and PIP2 ( Pennington 
and Martin 1985 ) . In hepatocytes , however , insulin appears to 
have no effect upon. ax agonist-mediated PIP2 hydrolysis ( Creba 
et al 1983 ; Pushpendran et al 1984 ) and attenuates their 
effects upon intracellular calcium levels ( Strickland et al 1980 
; Thomas et al 1985 ) although it has no effect upon the calcium 
mobilisation mediated by either vasopressin or A23187 ( Dehaye et 
al 1981 ) .
In addition to activation of phosphatases , insulin also 
activates a number of protein kinases e.g. riboscmal protein S6 
kinase , protease-activated kinase and a cytosolic serine kinase 
( Blackshear et al 1987 ; Yu et al 1987 ) and increases the 
phosphorylation of a number of hepatic proteins ( Le Cam 1982 ) 
although it has been reported to affect only cytosolic proteins 
( Vargas et al 1982 ) .
The mechanism by which insulin mediates its effects is , as 
yet , unclear . The insulin receptor is composed of two subunits
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/ the a subunit which binds insulin ( Yip et al 1978 ) and the p 
subunit which possesses tyrosine kinase activity ( Shia et al 
1983 ) . Phosphorylation by the p subunit may mediate the 
activation of an inhibitory GIF binding protein as has been 
reported for purified Ni from rat brain and may have seme 
relevance in insulin-mediated inhibition of adenylate cyclase 
( O'Brien et al 1987 ) . A number of reports have been made that 
the insulin-mediated attenuation of cyclic AMP levels can be 
mimicked by a peptide or glycopeptide intracellular mediator 
which can be isolated from insulin treated cells ( Caro et al 
1983 ; Zhang et al 1983 ; Malchoff et al 1987 ) . Alternatively a 
phospho-oligosaccaride polar head group of an insulin-sensitive 
glycolipid has been isolated f ran hepatocytes which mimics 
insulin-mediated inhibition of glucagon-stimulated cyclic AMP 
levels ( Alvarez et al 1987 ) and inhibits PKa ( Vi 11 alba et 2d 
1988 ) . A unifying theory of insulin action has been proposed by 
Brautigan and Kuplic ( 1988 ) which postulates that 
phosphorylation of a G7TP binding protein by the tyrosyl kinase 
activity of the insulin receptor p subunit , leads to the 
activation of a specific phospholipase c and the generation of 
two signals (a) myristate diacyglycerol which may activate FKc in 
a manner identical to arachidonyl diacylglycerol produce by 
hydrolysis of PrP2 ; and (b) inositol phosphoglucosamine glycan 
which may activate a number of enzymes including cyclic AMP 
phosphodiesterase and protein disulphide iscmerase . This latter 
enzyme may catalyse rearrangement of the disulphide bonds in 
phosphatase-1 ( PP-1 ) thereby stabilising and subsequently
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activating it
1.16(e) Growth hormone .
Although growth hormone receptors are present cn the plasma 
membrane of liver cells ( Baxter and Zaltzman 1984 ) little is 
known of the intracellular transduction mechanism for this 
hormone . The growth stimulatory effects of growth hormone are 
thought to be mediated by the growth hormone-stimulated induction 
of sana toned ins in the liver and other tissues . One of these 
scmatcmedins , somatomedin c is also known as insulin like growth 
factor-1 ( IGF-1 ) ( Isaksscn et al 1985 ) . However , although 
the liver is the main site of IGF-1 production , production of 
IGF-1 can be directly stimulated in the brain by a direct action 
of growth hormone and is thought to mediate the effects of growth 
hormone upon various neuronal growth processes ( Hynes et al 
1987). In the liver , growth hormone is thought to act directly to 
elevate levels of IGF-mRNA ( Norstedt and Moller 1987 ) perhaps by 
derepression of chromatin ENA and enhancement of KNA polymerase 
activity ( Spelsberg and Wilson 1976 ) . Although the growth 
stimulatory effects of growth hormone are thought to be mediated 
by sanatcmedins , the other actions of growth hormone are thought 
to be mediated directly by samtanedin-independent mechanisms . 
Receptor populations for growth hormone may be heterologous as 
there appear to be different structure/activity requirements for 
direct effects and IGF-inducing effects of growth hormone 
(Isaksscn et al 1985 ) . Growth hormone increases the
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phosphorylation states of a number of protein substrates in 
isolated rat hepatocytes and this action is not thought to be due 
to stimulation of IGF production ( Yamada et al 1986 ) . The 
identity of the protein kinase ( or combination of protein 
kinases) which mediates growth hormone-stimulated protein 
phosphorylation has not been elucidated although growth hormone 
has been reported to mediate seme of its direct actions in 
adipocytes by activation of FKc ( Smal and De Meyts 1987 ) .
Growth hormone has also been reported to increase the levels of 
cyclic GMP which may lead to activation of PKg . The elevation of 
cyclic GMP occurs concomitant with a decrease in the levels of 
cyclic AMP and these effects are thought to be due to direct 
interaction with adenylate cyclase or guanylate cyclase ( Isaksscn 
et al 1985 ) .
1.16(f) Glucocorticosteroid effects in the liver .
The glucocortisteroids are identical to the sex steroids in 
that they enter the cell and bind to a cytosolic receptor . This 
receptor is similar to the receptor for the sex steroids 
( reviewed by King 1987 ) and can be phosphorylated . The role of 
receptor phosphorylation is unclear , however , and although 
phosphorylation has been proposed to be important for seme of the 
actions of the glucocorticosteroids ( Perisic et al 1987 ) , 
phosphorylation by PKa is not required for the function of the 
receptor in the induction of tyrosine aminotransferase ( Schmid 
et al 1987 ) . The receptor is , however , able to interact with
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ATP and this enhances its activation by the glucocorticosteroids 
tut this effect is not thought to be due to phosphorylation as it 
can be mimicked by ncn-hydrolysable analogues of ATP ( Diehl and 
Schmidt 1987 ) . Once binding has occurred the glucooortico- 
steroid/receptor complex is translocated into the nucleus and 
increases transcription by interacting with regulatory ENA regions 
5' to the structural gene ( King 1987 ) . Unlike the sex steroids, 
however , glucocorticosteroids exert permissive control over 
cyclic AMP generation and inositol phospholipid degradation in 
determining the responses of these intracellular events to 
circulating catecholamines . This permissive control is thought to 
be mediated via inhibition of phospholipase Ag and a subsequent 
decrease in the metabolism of the phospholipids to arachidcnic 
acid and prostaglandins and it has been postulated that this is 
the mechanism by which p2 adrenergic receptor activity is 
suppressed in the male rat ( Kunos and Ishac 1987 ) . This 
suppression may be mediated by Ni ( Itoh et al 1984 ) or 
alternatively may be due to a deficiency of Ns linking the p2 
receptor to adenylate cyclase ( Goodhardt et al 1982 ) . When 
hepatocytes are cultured or the animal is adrenalectcmised , this 
inhibitory effect is lost and the activity of p2 adrenergic 
stimulation of adenylate cyclase and the elevation of cyclic AMP 
is enhanced with a concomitant decrease in the activity of the a: 
receptors ( Studer and Borle 1984 ; Kunos et al 1984 ; Kunos and 
Ishac 1987 ) . This effect can be reversed by the administration 
of glucocorticosteroids ( Bitensky et al 1970 ) and does not 
appear to be due to a change in the coupling of ax receptors f ran
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P3P2 hydrolysis to adenylate cyclase ( Chan et al 1979 ) . It 
differs , therefore , fran the mechanism proposed for the changes 
in the receptor coupling which occur in the aging rat and in 
calcium-depleted hepatocytes ( see section 1.16(b) ) and has been 
proposed to be due to changes in the levels of the GZEP binding 
proteins which are postulated to couple the receptors to their 
respective intracellular pathways ( Goodhardt et al 1982 ) .
1.16(g) Thyroid hormones .
Thyroid hormones have little direct effect upon intracellular 
cyclic AMP levels or PKa activation ( Muller and Seitz 1987 ) but 
increase the sensitivity of the target cells to the cyclic 
AMP-elevating effects of the circulating catecholamines and 
glucagon . Uiis is well documented in the heart ( Tsai and Chen 
1978 ) and adipocytes ( Malbcn et al 1978 ) where the p 
adrenergic responses to catecholamines are blunted in 
hypothyroidism and enhanced in hyperthyroidism . In the liver , 
however , it has been reported that the effects of thyroid 
hormones are opposite to those seen in the heart and in adipocytes 
( Malbcn 1980 ) and that thyroid hormones blunt the activation of 
glycogen phosphorylase by adrenaline ( Malbcn and Lo Presti 1981). 
This may , however , be due to the exhaustion of substrates for 
these metabolic pathways as Muller and Seitz ( 1987 ) reported 
that , in the presence of unlimited substrate , hyperthyroidism 
resulted in enhancement of glucagon-mediated effects upon 
gluccneogenesis in the liver which correlates with the effects of
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hyperthyroidism in the heart and in adipocytes . The changes in 
the sensitivity of target cells to glucagon and catecholamines m y  
be due to (a) alteration in receptor number and binding which is 
increased in hyperthyroidism and decreased in hypothyroidism (Tsai 
and Chen 1978 ; Ali et al 1987 ) ; (b) alteration in the levels of 
the a subunit of Ni which is elevated in hypothyroidism ( Milligan 
et al 1987 ) and (c) alteration in the activity of cyclic AMP 
phosphodiesterase which is enhanced by hypothyroidism ( Gumaa et 
al 1977 ) and blunted by hyperthyroidism ( Morgan et al 1982 ) .
Thyroid hormones also exert permissive control over a± 
adrenergic function and upon the effects of calcium-mobilising 
hormones ( e.g. vasopressin and angiotensin II ) . ax adrenergic 
receptors and receptors for the calcium mobilising hormones are 
reduced ( Preiksaitis et al 1982 ; Ali et al 1987 ) and the 
calcium mobilising actions of these hormones are slower and of 
less magnitude in the hypothyroid rat ( Storm and Van Hardeveld 
1986 ) .
Thyroxine does not appear to produce its effects by binding 
to a plasma membrane receptor but has been reported to be taken 
up into the cell by a saturable , stereospecif ic , sodium 
ion-independent carrier system ( Blcndeau et al 1988 ) . Receptors 
for triiodothyronine ( the active form of thyroxine ) are attached 
to the ENA nuclear matrix ( Venkatraman and Lefebvre 1987 ) and 
are concentrated in fractions which contain the most endogenous 
KNA polymerase activity ( Spindler et al 1975 ) . Binding differs 
from that of the steroids in that cytosolic binding does not occur 
prior to triiodothyronine action in the nucleus and is not
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necessary for its action ( Degroot et al 1976 ) . By binding to 
its nuclear receptors , triiodothyronine induces an increase in 
the number of messenger KNAs in the liver , the synthesis of which 
are blocked by cycloheximide thus implying that short lived 
proteins act as intermediate transducers of triiodothyronine 
action ( Hamblin et al 1987 ) . Thyroxine stimulation of gene 
transcription has been proposed as the mechanism by which 
triiodothyronine increases the activity of a number of enzymes 
involved in carbohydrate metabolism in the liver ( Bottger et al 
1970 ) and stimulates the synthesis of growth hormone in the 
pituitary gland ( Mirell et al 1987 ; Santos et al 1987 ) . No 
evidence exists , however , for a role of protein induction in 
the membrane effects of thyroxine/triiodothyronine e.g. increase 
in adenylate cyclase sensitivity to hormones and subsequent cyclic 
AMP accumulation . In rat thymocytes thyroxine promotes the rapid 
influx of external calcium and it has been proposed that 
calcium/calmodulin mediates the extranuclear/plasma membrane 
effects of thyroxine in these cells ( Segal 1988 ) . 
Thyroxine-stimulated influx of calcium , therefore , m y  be a 
mechanism by which thyroxine mediates its plasma membrane effects 
in other cell types .
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1.17 INDICATIONS FOR A ROLE OF CYCLIC AMP IN HEPATIC MGNQ-
QXYGENASE RE3GULATICN .
1.17(a) Inhibition .
It is apparent from the previous sections that hormones or 
hormone deficiency states which lead to feminisation or inhibition 
of monooxygenase activity ( thyroid hormones , diabetes , 
adrenalectomy , glucagon and adrenaline ) tend to increase 
intracellular cyclic AMP levels directly or indirectly as one of 
their actions whereas insulin which increases monoaxygenase 
activity when added directly to hepatocytes ( Hussin and Skett 
1987 ) has been reported to decrease intracellular cyclic AMP 
levels ( Heyworth et al 1985 ; O'Brien et al 1987 ) ( section 
1.16(f) ) . More direct evidence for a role of cyclic AMP in the 
regulation of mcnooxygenase activity was provided by Weiner et al 
( 1972a ) who reported that in vivo administration of the cyclic 
AMP analogue , dibutyryl-cyclic AMP inhibited the metabolism of 
hexobarbitcne . Similarly in vivo administration of 
dibutyryl-cyclic AMP has also been reported to inhibit the 
phgttYTharh-i a-t-pd induction of cytochrome P450 ( HUtterer et
al 1975 ) and has been implicated as the intracellular mediator of 
the inhibitory effects of the Walker 245 carcinoma toxohormones 
upon the metabolism of p-chloro-N-methylaniline ( Olson and Weiner 
1980 ) . One of the problems encountered when using in vivo 
studies is the possibility that cyclic AMP may be producing its 
effects indirectly by altering hormone levels . This problem was
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overcome by Weiner et al ( 1972b ) using the perfused rat liver 
and liver slices and they reported that in these models , 
administration of dibutyryl-cyclic AMP inhibited the metabolism of 
hexobarbitone and p-chloro-N-methylaniline . Similarly , Banhegyi 
et al ( 1988 ) reported that dibutyryl-cyclic AMP inhibited the 
biotransformation of aminopyrine in isolated mouse hepatocytes . 
These models eliminate the possibility of indirect effects and 
indicate that dibutyryl-cyclic AMP produces effects directly at 
the levels of the liver . Weiner et al ( 1972b ) also noted that 
the effects of dibutyryl-cyclic AMP upon drug metabolism did not 
occur in whole liver hcmogenates and it was postulated that 
dibutyryl-cyclic AMP did not have a direct effect upon the enzymes 
themselves but inhibited enzyme activity indirectly via sane 
intracellular intermediate . As cyclic AMP is thought to produce 
most of its actions through activation of PKa ( see section 
1 .1 2(a) ) , it is conceivable that the identity of this postulated 
intermediate is PKa .
Pyerin et al ( 1983 ) have recently shewn that incubation of 
the purified rabbit cytochrome P450 , P450 IMg , with the 
catalytic subunit of PKa in a reconstituted system , leads to 
phosphorylation of the cytochrome P450 and the identity of the 
phosphorylated residue has subsequently been shewn to be serine 
128 ( Pyerin et al 1986a ) which is on the cytoplasmic surface of 
the cytochrome P450 ( Nelson and Strobel 1988 ) . It has been 
proposed by Janssen et al ( 1987 ) that the phosphorylatable 
residue may be at the site of interaction of cytochrome P450 with 
cytochrome b§ . The phosphorylation of the cytochrome P450 has
-99-
been reported to convert the cytochrome P450 to cytochrome P420 
( Taniguchi et al 1985 ) with a concomitant decrease in the 
metabolism of benzphetamine and ethoxycoumarin ( Pyerin et al 
1984 ) . These in vitro findings provide further evidence of an 
indirect effect of cyclic AMP upon monooxygenase activity via 
activation of PKa . In a later study Pyerin and co-workers ( 1987) 
reported that the phosphorylation of cytochrome P450 was not 
restricted to rabbit cytochrome P450 but that PKa can also 
phospborylate several cytochrome P450 isozymes purified from the 
liver of the rat . In the same study , however , it was reported 
that many of these same isozymes could also be phosphorylated by 
FKC and seme isozymes could be phosphorylated by PKc and not by 
PKa . In vitro phosphorylation of cytochrome P450 , therefore , 
does not appear to be a PKa-specific effect . Furthermore it has 
also been reported that activation of PKc utilising IMA or 
1 ,2-dioleoylglycerol in isolated rat hepatocytes inhibits the 
metabolism of androstenedicne in a nonspecific manner ( Allan and 
Skett 1988 ) but mobilisation of intracellular calcium with 
A23187 ( Hussin et al 1988 ) and incubation of isolated rat 
hepatocytes with vasopressin or angiotensin ( C.J. Allan : 
personal communication ) was reported to have no effect upon the 
metabolism of steroids . Banhegyi et al ( 1988 ) reported , 
however , that A23187 inhibited the metabolism of amincpyrine in 
isolated mouse hepatocytes . It appears , therefore , that PKa 
activation , PKC activation and calcium may all contribute to 
inhibitory effects upon monooxygenase activity although calcium 
appears to mediate inhibition in the mouse hut not in the rat and
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may represent a species difference in regulatory mechanisms .
Paradoxically Pyerin et al ( 1983) also reported that 
incubation of rabbit liver cytochrome P450 IM2 with phosphatases 
in a reconstituted system inhibited the biotransformaticn of 
ethoxycoumarin and this inhibitory action was later proposed to be 
due to inactivation of NADFH-cytochrcme P450 reductase ( Pyerin et 
al 1986b ) by the conversion of FMN to riboflavin ( Taniguchi and 
Pyerin 1987 ) .
Theoretically , therefore , cyclic AMP may inhibit hepatic 
monooxygenase components by :
(a) Activation of PKa and direct phosphorylation of cytochrome 
P450 .
(b) Interaction with the components of the 
phosphatidylinositol hydrolysis pathway and subsequent 
activation of corresponding protein kinases .
(c) Activation of PKa and secondary activation of phosphatases 
perhaps involving elevation of calcium as an intermediate 
step .
A similar mode of regulation for another cytochrome P450 
has been reported for the action of PKa and phosphatases upon the 
activity of cholesterol-7a-hydroxylase , a cytochrome 
P450—containing mircoscmal monooxygenase which catalyses the rate 
limiting step in the conversion of cholesterol to bile acids .
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The regulation of this enzyme , however , differs from that 
proposed for the regulation of xenbbiotic/steroid metabolising 
enzymes in that the enzyme is activated by PKa-medlated 
phosphorylation and deactivated by phosphatase-mediated 
dephosphorylation ( Sanghvi et al 1981 ; Goodwin et al 1982 ; 
Holsztynska and Waxman 1987 ) .
1.17(b) Induction .
It has been reported that the in vivo induction of cytochrome 
P450 by Arochlor-1254 ( Costa et al 1976 ) , 3-methylcholanthrene 
and phenobarbitone ( Byus et al 1976 ) is accaipanied by elevation 
of cyclic AMP and activation of PKa . Furthermore , the activation 
of PKa and the increase in cytochrome P450 levels mediated by 
3-methylcholanthrene both required the presence of the polycyclic 
aromatic hydrocarbon receptor whereas the phenbbarbitcne-mediated 
PKa activation and induction of cytochrome P450 occurred 
independently of the receptor ( Manen et al 1978 ) . The effects 
of Arochlor-1254 upon cytochrome P450 induction were augmented by 
the presence of the cyclic AMP phosphodiesterase Inhibitor , 
aminophylline ( Costa et al 1976 ) and it was concluded, therefore 
, that the elevation of cyclic AMP and the activation of PKa is 
the mechanism by which inducing agents produce their effects . toe 
of the mechanisms by which cyclic AMP is thought to turn on gene 
expression is by phosphorylation of acidic nuclear proteins 
( Johnson and Allfrey 1972 ) and this is thought to stimulate 
transcription as correlation exists between the binding of
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phosphcproteins to specific initiation sites and the subsequent 
enhancement of RNA synthesis ( Teng et al 1971 ) which has been 
reported to occur in the liver within one hour following the in 
vivo administration of cyclic AMP ( Dokas and Kleinsmith 1971 ) . 
It is interesting to note that phendbarbitone has similarly been 
reported to stimulate the phosphorylation of acidic nuclear 
proteins in rat liver nuclei ( Blankenship and Bresnick 1974 ) .
Cyclic AMP has also been implicated in the induction of a 
number of extrahepatic forms of cytochrome P450 and is thought to 
mediate ACTH-stimulated induction of cytochrome P45017a ( Zuber 
et al 1985 ) and of cytochrome P45011P ( John et al 1985 ) in 
bovine adrenocortical cells , LH-mediated induction of cytochrome 
P45017a and cytochrome P450C17_C20 iya3e 1° mouse leydig cells 
(Hales et al 1987 ; Malaska and Payne 1984 ; Anakwe and Payne 
1987) and FSH-mediated induction of cytochrome P450aromata#e in 
huoan adipose stromal cells ( Evans et al 1987 ; Steinkanpf et al 
1987 ) .
1.18 AIMS OF THE PRESENT PROJECT .
(a) To assess the direct effects of elevating cyclic AMP upon 
the metabolism of 4-androstene-3,17-dicne using indirect 
methods ( 8-brcmo-cyclic AMP , adrenaline , isofcutyl- 
methylxanthine and forskolin ) in isolated rat 
hepatocytes.
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(b) To assess the effects of different concentrations of 
cyclic AMP upon the metabolism of 4-androstene-3,17-dione 
when added directly to electropermeabilised rat 
hepatocytes .
(c) To elucidate the roles of the protein kinases in the 
actions of cyclic AMP using specific protein kinases 
inhibitors .
(d) To elucidate the role of protein synthesis in the actions 
of cyclic AMP .
(e) To determine if the effects of cyclic AMP upon the 
metabolism of 4-androstene-3,17-dione were due to 
alteration in the levels of whole cell cytochrome P450 .
(f) To determine if the effects of cyclic AMP upon the 
metabolism of 4-androstene-3/ 17-dione were due to changes 
in the phosphorylation states of the cytochrome P450 
isozymes .
We therefore hoped to elucidate the effects of cyclic AMP 
upon steroid-metabolising enzymes in the liver and the mechanisms 
by which it produces its effects and in doing so we hoped to 
determine the physiological and pharmacological roles of 
cyclic AMP in the regulation of the hepatic biotransformaticn 
system .
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MATERIALS AND METHODS
2 MATERIALS AND METHODS
Methods used can be separated into three main categories .
(1) Assessment of agent-generated cyclic AMP / cyclic AMP 
analogue effects upon androstenedione metabolism and 
cytochrcxne P450 levels in intact rat hepatocytes .
(2) Assessment of cyclic AMP effects upon steroid metabolism 
and cytochrane P450 levels in electnopermeabilised rat 
hepatocytes .
(3) Assessment of cyclic AMP effects upon protein 
phosphorylation in electnopermeabilised rat hepatocytes .
The methods used in each of these three categories are 
surrmarised in figure 5 .
2.1 ANIMALS .
Mature Wistar rats , bred in the department and weighing 
250g-300g were used throughout the study . Male rats were used in 
every case with the exception of section 2.7 in which female rats 
were used . The animals were housed in light- and temperature- 
controlled conditions ( lights on 0700-1900 ; 19 ± 1°C ) allowed 
free access to food ( CRM Nuts , Labsure , Croydon ) and tap 
water .
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Rat (2.1)
SDS-PAGE (2.18)
Isolation of 
Hepatocytes 
(22)
Autoradiography
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cyclic AMP 
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Electropermeabilisation
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(32p) orthophosphate 
(2.13
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cyclic AMP - 
-elevating agents 
(2.3)
Isolation of 
Hepatocytes 
P04.3--free medium 
(2.14)
Figure 5 : Summary of methods ( Numbers in brackets refer to sections of 
this thesis in which more detailed explanation of the methods are given ) .
To avoid introducing effects due to diurnal variation in 
hormonal secretory patterns , the rats were sacrificed between 
the hours of 0900 and 1100 in all cases .
2.2 ISOLATION OF HEPATOCYTES .
Prior to the isolation of hepatocytes , the rat was placed 
under anaesthesia using halothane 3.5% in oxygen/nitrous oxide 
0.4L/0.8L per minute . Hepatocytes were isolated essentially by 
the two step collagenase perfusion technique of Seglen (1973) . 
Prior to hepatocyte isolation approximately 500ml of calcium- 
free Hanks B.S.S. ( section 2.19(a) ) was gassed for 30 minutes 
with 95%: 5% 02/C02 at 37° C . Throughout the perfusion , 
temperature of the perfusate was maintained at 37°C and the 
perfusate was gassed with 02/C02 in the ratio stated above . 
Following cannulaticn of the hepatic portal vein , the liver was 
perfused "in situ" with calcium-free Hanks B.S.S. at a flew rate 
of 90ml per minute to remove the blood . Following puncture of 
the vena cava the liver was perfused for a further 7-8 minutes at 
a flow rate of 6Cml per minute to allow break down of the 
calcium-dependent bonds between the cells . The perfusing buffer 
was then changed and the liver was perfused for 10-15 minutes with 
a collagenase buffer containing 60mg of collagenase in 120ml of 
calcium-free Hanks B.S.S. resupplemented with 4mM of CaCl2 .
During this time the collagenase buffer was recirculated through 
the liver . When the liver was judged to be sufficiently digested, 
the liver was removed from the rat carcase and following the
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removal of the liver capsule , the hepatocytes were "ccmbed out" 
into calcium-free Hanks B.S.S. The hepatocyte suspension was 
filtered through gauze to remove connective tissue and portions of 
the liver which remained undigested following perfusion with 
collagenase and then centrifuged at 300g for 3 minutes in a 
Damon-IEC DPR 6000 centrifuge to sediment intact cells . The 
supernatant , containing extraneous cell debris , was removed and 
the cells were resuspended in Hams F10 culture medium supplemented 
with 0.1% bovine serum albumin and 100IU penicillin/streptomycin 
per ml ( Hussin & Skett 1987 ) at a cell density of 3 x 107 cells 
per ml . This method yielded approximately 5 x 107 cells per g wet 
weight liver with a viability , as assessed by trypan blue 
exclusion , of greater than 97% and negligible contamination by 
ncn-parenchymal cells .
2.3 INCUBATION OF INTACT HEPATOCYTES WITH CYCLIC AMP
ELEVATING AGENTS .
Freshly isolated hepatocytes were incubated in the 
presence of the cyclic AMP-elevating agents for times ranging from
2 minutes to 24 hours . For studies involving incubation times of 
^ to 24 hours the hepatocytes were plated out into sterile 10cm 
diameter culture dishes ( Nunclon , Denmark ) with 107 cells in 
10ml of Hams F10 supplemented with 0.1% bovine serum albumin and 
100IU penicillin/streptomycin per ml . The cultures were placed 
in an incubator set at 5% C02 , 98% humidity and 37° C for 30 
minutes before proceeding to allcw the cells to recover from the
-107-
isolation process . For studies involving incubation times of 2 to 
20 minutes difficulties arose when using an incubator for cell 
incubations . These were overcome by incubating the cell samples 
as suspensions in 25ml conical flasks maintained at 37° C in a 
shaking water bath . The cell density and medium was the same as 
that used during the longer incubation periods and the cell 
suspensions were similarly placed for 30 minutes in an incubator 
under identical conditions to recover frcm the isolation process 
before being transferred to the water bath . The following 
additions were added to the cells either in culture dishes or in 
conical flasks and left for the designated times of between 2 
minutes and 24 hours ; (a) 8-brano-cyclic AMP 10" 4M ; (b) 
adrenaline 10" 7M ; (c) isobutylmethylxanthine (IEMX) 10"3M ; (d) 
adrenaline and iaflX 10"7M/10"3M ; (e) forskolin 10"5M ; (f) 
forskolin and IEMX 10"5M/10"3M . Incubation with adrenaline 
(10-7M) was repeated in the presence of prazocin (10"5M) and 
propranolol (10"5M) to differentiate between ax- and p-adrenergic 
receptor-mediated responses . Adrenaline was dissolved as the 
bitartrate in ascorbic acid solution ( 10" 7 M ) and forskolin in 
dimethylsulphoxide ( EMSO ) . All other compounds were dissolved 
in distilled water . Control cells received vehicle alone except 
for those used as control for the addition of adrenaline where 
sodium tartrate ( 10_7M ) in ascorbic acid solution was used . 
Following incubation with the agents the cells were removed frcm 
the culture plates or flasks and centrifuged at 300g for 3 minutes 
in a Damcn-IEC DPR-6000 centrifuge . The supernatant was then 
removed and the cells washed in incubation medium ( section
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2.19(b) ) . Viability , as assessed by trypan blue exclusion , was 
in excess of 90% following each incubation period . The cell 
suspensions were then centrifuged under the same conditions as 
above and finally resuspended in either incubation medium , for 
the determination of androstenedione-metabolising enzyme activity 
or cytochrcme P450 levels , or sodium acetate buffer ( section 
2.19(c) ) for the determination of cyclic AMP levels .
2.4 DETERMINATICN OF CYCLIC AMP LEVELS .
Cyclic AMP levels were determined essentially by the
radioiiimunoassay technique of Brocker et al ( 1979 ) . Hepatocytes 
were suspended in sodium acetate buffer ( section 2.19(c) ) at a 
concentration of 1 x 107 cells per ml and the cellular proteins 
were denatured by placing samples in a boiling water bath for
10-15 minutes . The suspensions were subsequently centrifuged at 
4000g for 5 minutes in a Damon IEC DPR 6000 centrifuge and the 
supernatant taken for cyclic AMP determination . Standard 
concentrations (10"10M -10~6M ) of cyclic AMP were prepared in 
sodium acetate buffer and cyclic AMP content was determined in 
100mL aliquots of the standards or the unknowns . All samples
(including the standards ) were acetylated by the addition of 10mL 
of a freshly prepared mixture of triethylamine and acetic 
anhydride ( 2:1 ) followed by rapid vortex mixing . To the 
acetylated samples were then added 150mL of an anti-cyclic AMP 
antibody ( raised in goats against human serum albumin conjugated 
to succinyl-cyclic AMP ) and 100M1 ( approximately 3000 c.p.m.) of
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adenosine-3', 5-cyclic phosphoric acid
21 -O-succinyl-3- (12 51 )-iodotyrosine methyl ester in sodium acetate 
buffer . The samples were then vortex mixed and incubated at 4°C 
for 16 hours . Following incubation , 0.5ml of a suspension of 
activated charcoal in lOGmM phosphate buffer ( section 2.19(d) ) 
containing 0.25% bovine serum albumin was added to each of the 
samples which were then immediately mixed and centrifuged at 4000g 
for 4minutes at 4°C in a Damon IEC DPR 6000 centrifuge . 0.6ml 
aliquots of the supernatant containing antibody bound cyclic AMP 
were taken and counted in an LKB Gairma counter . Standard 
displacement curves were constructed for the assay on each 
occasion of radioactivity bound ( c.p.m.) against concentration of 
cyclic AMP . The amount of cyclic AMP in the unknown samples was 
subsequently determined and expressed as pmoles of cyclic AMP per 
106 cells . The specificity of the antiserum was tested by 
measuring the ability of a range of adenine and guanine 
nucleotides to compete with(125I)-cyclic AMP for binding to the 
antiserum . The antiserum was relatively specific for cyclic AMP 
with 103 fold ( cyclic (24P ) and 104 fold ( AMP , ADP and ATP ) 
higher concentrations of the other nucleotides required to produce 
50% displacement of the (125I)-cyclic AMP .
2.5 DETERMINATION OF ANDROSTENEDIGNE METABOLISM .
The steroid 4-androstene-3,17-dione undergoes metabolism by 
the enzymes of the liver at the sites shewn in figure 2
The activities of the enzymes responsible for the metabolism
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of 4-androstene-3,17-dione were determined essentially by the 
method of Gustafsscn and Stenberg ( 1974 ) . Approximately 107 
hepatocytes were suspended in 3ml of incubation medium ( section 
2.19(b) ) to which was added 500Mg ( 0.1MCi ) of 
4- (4- 14 C) -androstene-3,17-dione and the suspension was incubated 
for 30 minutes at 37° C in a shaking water bath . The reaction was 
stopped by the addition of 10ml of Polch ( chloroform/methanol 
2 :1 ) to each of the samples followed by the addition of 1ml of 
NaCl solution 0.9% to aid the extraction of the substrate and its 
metabolites into the organic layer . The organic layer was then 
removed , evaporated to dryness at 45° C under nitrogen and the 
residue dissolved in a small quantity of chloroform . Samples 
were then applied to TLC plates ( Merck F254 ) and developed in 
chloroform/ethyl acetate (4:1) to separate the metabolites and 
unchanged substrate . The position of each of the bands on the 
plate were identified by autoradiography as shewn in figure 6 and 
then the amount of 14 C-label in each band ( metabolites and 
substrate ) was evaluated by liquid scintillation counting in 5ml 
of Ecoscint ( National Diagnostics , New Jersey ) in a Packard 
Tri-Carb 2000CA counter . The amount of each metabolite , 
expressed as pinoles of metabolite/min/106 cells , was 
subsequently determined by the following formula :
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5<x-reductase
Substrate
3oc(/3) hydroxysteroid 
1 dehydrogenase
17a(fl) hydroxysteroid 
1 dehydrogenase
16oc-hydroxylase 
6/3-hydroxylase 
7oc-hydroxylase 
Substrate
Figure 6 : Diagrairmatic representation of the separation of 4-androstene-
3,17-dione metabolites by one dimensional thin layer chromatography .
pmoles metabolite/min/106 cells = S x Q n x l x l x l
Ct t n MW
S = amount of substrate added ( pg )
On = c.p.m metabolite 
Ct = c.p.m. total
t = incubation time ( in minutes ) 
n = number of cells ( divided by 106 )
MW = molecular weight of the substrate ( 280 ) .
It is apparent frcm figure 6 that six major metabolites of 
androstenedione can be separated by this method however in figure 
2 we shewed that 3 a/p hydroxysteroid dehydrogenase does not 
metabolise the parent compound but metabolism by this enzyme 
occurs subsequent to metabolism by 5a reductase . For the purpose 
of this study only the activities of the enzymes metabolising the 
parent molecule were evaluated and therefore the amount of 
metabolite produced by subsequent metabolism of 
5a-androstane-3,17-dione ( as produced by 5a reduction of 
androstenedione ) by 3a/p hydroxysteroid dehydrogenase was not 
determined separately but the amount of metabolite produced by 
this enzyme was added to the amount of unchanged 
5a-androstane-3,17-dione to determine the total amount of 
metabolite produced by the activity of 5a reductase per minute per 
106 cells .
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2.6 ASSESSMENT OF THE ROLE OF COEACTORS IN CYCLIC AMP-
MEDIATED ALTERATION OF ANDROSTENEDIONE METABOLISM .
To investigate if the effects of the cyclic AMP-generating 
agents and 8-bromo-cyclic AMP are mediated by changes in the 
levels or activities of the cofactors associated with cytochrome 
P450-linked enzymes , the metabolism of 4-androstene-3,17-dicne 
was examined in hepatocytes which had been hcmogenised and 
supplemented with excess of the cofactors following incubation 
with 8-brano-cyclic AMP . Before resuspending in incubation medium 
prior to the determination of 4-androstene-3,17-dicne metabolism , 
the washed hepatocytes were resuspended in a small volume of 
incubation medium and hcmogenised using a Potter-Elvehjem 
hcmogeniser with a loose fitting teflon pestle ( 2500 r.p.m./5 
strokes ) . The volume of each of the hcmogenised samples was the 
made up to 3ml with incubation medium to give a cell density of 
approximately 107 hcmogenised cells in each 3ml aliquot . To each 
aliquot was then added 0.8mg NADP and 4mg isocitric acid In 100M1 
of MnCl2 solution ( 6mg/10Qml ) followed by 10M1 of isocitrate 
dehydrogenase to start the reaction . The samples were then 
pnpj pnihgt-pri for 2 minutes at 37° C in a water bath to allow for 
the formation of NADFH . 500pg ( 0.1MCi ) of 4-androstene-
3,17-dione was then addpd to each of the samples ( time zero ) . 
Hie metabolism of androstenedione was assayed as described in 
section 2.5 .
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2.7 DETERMINATION OF SEX DIFFERENCES IN CYCLIC AMP-MEDIATED
ALTERATION OF ANDROSTENEDIONE METABOLISM .
To examine if the effects of 8-bromo-cyclic AMP upon steroid- 
metabolising enzymes are dependent upon the sex of the animal , 
the effects of this agent upon the metabolism of androstenedione 
were examined in hepatocytes isolated frcm female Wistar rats 
kept under the same conditions as described in section 2.1 . 
Hepatocytes were isolated as described in section 2.2 , 
preincubation with 8-bromo-cyclic AMP (10~4M) for £ to 2 hours was 
carried out as described in section 2.3 and androstenedicne- 
metabolising enzyme activity was assessed as described in section
2.5 .
2.8 DETERMINATION OF WHOLE CELL CYTOCHRCME P450 CONTENT .
The total cytochrome P450 content of the hepatocytes was 
determined by the method of Cmura and Sato ( 1964b ) . Following 
incubation with the cyclic AMP-elevating agents , the cell 
samples were resuspended in a small quantity of incubation medium 
and then hcmogenised using a Potter-Elvehjem hcmogemser with a 
loose fitting teflon pestle ( 2500 r.p.m./5 stroikes ) .
Hcmogenised cell samples were then suspended in incubation medium 
to give a cell density of 5 x 107 hcmogenised cells per ml . The 
hcroogenates were assayed for cytochrome P450 content in 3ml 
aliquots of cell suspension . Samples were first reduced by the
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add it ion of 5mg of sodium dithionite and then bubbled for 30 
seconds with carbon monoxide . The reduced CO absorption spectrum 
was measured in a Schimadzu UV/VIS spectrophotometer between the 
wavelengths of 500 and 400 nm against a reference of hcmogenised 
cell suspension reduced with 5mg sodium dithionite . The 
absorbance relative to baseline measured at 450nm was converted to 
a concentration of cytochrome P450 by the use of the millimolar 
extinction coefficient of 91 . The cytochrome P450 concentration 
was subsequently expressed as nmoles of cytochrome P450 per 10® 
cells .
2.9 ELECTH3PEFMEABILISATICN OF HEPATOCYTES .
2.9(a) Theoretical assessment of electropermeabilisation 
parameters .
Electropermeabilisation of freshly isolated hepatocytes was 
carried out essentially by the method of Knight and Baker ( 1982). 
By this method a potential difference applied across the 
plasma membrane of the hepatocyte punctures two pores in the 
membrane which allows the access of small molecules ( cyclic AMP ) 
to the interior of the cell . A diagrammatic representation of the 
hepatocyte subjected to an electrical field is shewn in figure 7 
and the potential difference across the membrane at any point ( p) 
around the circumference of the cell ( Vp ) is given by the 
equation :
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EFigure 7 : Diagrammatic representation of a cell of radius b subjected 
to an electric field of strength E . For full explanation see section 2.9(b) 
( adapted frcm Knight and Baker 1982 ) .
Vp = CbEcosB
Where b is the radius of the cell , E is the strength of the 
applied field , the angle 0 is as shewn in figure 7 and C is a 
constant dependent upon the relative conductivities of the 
extracellular fluid , the cytosol and the membrane with relation 
to cell size and membrane thickness . For simplicity the value of 
C is taken as 1.5 ( Knight and Baker 1982 ) . By the equation it 
can be seen that the potential difference across the membrane of 
the hepatocyte will be maximum at points A and B as shewn in 
figure 7 at which point the value of cos 0 will be 1 therefore the 
equation can be simplified to :
Vp = 1.5bE
Plasma membranes have been shown to rupture at voltages in 
excess of IV ( Zimmerman et al 1974 ). Hepatocytes have a radius 
of approximately 10Mm ( Drocbmans et al 1975 ) and so it can be 
calculated that an applied field strength of lOOOV/cm would 
produce a transmembrane potential of 1.5 V across the plasma 
membrane . The mitochondria have a radius of approximately 0.5Mm 
( Knight and Baker 1982 ) therefore an applied field strength of 
lOOOV/cm would produce a transmembrane potential of 75mV . An 
applied field strength of lOOOV/cm is theoretically sufficient , 
therefore , to rupture the cell membrane of the hepatocyte without
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damaging other internal organelles
2.9(b) Experimental assessment of electropermeabl 11 sation 
parameters
The apparatus used to effect electropermeabilisation of the 
hepatocytes is shown in figure 8
To assess the efficiency of the apparatus to 
electropermeabilise the hepatocytes and allow access of cyclic 
AMP , freshly isolated hepatocytes were suspended in Ham's F10 
supplemented with 0 .1% bovine serum albumin with or without 10-4 
cyclic AMP at a cell density of 3 x 107 cells per ml . The cells 
were electropermeabilised using a range of parameters ( 2-10 
pulses at 1000-3000 V/cm ) and then centrifuged at 300g for 3 
minutes in a Damon IEC DPR 6000 centrifuge . The medium was 
subsequently removed and the cells were resuspended in sodium 
acetate buffer ( section 2.19(c) ) and assayed for cyclic AMP 
content by radioimnunoassay as described in section 2.4 . The 
extracellular cyclic AMP carried over in the supernatant following 
centrifugation was determined by comparing the amount of cyclic 
AMP in the permeabilised cell samples ( ± 10-4M ) with 
nonpermeabilised cells treated in the same way . Assuming that the 
amount of cyclic AMP permitted access to the interior of the cell 
in the nonpermeabilised cell is negligible compared to the cyclic 
AMP in the extracellular medium and that the cyclic AMP carried 
over in the extracellular medium is a constant for a given number 
of cells centrifuged at a given g-force independent of
-117-
High voltage 
supply
Capacitor
Metal electrodesCell suspension
M
1 cm
Figure 8 : Diagramnatic representation of the apparatus used to 
electropemeabilise hepatocyte suspensions ( adapted from Knight and Baker 
1982 ) .
permeabilisation , the amount of cyclic AMP carried over in the 
permeabilised test samples (Y) is equal to the difference between 
the intact cell cyclic AMP levels in the presence and absence of 
cyclic AMP . The cyclic AMP allowed access to the cell interior 
(X) , therefore , is given by the formula :
X = (perm+cAMP) - (perm-cAMP) - Y 
where Y = (intact+cAMP) - (intact-cAMP)
Assuming that the hepatocyte is a sphere of radius 10-5 
metres ( section 2.9(a) ) and that the volume of the intracellular 
organelles is negligible in comparison to the total intracellular 
volume of the cell , the intracellular volume of the cell (4/3nr3) 
is 4.189 x 10~121 . Fran this the intracellular concentration of 
cyclic AMP can be determined .
The cyclic AMP content of the intact cells ( intact-cAMP ) was 
calculated experimentally to be 0.054 ± 0.007 nmoles ( n = 4 ) and 
the cyclic AMP levels of 3 x 107 cells sedimented fran medium 
containing 10~4M cyclic AMP ( intact+cAMP ) was calculated 
experimentally to be 1.95 ± 0.067 nmoles ( n = 4 ) .
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The amount of cyclic AMP carried over fran the medium for 3 x 
107 hepatocytes centrifuged at 300g (Y) was calculated thus :
Y = 1.95 - 0.054 nmoles 
therefore Y = 1.895 n moles
Hie increase in the intracellular concentration of cyclic AMP 
which occurs as a result of electropermeabilisation was calculated 
by determining the increase in the intracellular content of cyclic 
AMP (X) using the above formula and then dividing the content by 
the volume of 3 x 107 hepatocytes ( 1.26 x 10~4L ) .
Table 3 shews the effects of the different 
electropermeabilisation parameters upon the cyclic AMP content of 
hepatocytes and the derived intracellular concentration . 
Comparison of the intracellular and extracellular concentrations 
of cyclic AMP was taken as a measure of the degree of 
permeabilisaticn of the cell . It is apparent fran table 3 that 5 
pulses at 1000 V/an results in almost 100% permeabilisaticn which 
correlates well with the theoretical assessment of 
permeabilisaticn .
Cell viability , as assessed by trypan blue exclusion , was 
reduced to 75-80% by the electropermeabilisation ( 1000 V/an x 5) 
process but did not shew any further reduction over a 3 hour 
incubation period following permeabilisaticn . 5 pulses at 1000 
V/an were considered to be the best carpranise parameters to use 
for further experiments .
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Permeabilised Permeabilised Y X intracellular
Parameters + cAMP 10" 4M cAMP-free concentration
(nmoles) (nmoles) (nmoles (nmoles)
1000V x 2 8.88 ± 0.79 0.045 ± 0.007 1.896 6.939 0.55 x 10-4M
1000V x 5 13.775 ± 0.48 0.036 ± 0.006 1.896 11.843 0.94 x 10-4M
1000V x 10 13.475 ± 0.68 0.030 ± 0.001 1.896 11.549 0.91 x 10-4M
2000V x 2 9.15 ± 0.75 0.043 ±’0.007 1.896 7.210 0.57 x 10-4M
2000v x 5 12.85 ± 2.06 0.032 ± 0.009 1.896 10.922 0.86 x 10-4M
2000v x 10 13.35 ± 0.85 0.026 ± 0.007 1.896 11.428 0.91 x 10-4M
3000v x 2 10.89 ± 1.13 0.034 ± 0.007 1.896 8.96 0.71 x 10-4M
3000v x 5 14.525 ± 0.64 0.025 ± 0.009 1.896 12.604 1.00 x 10-4M
3000v x 10 13.75 ± 2.25 0.025 ± 0.010 1.896 11.829 0.94 x 10-4M
Table 3 . The efficiency of a range of electropermeabilisation parameters 
( 2-10 pulses at 1000-3000 V/an ) to effect permeabilisation of rat 
hepatocytes to cyclic AMP . Calculation of the intracellular concentration 
of cyclic AMP and subsequent determination of efficiency of permeabilisation 
are as discussed in the text .
2.10 INCUBATION OF PERMEABILISED HEPATOCYTES WITH CYCLIC AMP
Hepatocytes were permeabilised in the presence of varying 
concentrations of cyclic AMP ( 5 x 10" 6 to 5 x 10-3M ) using the 
parameters chosen in 2.9(b) at a cell density of 3 x 107 cells 
per ml . The cells were plated onto 10cm culture dishes ( NUnclon 
, Denmark ) with 107 cells in 10ml of Ham's F10 supplemented as 
described previously and containing the concentrations of cyclic 
AMP used during permeabilisation . The cell samples were incubated 
as described in section 2.3 for times ranging frcm ^  to 3 hours . 
Viability of the cells was unaffected by the addition of cyclic 
AMP at the concentrations stated . Concentrations above 5 x 10- 3M 
caused progressive cell destruction and , thus , were not used .
2.11 ASSESSMENT OF CYCLIC AMP EFFECT UPON ANDROSTENEDICNE 
METABOLISM AND CYTOCHRCME P450 LEVELS IN 
ELECTROPEEMEABILISED HEPATOCYTES .
Following incubation with the different concentrations of 
cyclic AMP , the cells were removed frcm the culture plates , 
washed and resuspended in incubation medium as described in 
section 2.3 . Androstenedione metabolism and cytochrome P450 were 
assessed as described in sections 2.5 and 2.8 respectively .
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2.12 ASSESSMENT OF THE ROLE OF PROTEIN SYNTHESIS IN THE
ACTIONS OF CYCLIC AMP .
To assess the role of protein synthesis in the effects of (a) 
forskolin 10" 5M and (b) forskolin and IEMX 10-5M/10“3M in intact 
hepatocytes , the translation blocker , cycloheximide ( 10“ 5M )
( Peshka 1971 ) was added during the 30 preincubation period 
prior to the addition of the cyclic AMP elevating agents . To 
assess the role of protein synthesis in the effects of cyclic AMP 
( 5 x 10” 5M to 5 x 10” 3M ) in permeabilised hepatocytes , 
cycloheximide 10” 5M was added during the 30 minutes preincubation 
period prior to permeabilisation and then resuppleraented to give 
a final concentration of 10-5M in the culture dishes . Cell 
samples were incubated for times ranging fran i to 3 hours under 
conditions described previously ( section 2.3 ) . Androstenedione 
metabolism and cytochrome P450 levels were assessed as described 
in sections 2.5 and 2.8 respectively .
2.13 A ^ ^ M E N T  OF THE ROLE OF PROTEIN KINASES IN THE EFEHCTS 
OF CYCLIC AMP .
The role of the protein kinases in the effects of cyclic AMP 
in pprmaahi 1 i sad hepatocytes was assessed by using the specific 
protein kinases inhibitors (a) K-252a , 2 x 10”8M ( 8R* ,9S,11S*)-
(-) -9-hydroxy-9-nethcxycarbonyl-8-methyl-2 ,3,9,10 -tetrahy- 
dro-8 ,11-epoxy-lH, 8H, 11H-2, 7b, lla-triazadibenzo (a, g) cycloocta 
(c,d/e)trinden-"l-one ; inhibits all protein kinases ) ; (b)
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K-252b , 2 x 10~ 8M ( the 9-carboxylic acid derivative of K-252a ; 
a selective inhibitor of protein kinase c ) ; (c) KT5720 , 6 x 
10-8M ( the 9-hexoxy-carbcnyl derivative of K-252a ; a selective 
inhibitor of protein kinase a ) and (d) KT5822 , 2.5 x 10“9M 
(the 9-methoxy derivative of K-252a ; a selective inhibitor of 
protein kinase g ) ( Kase et al 1986 ; Nakanishi et al 1986 ; 
Yasazawa et al 1986 ; Kase et al 1987 ). The inhibitors were 
added to the hepatocytes prior to permeabilisaticn to give the 
concentrations stated above . Following permeabilisation the cell 
cultures were resupplemented with the inhibitors to maintain the 
correct concentration . The inhibitors were added in solution in 
EMSO , control cells received EMSO only . Incubation with cyclic 
AMP ( section 2.11 ) , assessment of androstenedione metabolism 
(section 2.5 ) and cytochrome P450 levels ( section 2.8 ) were as 
previously described . Preliminary experiments indicated that the 
protein kinase inhibitors appeared not to be able to penetrate 
the plasma membrane in the intact cell and so the roles of the 
protein kinases in the actions of cyclic AMP were assessed in the 
permeabilised cells only .
2.14 ISOLATION OF HEPATOCYTES IN PH3SPHATE-FREE MEDIUM .
Hepatocytes were isolated by two step collagenase perfusion 
as described in section 2.2 . The method differed slightly , 
however , in that phosphate-free , calcium-free Hanks BSS (section 
2.19(e) ) was used throughout the isolation procedure instead of 
calcium-free Hanks BSS as used in section 2.2 . Viability
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following isolation , as assessed by trypan-blue exclusion , was 
comparative to that in section 2.2 ( greater than 97% ) . 
Following isolation the hepatocytes were suspended in 
phosphate-free incubation medium ( section 2.19(f) ) supplemented 
with 0 .1% bovine serum albumin at a cell density of 2 x 107 
per ml . This medium was found not to adversely affect cell 
viability , as assessed by trypan-blue exclusion , over a 3 hour 
incubation period following its addition to the cells .
2.15 PREINCUBATION OF HEPATOCYTES WITH (32P) 0RTH3PH3SPHMCE .
To allow for the labelling of hepatocyte ATP with (32P) , 
hepatocyte suspensions were incubated for 1 hour at 37° C with 
(32P)-orthophosphate at a concentration of lOpCi per 106 cells . 
incubations were conducted in 25ml conical flasks placed in a 
water bath maintained at 37° C and the atmosphere above the cell 
suspension was maintained at 02/C02 , 95%: 5% by using a closed 
system connected to a gas cylinder .
2.16 EIaEXIIHIPERMEABILISATION AND INCUBATION WITH CYCLIC AMP .
Due to the changes in the levels of whole cell cytochrome 
P450 mediated by high concentrations of cyclic AMP ( 5 x 10~3M )
( results : section 3 .6 (b) ) the effects of high concentrations 
of cyclic AMP upon phosphorylation of cytochrome P450 were not 
determined as comparison between control and test cell samples
-123-
would have been complicated by the cyclic AMP-mediated alteration 
in cytochrome P450 as determined in section 2.8 due to the 
limitations of this assay procedure .
Following preincubation with (32P)-orthophosphate , the 
hepatocytes were centrifuged at 300g for 3 minutes in a Damcn-IEC 
DPR 6000 centrifuge , the supernatant was removed and the cells 
washed with fresh phosphate-free incubation medium supplemented 
with 0.1% bovine serum albumin . This was repeated three times to 
ensure removal of excess (32P) orthophosphate from the cells .
The hepatocytes were then suspended in phosphate-free incubation 
medium supplemented with 0 .1% bovine serum albumin at a cell 
density of 3 x 107 cells/ml and electropermeabilised as described 
previously ( section 2.9(b) ) . Viability , as assessed by 
trypan-blue exclusion was comparable to that following 
electropermeabi 1 i sation of the hepatocytes in the presence of Hams 
F10 supplemented with 0.1% bovine serum albumin and 100IU 
penicillin/streptomycin ( 75-80% ) indicating that 
electropermeabilising the cell in the presence of phosphate-free 
incubation medium supplemented with 0 .1% bovine serum albumin did 
not have any additional adverse effects upon cell viability other 
than those considered to be acceptable in section 2.9(b) .
For assessment of the cyclic AMP-mediated phosphorylation of 
whole cell proteins , the electropermeabilised hepatocytes were 
suspended in phosphate-free incubation medium supplemented with 
0.1% bovine serum albumin at a cell density of 5 x 106cells/ml 
and incubations were conducted in lOOpl aliquots of this cell 
suspension ( 5 x 105 cells ) .
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For assessment of cyclic AMP-mediated phosphorylation of 
specific cytochrome P450 isozymes . the el entnrppTmftahi 1 i 
hepatocytes were suspended in phosphate-free incubation medium 
supplemented with 0 .1% bovine serum albumin at a cell density of 
107 cells/ml and incubations were carried out in 1ml aliquots of 
this cell suspension ( 107 cells ) .
Cyclic AMP was added to each of the test cell samples to give 
a final concentration in the aliquot of 5 x 10-5 M . Cyclic AMP 
was added to the lOOpl aliquots of cell suspension in 5pl of 
distilled water and to the 1ml aliquots of cell suspension in 
50pl of distilled water . Control cells samples received the 
equivalent volume of vehicle only . Incubations were conducted in 
a water bath maintained at 37° C for times ranging from 15 to 60 
minutes .
2.17 PREPARATION OF SOLUBILISED CFTT, SAMPLES .
2.17(a) Whole cell proteins .
Following incubation with 5 x 10-5 cyclic AMP , 400pl of 
sample solvent ( brcmophenol blue 0 .01%w/v , sodium dodecyl 
sulphate 4.6%w/v , "Tris" buffer 20%w/v , mercaptoethanol 10%v/v 
and glycerol 15%v/v in distilled water pH 6.8 ) was added to 
each of the 100pl aliquots of cell suspension and then samples 
were placed in a boiling water bath for 3 minutes to ensure 
sollnh-i 1 of relInlar proteins . The solubi 1 ised samples were
then allowed to cool to roan temperature before proceeding .
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2.17(b) Specific cytochrcme P450 isozymes
Following incubation with 5 x 10-5M cyclic AMP , the 
hepatocyte cell samples were centrifuged at 300g for 3 minutes in 
a Damcn-IEC DPR 6000 centrifuge and the supernatant was removed . 
A snail volume ( l-2ml ) of sodium cholate solution 1.8%"/v was 
added to each of the cell samples and homogenisation of cells was 
ensured by drawing each of the samples into a syringe fitted with 
a 26g needle . The volume of each of the samples was made up to 
10ml with sodium cholate solution 1 .8%w/v and samples were 
centrifuged at 105,000g for 1 hour at 4°C in a Beckman L8-M 
ultracentrifuge . 500pl of a 1:1000 dilution of specific 
cytochrcme P450 FB-2a antibody , cytochrcme P450 FB-3a antibody or 
cytochrcme P450 M3-lb antibody ( nomenclature of Wolf : table 1 ) 
in phosphate-free incubation medium supplemented with 0 .1% bovine 
serum albumin was added to 1ml aliquots of the supernatant ( 10® 
cells ) . Antibodies had been raised in rabbits against isolated 
rat cytochrcme P450 isozymes . Cytochrcme P450 PB-2a antibody was 
found to be highly specific for cytochrcme P450 FB-2a hut shewed 
very slight cross reactivity with three other unspecified 
isozymes. Cytochrcme P450 PB-3a antibody was found to be 
relatively specific for cytochrcme P450 PB-3a , the major 
phenobarbitone inducible isozyme ( table 1 ) tut it also shewed 
seme cross reactivity with cytochrcme P450e which is the second 
phenobarbitcne inducible cytochrcme P450 isozyme . Cytochrcme P450 
M3-lb antibody was found to be relatively specific for cytochrcme 
P450 M3-lb , the major 3-methylcholanthrene-inducible isozyme
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( table 1 ) but it also showed very slight cross reactivity with 
cytochrcme P450d which is the second 3-methylcholanthrene- 
inducible isozyme. Following the addition of the specific 
antibodies , cell samples were placed on ice for 30 minutes and 
then centrifuged at 25,000g for 20 minutes at 4°C in a Beckman 
L8-M ultracentrifuge . The supernatant was removed from each of 
the samples and the iirmuncprecipitate was washed and dissolved in 
50jil of sample solvent ( section 2.17(a) ) . Samples were then 
boiled as described in section 2.17(a) and then allowed to cool to 
room temperature before proceeding .
2.18 SODIUM DQDECYL SULFHATE POLYACRYLAMIDE GEL
ELECTROPHORESIS ( SDS-PAGE ) OF SOLUBILISED CELL SAMPLES 
AND DETECTION OF PHOSPHOPRQTEINS .
Samples were resolved into their constituent proteins on 7.5% 
polyacrylamide slab gels as described by Smith ( 1984 ) . For 
samples containing whole cell proteins , 20pl ( 2 x 104 cells ) 
were added to each sample well . For samples containing 
inmunoprecipitated cytochrcme P450 isozymes , the whole of the 
sample was added to the well ( extract frcm 106 cells ) . Hie 
samples were subjected to electrophoresis towards the anode at a 
constant voltage of 150V for about 3 hours until the brcmophenol 
blue marker in the sample solvent ( section 2.17(a) ) was at the 
bottom of the gel and then the gels were fixed and stained for 1-2 
hours at room temperature in 0.1% w/v Cocmassie Brilliant Blue 
R-250 in methanol/glacial acetic acid/water ( 5:1:1 ) . Gels were
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destained for approximately 24 hours at rocm temperature in 
methanol/glacial acetic acid/water ( 8:1:1 ) with several changes 
of the solution . The gel was then placed on a piece of absorbant 
paper , covered in non porous plastic film ( Cling Film ) and then 
dried under vacuum at a temperature of 60°C on a Bio-Rad Model 224 
Gel Slab Dryer for 3 hours . Dried gels were then autoradiographed 
at -70°C for up to four weeks . The incorporation of (32P) into 
whole cell proteins or inrnunoprecipitated cytochrome P450 isozymes 
was assessed by visual examination of the X-ray film after 
developing .
2.19 BUFFERS AND PHYSIOLOGICAL SQUJITCNS .
(a) Calcium-free Hanks Basic salt solution .
KCl : 20Ctag
KH2PO4 : 30mg
NaCl : 400Ctog ( 4g )
Na2HP04 : 24mg
NaHX)3 : 1050ng ( 1.05g )
m  glass distilled water to 1 litre .
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(b) Incubation medium
Glucose : lOOOtog ( lg )
MgS04 : lOOmg
MgCl2 : lOOmg
CaCl2 : 185mg
In calcium-free Hanks basic salt solution to 1 litre .
(c) Sodium acetate buffer ( 50nM ) .
Sodium acetate : 4.1g 
Glass distilled water : 500ml
Adjusted to pH 5 with glacial acetic acid
Glass distilled water to 1 litre .
II
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(d) Potassium phosphate buffer ( lOChM )
K2HP04 : 4.61g 
KHgFCU : lOg
Glass distilled water : 500ml 
Adjusted to pH 6.4 with HCl .
Glass distilled water to 1 litre .
(e) Calcium-free , Phosphate-free Hanks basic salt solution .
KCl 200mg
KgSCU 30mg
NaCl 4000mg ( 4g )
Na2S04 24mg
NaH003 1050mg ( 1.05g )
In glass distilled water to 1 litre
(f) Phosphate-free incubation medium .
As in 2.19(b) above but made up to 1 litre in calcium-free 
phosphate-free Hanks basic salt solution .
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2.20 CHEMICALS .
Chemicals and reagents are listed according to manufacturer .
Sigma Chemicals Ltd. , Poole , Dorset , U.K.
8-Brcmo-cyclic AMP 
Adrenaline
Isofcutylmethylxanthine
Forskolin
Cyclic AMP
4-Androstene-3,17-dicne
Cycloheximide
Branophenol Blue
Cocmassie Brilliant Blue R-250
Sodium dodecyl sulphate
"Tris" buffer
bis-Acrylamide
Acrylamide
BCL Ltd. , Lewes , East Sussex , U.K. 
Collagenase
Bovine serum albumin ( Frakticn V ) 
NADP
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Isocitric acid 
Isocitrate dehydrogenase
Amersham International pic , Aylesbury , Bucks. U.K.
Adenosine-3' 51-cyclic phosphoric acid 21 -O-succinyl
3-(i25I)iodotyrosine methyl ester
4-(4_i a. q  ) Androstene-3,17-dione
Gibco BRL Ltd. , Paisley , Scotland , U.K.
Hams F10
Penicillin/streptomycin solution
Kodak , France
X ray film ( X-Ctnat S )
Developer ( D-19 )
Fixer ( FX-40 )
Miscellaneous
Prazocin was supplied by Pfizer , Sandwich , Kent , U.K.
(32P)Orthophosphate was supplied by the Western Infirmary , 
Glasgow , Scotland , U.K.
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K-252a , K-252b , KT5720 , KT5822 : Vfere kind gifts from Dr 
H. Kase , Kycwa Hakko Kogyo Co. Ltd. , Tokyo , Japan
Cytochrome P450 antibodies specific for cytochromes P450 
FB-2a , PB-3a and M3-lb , were a kind gift from Dr C.R. Wolf 
, ICRF , Edinburgh , Scotland , U.K.
All other chemicals used were of the highest analytical grade 
commercially available .
2.21 STATISTICS .
Results were expressed as percentage of relevant control ± 
standard deviation . Statistical analysis was performed using 
Student's t-test and statistical significance was set at p<0.05 
in all cases .
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RESULTS
3 RESULTS
3.1 METABOLISM OF ANDROSTENEDIONE IN HEPATOCYTES ISOLATED 
FRCM MALE RATS AND CULTURED FOR 24 HOURS .
Using the substrate , androstenedione , at least five 
different enzyme activities can be calculated : 7a-, 60- and 
16a-hydroxylase , 17a/0 hydraxysteroid dehydrogenase ( 17-CHSD ) 
and 5a reductase . Although not dealt with in this thesis , it has 
previously been established in this laboratory that the metabolism 
of androstenedione proceeds linearly with time ( up to 70 minutes) 
and cell number ( up to 1.2 x 107 cells ) ( Hussin 1988 ) .
Using an identical concentration of androstenedione ( 500Mg in 3ml 
of cell suspension ) in this present study , therefore , the cell 
number of 107 cells and incubation period of 30 minutes are within 
the limits of linearity established above .
Table 4 shows the activities of these five enzymes in 
hepatocytes isolated from male rats and maintained in Hams F10 
supplemented with 0.1% bovine serum albumin and 100IU 
penicillin/streptomycin . It is apparent from the table that 
although the activities of the enzymes decline progressively over 
the 24 hour incubation period under these culture conditions , the 
ratios of the enzyme which results in the overall enzyme profile 
does not vary significantly over this time period.
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time 7a-QH 6P-CH 16a-CH 17-QHSD 5a-Red
£hr 26.2 ± 4.1 74.8 ± 14.7 196.0 ± 21.2 118.1 ± 15.4 304.4 ± 91.9
lhr 24.0 ± 3.1 78.0 ± 6.8 166.7 ± 18.4 93.8 ± 14.8 202.5 ± 7.6
2hr 14.8 ± 2.8 47.2 ± 11.6 87.3 ± 24.1 72.0 ± 2.1 173.3 ± 42.0
24hr 12.8 ± 4.0 15.4 ± 3.6 19.0 ± 3.2 14.4 ± 4.2 80.3 ± 10.3
Table 4 : The activities of 7a-hydroxylase ( 7a-QH ) , 6p-hydroxylase 
( 6p-GH ) , 16a-hydroxylase ( 16a-QH ) , 17a/p-hydroxysteroid 
dehydrogenase ( 17-OOSD ) and 5a-reductase ( 5a-Red ) in isolated rat 
hepatocytes over a 24 hour period of culture in Hams F10 supplemented 
with 0.1% bovine serum albumin and 100IU penicillin/streptcxnycin . 
Results are expressed as pinoles of metabolite formed per minute per 
106 cells ± S.D. for 12 different cell samples .
3.2 METABOLISM OF ANDROSTENEDIONE IN HEPATOCYTES ISOLATED
FRCM MALE AND FEMALE RATS .
Table 5 shows the activities of each of the five enzymes 
which metabolise androstenedione in untreated hepatocytes freshly 
isolated from either male or female rats . It can be seen that 
the well documented , sexually differentiated enzymes profiles 
( table 2 ) are expressed in the isolated hepatocyte . Thus :
7 a-hydroxylase 
6p-hydroxylase 
16a-hydroxylase 
17-QHSD 
5a-reductase
female = male 
female < male 
female «  male 
female < male 
female »  male
In the results shown in table 5 female 16a-hydroxylase 
activity is 25.9% of male 16a-hydroxylase activity , female 
6p-hydroxylase activity is 40.6% of male 6p-hydroxylase activity 
and female 5a-reductase activity is 233.6% of male 5a-reductase 
activity . The non sexually differentiated enzymes involved in the 
metabolism of 4-androstene-3,17-dione ; 7 a-hydroxylase and 
17-CHSD, have activities in the female rat of 83.3% and 91.9% , 
respectively , of corresponding male activities .
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7a-CK 6p-QH 16a-GH 17-GHSD 5a-Red
Male
Female
47.7 ± 4.4
39.8 ± 3.0
76.1 ± 2.4 
30.7 ± 3.5
117.5 ± 5.0 
30.4 ± 2.0
87.9 ± 6.1 
80.8 ± 3.1
320.6 ± 17.5 
748.9 ± 93.9
Table 5 . The activities of 7a-hydroxylase ( 7a-GH ) , 6{3-hydroxylase 
( 6p-QH ) , 16a-hydroxylase ( 16a-QH ) , 17a/p-hydroxysteroid- 
dehydrogenase ( 17-GHSD ) and 5a-reductase ( 5a-Red ) in hepatocytes 
freshly isolated fran male and female rats . Results are expressed in 
pmoles of metabolite formed per minute per 106 cells ± S.D. for four 
different cell samples .
3.3 EFFECT OF ELEVATING CYCLIC AMP UPCN IHE METABOLISM OF
ANDROSTENEDIONE IN ISOLATED RAT HEPATOCYTES .
3.3(a) Effects of 8-brcmo-cyclic AMP .
(i) Effects of 8-brano-cyclic AMP in male rat hepatocytes
As illustrated in table 5 , the control activity of each of 
the enzymes is dependent upon the particular enzyme being studied, 
to illustrate the effects of cyclic AMP upon the activities of 
the enzymes , therefore , each of the activities is expressed as 
percentage of the relevant control activity .
The effects of 8-brcmo-cyclic AMP (10_4M) upon each of the 
enzyme activities following a 2 hour incubation period are shewn 
in table 6 . It is apparent that 8-brcmo-cyclic AMP causes a 
reduction in the activities of all of the enzymes in a ncn- 
selective manner and produces no change in the sexually 
differentiated male profile of the enzyme activities . The 
activities of 6p-hydroxylase and 16a-hydroxylase which are 
inhibited to 43.76% and 41.94% , respectively , of corresponding 
control activities would be consistent with a fanimsing effect of 
cyclic AMP however the inhibition of the activity of 5a—reductase 
to 31.45% of corresponding control activity , is inconsistent with 
regards to a feminising effect of cyclic AMP . The time course of 
the effect of 8-brcmo-cyclic AMP upon the activities of the 
sexually differentiated enzymes ; 6p-hydroxylase , 16a-hydroxylase 
and 5a-reductase is shown in figure 9 . No inhibition of enzyme
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7a-QH 6p-CH 16a-QH 17-QHSD 5a-Red
Control 47.8 ± 4.4 76.1 ± 2.4 117.5 ± 5.0 87.9 ± 6.1 320.6 ± 17.5
8Br-cAMP 25.8 ± 1.5* 33.3 ± 2.0* 49.3 ± 5.7* 50.4 ± 3.6* 100.8 ± 29.0*
(54.0 ± 3.3) (43.8 ± 2.7) (41.9 ± 4.9) (57.3 ± 4.1) (31.5 ± 9.1)
Table 6 . The effects of 8-brcmo-cyclic AMP (10"4M) upon the activities 
of 7a-hydroxylase ( 7a-0H ) , 6{3-hydroxylase ( 6p-QH ) , 16a-hydroxylase 
( 16a-GH ) , 17a/p hydroxysteroid dehydrogenase ( 17-QHSD ) and 5a- 
reductase ( 5a-Red ) in isolated rat hepatocytes following an incubation 
period of 2 hours . Results are expressed as pinole of metabolite formed 
per minute per 106 cells ± S.D. or (in brackets) as percentage of 
control ± S.D. for 4 different cell samples . ( * : p<0.05 )
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Figure 9 : Change in 60- (-o- ) ( 60-QH ) and 16a-hydroxylase (-A- )
( 16a-CH ) and 5a-reductase ( )  ( 5a-Red ) activities with time in 
hepatocytes isolated fran male rats , following administration of 8-brcrro- 
cyclic AMP ( 10~4M ) . Results are expressed as percentage of relevant 
control ± S.D. of at least 4 different cell samples ( * : p<0.05 ) . Control 
activities expressed as pmoles of metabolite formed per minute per 10® cells 
at each time were as follows :
60-QH 16a-QH 5a-Red
i hour
1 hour
2 hour 
24 hour
50.1 ± 12.8
67.7 ± 22.4
76.1 ± 2.4
29.1 ± 2.4
72.9 ± 13.5
99.9 ± 25.2
117.5 ± 5.0
45.4 ± 2.2
249.0 ± 71.5
299.1 ± 36.3
320.6 ± 17.5
169.5 ± 28.3
activities occurs following the short incubation periods ( 2-20 
minutes ) ( as shewn in table 7 ) but inhibition is apparent 
following an incubation period of i hour and maximal inhibition 
( 30-50% of control ) occurs at 2 hours following addition . The 
activities have returned to control levels by 24 hours .
(ii) Effects of 8-brcmo-cyclic AMP in female rat hepatocytes
The effects of 8-brano-cyclic AMP upon the activities of 
60-hydroxylase , 16a-hydroxylase and 5a-reductase in the female 
rat are shown in figure 10 . As was apparent in the male rat , 
non-specific inhibition of enzyme activity ( 40-60% of control ) 
occurs between £ hour and 2 hours following addition and the 
activities have returned to control levels by 24 hours .
The nonspecific inhibitory effect of 8-brcmo-cyclic AMP which 
was of the same magnitude in rats of both sexes , indicates that 
the effects of elevating cyclic AMP using this agent are not sex 
dependent and do not affect sexual differentiation of enzyme 
activity . This was the case for all of the cyclic AMP elevating 
agents studied in the intact hepatocytes and for cyclic AMP in 
electropermeabilised hepatocytes . To simplify the discussion , 
therefore , only the activities of the cytochrcme P450 containing 
enzymes ; 60-hydroxylase , 16a-hydnoxylase and 7a-hydroxylase , 
will be shown and discussed in subsequent experiments as being 
representative of all of the enzyme activities .
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7a-QH 6p-0H 5a Red
2 min 105.3 + 16.1 115.6 + 0.2 106.5 + 13.9
5 min 111.6 + 12.2 99.3 + 14.8 107.9 + 13.7
10 min 97.9 + 11.3 92.1 + 11.0 104.6 + 13.9
20 min 102.5 + 25.8 99.9 + 14.6 112.0 + 20.2
Table 7 : Activities of 7a-( 7a-0H ) and 6p-hydroxylase ( 6p-0H ) and 50- 
reductase ( 5a-Red ) in isolated hepatocytes , 2 to 20 minutes following the 
administration of 8-brano-cyclic AMP ( 10_4M ) . Results are expressed as 
percentage of relevant control activities ± S.D. for at least 3 different 
cell sanples . Control activities , expressed in pmole of metabolite per 
minute per 106 cells , were as follows :
7a-OH 6p-QH 16a-OH
2 min 
5 min 
10 min 
20 min
19.0 ± 4.5
22.6 ± 1.5
18.7 ± 1.9
21.1 ± 3.5
19.6 ± 2.7
18.7 ± 4.7
22.5 ± 3.3
22.7 ± 3.3
151.8 ± 7.6
160.2 ± 45.8
148.3 ± 44.2
166.1 ± 25.1
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Figure 10 : Change in 6{3- (-O- ) ( 60-QH ) , 16a-hydroxylase ( )
( 16a-CH ) and 5a-reduc±ase (-♦* ) ( 5a-Red ) activities with time in 
hepatocyte isolated fran female rats , following administration of 8-brano- 
cyclic AMP ( 10_4M ) . Results are expressed as percentage of relevant 
control ± S.D. of at least 4 different cell sanples ( * : p<0.05 ) .
Control activities expressed as proles of metabolite formed per minute per 
106 cells at each time are as follows :
6p-QH 16a-OH 5a-Red
■£■ hour
1 hour
2 hour 
24 hour
30.9 ± 4.0
45.2 ± 3.6
24.5 ± 4.6
28.6 ± 4.2
30.4 ± 2.3
55.7 ± 10.8
34.8 ± 0.7
42.3 ± 6.9
749.9 ± 111.7
865.8 ± 186.9
449.6 ± 76.1
327.0 ± 78.5
(iii) Effects of homogenisation and readdition of excess
cofactors on the actions of 8-brano-cyclic AMP in male 
rat hepatocytes .
The time course of the effect of 8-brcmo-cyclic AMP in 
hepatocytes homogenised and resupplemented with excess cofactors 
prior to assessment of 4-androstene-3,17-dione metabolism is shewn 
in figure 11 . As was apparent in intact hepatocytes , 
non-specific inhibition ( 50-60% ) of all of the enzyme activities 
occurred between i an hour and 2 hours following the addition of 
the 8-hrcmo-cyclic AMP . This indicates that the effects of 
elevating cyclic AMP are not mediated by depletion of cofactors .
3.3(b) Effects of adrenaline and correlation with cyclic AMP 
levels .
(i) Adrenaline alone .
Figure 12 shows the time course of the effect of adrenaline 
(10~7M ) upon cyclic AMP levels and 4-androstene-3,17-dione 
metabolism . The baseil control level of cyclic AMP in freshly 
isolated hepatocytes f ran male rats was approximately 1 nanomole 
per 10® cells , this level was found not to vary significantly 
over the early time periods studied ( 2 minutes to 1 hour ) 
although cyclic AMP levels increased to approximately 1.5 
nanomoles per 10® cells after 2 hours in culture and to 3 
nanomoles per 10® cells by 24 hours . This may indicate seme
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Figure 11 : Change in 7a-( ) ( 7a-QH ) , 6p-(-0- ) ( 6p-CH ) and 16a-
hydroxylase (-£r ) ( 16a-0H ) activities with time in hepatocytes isolated 
fran male rats following administration of 8-brcmo-cyclic AMP ( 10~4M ) and 
subsequent homogenisation and readdition of excess cofactors . Results are 
expressed as percentage of relevant control ± S.D. of at least 4 different 
cell samples ( * : p<0.05 ) . Control activities expressed in pmoles of 
metabolite formed per minute per 106 cells were as follows :
7a-QH 6p-QH 16a-CH
i hour 94.1 ± 13.8 133.1 ± 15.7 180.9 ± 14.4
1 hour 87.4 ± 3.2 112.4 ± 6.7 127.7 ± 12.3
2 hour 83.4 ± 5.4 96.2 ± 5.3 131.9 ± 4.3
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Figure 12 : Change in cyclic AMP content ( -±- ) , 7a-( ) ( 7a-CH ) ,
6p-( o -  ) and 16a-hydroxylase (-£r ) ( 16a-0H ) with time in isolated 
hepatocytes following addition of adrenaline ( 10_7M ) . Results are 
expressed as percentage of relevant control ± S.D. for at least 4 different 
cell samples ( * : <p0.05 ) . Control activities expressed in pinoles of 
metabolite formed per minute per 106 cells and cyclic AMP content expressed 
in pinoles per 106 cells at each time were as follows :
7a-CH 6J3-OH 16a-QH cyclic AMP
2 min — - - 1.08 + 0.16
5 min - - - 1.13 + 0.29
10 min - - - 1.02 + 0.36
20 min - - - 1.05 + 0.18
* hour 70.6 + 0.9 93.9 + 1.0 118.2 + 6.6 1.03 ± 0.17
1 hour 67.5 + 10.9 92.3 + 14.4 113.8 + 14.5 1.06 ± 0.33
2 hour 69.7 + 9.8 101.1 + 14.3 125.8 ± 22.7 1.47 ± 0.39
24 hour 19.4 + 5.7 14.6 + 1.2 31.9 ± 4.3 3.22 ± 0.11
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influence of the tartrate ion because control cyclic AMP levels in 
hepatocytes cultured in the absence of the tartrate ion tended to 
decrease over this 24 hour period ( 0.3 to 0.4 nanomoles per 106 
cells ) . The addition of adrenaline produced a rise in the cyclic 
AMP levels to 1.89 ± 0.39 nanomoles per 106 cells 10 minutes 
following its addition . This represents a rise to 185% of 
corresponding control levels . After 20 minutes cyclic AMP content 
had returned to control level and did not differ significantly 
from control over the rest of time period studied ( 24 hours ) . 
Enzyme activity was inhibited following an incubation period of 30 
minutes tut no inhibition was apparent before this time . 
Inhibition was maximal ( 60-75% of control ) between 1-2 hours 
following addition and at 24 hours did not differ significantly 
from control activities . It appears , therefore , that there is a 
time lag between the elevation of cyclic AMP levels and the 
subsequent inhibition of enzyme activity .
(ii) Adrenaline in the presence of propranolol and prazocin .
The effects of adrenaline (10~7M) in combination with 
propranolol (10~5M) ( panel A ) or prazocin (10"5M) ( panel B ) 
upon the metabolism of 4-androstene-3,17-dicne are shew in figure 
13 . The actions of adrenaline were unaffected by the presence of 
prazocin ( an ax-blocker ) . In the presence of prazocin 
inhibition of enzyme activities was of a similar magnitude 
(50-70%) and followed a comparable time course to that seen in the 
absence of prazocin ( see section 3.5 ) . The actions of
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Figure 13 : Change in 7a-( ) ( 7a-0H ) , 60-( -o- ) ( 6{3-GH ) and 16a-
hydroxylase ( tOt- ) ( 16a-QH ) with time in isolated hepatocytes following 
administration of adrenaline ( 10_7M ) in the presence of propranolol 
( 10~5M ) ( panel A ) or prazocin ( 10_5M ) ( panel B ) . Results are 
expressed as percentage of relevant control ± S.D. for at least 4 different 
cell samples ( * : p<0.05 ) . Control activities , expressed in ptnoles of 
product formed per minute per 106 cells , were as follows :
7a-QH 6p-OH 16a-QH
i hour 17.2 ± 4.5 31.5 ± 8.2 42.3 ± 10.6
1 hour 28.2 ± 5.3 45.0 ± 6.3 64.1 ± 5.7
2 hour 24.3 ± 2.2 37.1 ± 3.4 49.6 ± 5.6
adrenaline , however , were blocked by the presence of propranolol 
( a p-blocker ) . In the presence of propranolol enzyme activity 
did not differ significantly fran control over the time course 
studied ( 2 minutes to 2 hours ) . This indicates that the effects 
of adrenaline upon enzyme activity are probably mediated only by 
the elevation of cyclic AMP ( via stimulation of p2 receptors ) 
and are not influenced by phosphatidylinositol turnover and 
calcium mobilisation ( via stimulation of receptors ) .
3.3(c) Effects of isabutylmethylxanthine ( IEMX ) and 
correlation with cyclic AMP levels .
The effects of the phosphodiesterase inhibitor , IEMX (10~3M), 
upon cyclic AMP levels and the metabolism of 4-androstene- 
3,17-dione are shown in figure 14 . This compound inhibits the 
breakdown of cyclic AMP in the cell and so , therefore L would be 
expected to produce a rise in cyclic AMP . The cyclic AMP levels 
rose to 186% of control 2 minutes after addition of IEMX hut 
rapidly dropped back to control levels . This initial transient 
rise in cyclic AMP levels was followed by a secondary sustained 
rise which occurred after 30 minutes and levels of cyclic AMP were 
maximally elevated to 259% of control levels at 24 hours following 
addition . The effects upon androstenedione metabolism showed a 
similar pattern of inhibition to that seen with 8-brcmo-cyclic AMP 
and adrenaline in that maximum inhibition ( 60-75% of control ) 
occurred at 1-2 hours . Results obtained with adrenaline indicate 
that the inhibitory effect of IEMX upon androstenedione metabolism
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Figure 14 : Change in cyclic AMP content ( )  , 7a-( ) ( 7a-QH ) ,
6p-(-o- ) ( 6p-QH ) and 16a-hydroxylase ( )  ( 16a-QH ) activities with 
time in isolated hepatocytes following administration of isobutylmethyl- 
xanthine ( 10_3M ) . Results are expressed as percentage of relevant control 
± S.D. for at least 4 different cell sairples ( * : p<0.05 ) . Control 
activities , expressed in pinoles of metabolite formed per minute per 106 
cells , and cyclic AMP content , expressed in pinoles per 106 cells , were as 
follows :
7a-QH 6p-QH 16a-OH cyclic AMP
2 min = = = 2.77 ± 1.72
5 min - - - 1.37 ± 0.68
10 min - - - 1.29 ± 0.47
20 min - 0.76 ± 0.36
i hour 23.7 ± 3.6 50.1 ± 12.8 72.9 ± 13.5 1.59 ± 0.86
1 hour 37.1 ± 4.6 67.7 ± 22.4 99.9 ± 25.2 1.09 ± 0.52
2 hour 47.8 ± 4.5 76.1 ± 2.4 117.5 ± 5.0 1.40 ± 0.75
24 hour 35.8 ± 1.5 29.1 ± 2.4 45.4 ± 2.2 0.42 ± 0.24
is likely to be related to the initial increase in cyclic AMP 
levels rather than later sustained rise . Good correlation exists 
between the magnitude of the initial rise in cyclic AMP levels 
produced by adrenaline ( 185% of control ) and IEMX ( 186% of 
control ) and the subsequent inhibition of steroid metabolism 
( 60-75% of control ) by these agents .
3.3(d) Effects of a combination of adrenaline and IEMX and 
correlation with cyclic AMP levels .
The combination of adrenaline (10~7M) and IEMX (10~3M) , as 
shewn in figure 15 , produced a much greater increase in 
intracellular cyclic AMP levels than either of the two agents 
used alone , rising to 266% of control after 10 minutes 
incubation time . This sharp rise was followed by a slower
decline in cyclic AMP levels than produced by adrenaline alone .
The combination of these two agents resulted in marked inhibition 
of the metabolism of 4-androstene-3,17-dione ( to 20-40% of 
corresponding control activities after 1-2 hours ) . Hie 
magnitude of the enzyme inhibition was greater than that seen 
when using either adrenaline or IEMX alone . This indicates that
the degree of enzyme inhibition is related to the height of the
cyclic AMP peak in the first ten minutes .
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Figure 15 : Change in cyclic AMP content (tAp- ) , 7a-(-*- ) ( 7a-CH ) , 
60- (-o-) ( 60-QH ) and 16a-hydroxylase (-£r ) { 16a-0H ) activities with time 
in isolated hepatocytes following administration of adrenaline ( 10_7M ) and 
isdfcutylmethylxanthine ( 10~3M ) . Results are expressed as percentage of 
relevant control ± S.D. ( * : p<0.05 ) . Control activities , expressed in 
pnoles of metabolite per minute per 106 cells , and cyclic AMP content ,
expressed in pnoles per 106 cells , were as follows :
7a-QH 6p-QH 16a-OH cyclic AMP
2 min _ _ 1.08 ± 0.16
5 min - - - 1.13 ± 0.29
10 min - - - 1.02 ± 0.36
20 min - - - 1.05 ± 0.18
i hour 70.6 ± 0.9 93.9 ± 1.0 118.2 ± 6.6 1.03 ± 0.17
1 hour 67.5 ± 10.9 92.3 ± 14.4 113.9 ± 14.5 1.06 ± 0.33
2 hour 69.7 ± 9.8 101.1 ± 14.3 125.8 ± 22.7 1.47 ± 0.39
24 hour 19.4 ± 5.7 14.6 ± 1.2 31.9 ± 4.3 3.22 ± 0.11
3.3(e) Effects of forskolin and correlation with cyclic AMP 
levels .
Figure 16 shews the effects of directly stimulating adenylate 
cyclase with forskolin (10~5M) upon cyclic AMP and
4-androstene-3,17-dione metabolism . This canpound bypasses the 
need for receptor activation and was seen to greatly increase the 
cyclic AMP levels of the hepatocytes ( to 607% of control ) 5 
minutes after addition . Thereafter levels declined but remained 
elevated 2 hours after addition . Inhibition of androstenedione 
metabolism subsequent to this rise in cyclic AMP was , however , 
less narked than that observed with the combination of adrenaline 
and IEMX ( section 3.3(d) ) ( 65-75% of control activities ) .
This unexpected result may indicate that forskolin has additional 
actions ( other than stimulation of adenylate cyclase ) . In a 
different batch of hepatocytes ( figure 17 ) , however t cyclic 
AMP was maximally elevated to 488% of control by the addition of 
forskolin and the subsequent inhibition of enzyme activity ( 45% 
of corresponding control activity at 2 hours ) was of a similar 
magnitude to that observed with the combination of adrenaline and 
IEMX . Uiis suggests that the loss of enzyme inhibition 
illustrated in figure 16 is due to the excessive cyclic AMP levels 
produced rather than any additional action of forskolin .
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Figure 16 : Change in cyclic AMP content (-Ar ) , 7a-( ~m~ ) ( 7a-CH ) , 
6p-(-o- ) ( 6J3-GH ) and 16a-hydroxylase (-£r ) ( 16a-QH ) activities with 
time in isolated hepatocytes following administration of forskolin ( 10~5M). 
Results are expressed as percentage of relevant control ± S.D. for at least 4 
different cell samples ( * : p<0.05 ) . Control activities , expressed in 
pnoles of metabolite per min per 106 cells , and cyclic AMP content , 
expressed in pnoles per 106 cells , were as follows :
7a-OH 6p-0H 16a-GH cyclic AMP
2 min - - - 1.07 ± 0.40
5 min - - - 1.09 ± 0.14
10 min - - - 1.11 ± 0.13
20 min - - - 1.04 ± 0.17
i hour 60.1 ± 18.9 56.4 ± 7.5 86.7 ± 21.1 1.12 ± 0.29
l hour 49.3 ± 16.1 47.7 ± 15.6 48.4 ± 6.8 1.01 ± 0.24
2 hour 47.2 ± 11.4 54.1 ± 9.6 51.9 ± 5.8 0.81 ± 0.24
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Figure 17 : Change in cyclic AMP content (-Ar ) , la- ( ) ( 7a-CH ) ,
60-(-o- ) ( 60-OH ) and 16d-hydroxylase ( -Cx- ) ( 16a-0H ) activities with time 
in isolated hepatocytes following administration of forskolin ( 10_5M ) . 
Results are expressed as percentage of relevant control for at least 4 
different cell samples ( * : p<0.05 ) . Control activities , expressed in 
pnoles of metabolite per minute per 106 cells , and cyclic AMP content ,
expressed in pmoles per 106 cells , were as follows :
7a-OH 60-OH 16a-OH cyclic AMP
2 min - - - 1.08 ± 0.16
5 min - - - 1.13 ± 0.29
10 min - - - 1.04 ± 0.48
20 min - - - 1.24 ± 0.25
i hour 143.9 ± 30.8 108.0 ± 22.0 171.9 ± 44.7 1.08 ± 0.34
1 hour 93.7 ± 9.3 113.5 ± 12.0 148.2 ± 18.5 1.30 ± 0.20
2 hour 111.4 ± 16.1 123.6 ± 15.0 158.8 ± 23.5 1.22 ± 0.15
24 hour 69.3 ± 22.5 67.8 ± 16.3 132.8 ± 34.3 0.27 ± 0.03
3.3(f) Effects of a combination of forskolin and IEMX and
correlation with cyclic AMP levels .
The combination of forskolin (10_5M) and IEMX (10”3M) was 
used to examine further the effects of excessive cyclic AMP levels 
upon the metabolism of 4-androstene-3,17-dicne . Figure 18 shews 
the results obtained for hepatocyte samples in which addition of 
forskolin + IEMX resulted in increase in cyclic AMP levels to 
1256% of control 5 minutes after addition . Thereafter levels 
declined but remained elevated for the duration of the study . 
Androstenedione metabolism was slightly inhibited at i hour tut 
this was followed by significant stimulation of enzyme activity at 
1 hour ( 130-160% of control ) . The enzyme activities had 
returned to control levels by 2 hours . As no secondary 
stimulation of enzyme activity was seen after the addition of 
IEMX which also caused a marked rise in cyclic AMP levels at later 
time periods ( section 3.3(c) ) , it appears that both the 
inhibition and stimulation of enzyme activity are related to the 
initial rise in cyclic AMP levels produced in the first ten 
minutes . In a different batch of hepatocytes ( figure 19 ) cyclic 
AMP levels were elevated to 1912% of control by the addition of 
forskolin + IEMX . At this greater elevation of cyclic AMP no 
inhibition of enzyme activity is apparent and only the ( secondary 
) stimulatory effect ( 140-160% of control )is observed .
It appears , therefore , that the effects of elevating cyclic 
AMP upon hepatic steroid metabolism can be separated into two 
phases ; at lower , physiological levels ( 2-3 fold stimulation ),
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Figure 18 : Change in cyclic AMP content ( nfc* ) , 7a-( -m- ) ( 7a-CH ) , 
6p~(-o-) ( 6p-CH ) and 16a-hydroxylase (-£r- ) ( 16a-GH ) activities with time 
in isolated hepatocytes following the administration of forskolin ( 10"5 M ) 
and isohjtylmethylxanthine ( 10" 3M ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control activities , expressed in proles of metabolite per minute per 10 6 
cells , and cyclic AMP content , expressed in proles per 106 cells , were as 
follows :
7a-OH 6p-OH 16a-QH cyclic AMP
2 min 
5 min 
10 min 
20 min 
•£■ hour
1 hour
2 hour
74.1 ± 18.3
93.2 ± 37.9 
93.8 ± 37.9
69.0 ± 15.3
90.6 ± 14.9
94.7 ± 24.5
115.0 ± 26.2
129.6 ± 40 4
119.6 ± 33.1
1.16
1.11
1.03
1.09 
1.44
1.10 
0.95
0.16
0.47
0.38
0.12
0.47
0.24
0.23
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Figure 19 : Change in cyclic AMP content (-*-), 7a-( ) ( 7a-CH ) ,
6p-(-o-)( 6{3-CH ) and 16a-hydroxylase ( -£r- ) ( 16a-QH ) activities with time 
in isolated hepatocytes following the administration of forskolin ( 10“ 5M ) 
and isotatylmethylxanthine ( 10_3M ) . Results are expressed as percentage of 
relevant control ± S.D. ( * : p<0.05 ) . Control activities , expressed in 
pnoles of metabolite per minute per 106 cells , and cyclic AMP content , 
expressed in pnoles per 106 cells , were as follows :
7a-QH 6p-OH 16a-OH cyclic AMP
2 min - - - 1.07 ± 0.40
5 min - - - 1.09 ± 0.14
10 min - - - 1.11 ± 0.13
20 min - - - 1.04 ± 0.17
i hour 60.1 ± 18.9 56.4 ± 7.5 86.7 ± 21.1 1.12 ± 0.29
1 hour 49.3 ± 16.1 47.7 ± 15.6 54.1 ± 9.6 1.01 ± 0.24
2 hour 47.2 ± 11.4 54.1 ± 9.6 51.9 ± 5.8 0.81 ± 0.24
an inhibition is seen whereas at higher levels ( >10 fold 
stimulation ) a stimulatory effect is seen at a later time point 
than the inhibition .
3.3(g) Effects of different concentrations of cyclic AMP in 
electropermeabilised hepatocytes .
Ulne effects of different concentrations of cyclic AMP ( 5 x 
10~5M - 5 x 10“ 3M ) upon the metabolism of 4-androstene-3,17-dicne 
metabolism in electropermeabilised rat hepatocytes are shewn in 
figure 20 . Panel A shows the time course of the effect of 5 x 
10“5 M cyclic AMP ( concentrations of cyclic AMP below this level 
were found to be ineffective in modifying androstenedione 
metabolism ) . Enzyme activities were inhibited to 65-75% of 
control at 1 hour after addition but recovered rapidly to control 
levels between 2 and 3 hours . The effects of 5 x 10“ 4M cyclic AMP 
are shown in panel B . Effects were similar to those seen with 5 x 
10“5 M except that the magnitude of inhibition was less marked 
(80-85% of control ) and there was a tendency towards stimulation 
at 2 hours . The effect of 5 x 10“ 3M ( panel C ) , however , was 
markedly different , exhibiting little inhibition at the earlier 
time periods but marked stimulation of enzyme activity ( 130-137% 
of control activities ) at 2 hours . This stimulation was 
transient and had virtually disappeared at 3 hours following 
addition .
These results correlate with those obtained in intact 
hepatocytes and appear to indicate that the two opposing effects
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Figure 20 : Change in 7a-(>♦- ) ( 7a-OH ) , and 6p-hydroxylase (-o- )
( 6p-0H ) activities with time in electropermeabilised hepatocytes following 
administration of 5 x 10"5M cyclic AMP ( panel A ) , 5 x 10~4M cyclic AMP 
( panel B ) and 5 x 10~3M cyclic AMP ( panel C ) . Results are expressed as 
percentage of relevant control ± S.D. for at least 4 different cell samples 
( * : p<0.05 ) . Control activities , expressed in pnoles of metabolite per 
minute per 106 cells , were as follows :
\ hour 1 hour 2 hour 3 hour
7a-QH 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0 58.5 ± 5.4
60-OH 85.7 ± 6.5 94.9 ± 9.6 69.1 ± 6.1 77.3 ± 10.9
seen are due to cyclic AMP elevation rather than any alternative 
mode of action . Lew concentrations of cyclic AMP ( 5 x 10" 5M ) 
produce effects upon enzyme activity which correspond to those 
produced by 8-brcmo-cyclic AMP , adrenaline , IEMX , and 
adrenaline + IEMX i.e. primary inhibition . Intermediate 
concentrations ( 5 x 10“4M ) produce effects which correspond to 
those produced by forskolin ( figure 15 ) i.e. loss of the primary 
inhibitory effect and a tendency towards secondary stimulation . 
High concentrations of cyclic AMP ( 5 x 10~3M ) produce effects 
which correspond to those produced by forskolin + IEMX i.e. 
secondary stimulatory effect only .
3.4 THE EFFECTS OF CYCDGHEXIMIDE UPON THE ACTIONS OF CYCLIC 
AMP IN ALTERATION OF ANDROSTENEDIONE METABOLISM .
3.4(a) Effects of cycloheximide upon the actions of a 
combination of forskolin and IEMX in intact 
hepatocytes .
The effects of forskolin (10_5M) in combination with IEMX 
(10~3M) upon the metabolism of 4-androstene-3,17-dicne in the 
presence of cycloheximide (10-5M) are shewn in figure 21 . 
Cycloheximide is an inhibitor of messenger ENA translation at the 
level of the ribosomes ( Peshka 1971 ) and was used to evaluate 
the role of protein synthesis in the actions of the combination of 
forskolin and IEMX . When protein synthesis was blocked by 
cycloheximide , the secondary stimulatory response was abolished
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Figure 21 : Change in 7a-(-*~ ) ( 7a-QH ) , 6p-(-0- ) ( 6p-CH ) and 16a- 
hydroxylase (-a£r- ) ( 16a-QH ) activities with time in isolated hepatocytes 
following the administration of forskolin ( 10-5M ) in the presence of 
cycloheximide ( 10~5M ) . Results are expressed as percentage of relevant 
control ± S.D. for at least 4 different cell samples ( * : p<0.05 ) . Control 
activities , expressed as pmoles of metabolite per minute per 106 cells , 
were as follows :
\ hour 1 hour 2 hour 3 hour
7a-0H 23.3 ± 5.2 30.5 ± 7.8 28.6 ± 3.4 22.4 ± 1.2
6P-CH 36.6 ± 10.0 75.2 ± 12.1 74.7 ± 5.2 55.0 ± 5.2
)6a-GH 42.8 ± 10.0 81.9 ± 12.7 97.3 ± 5.7 62.1 ± 5.1
and the magnitude of the inhibitory effect of this large 
concentration of cyclic AMP was enhanced ( 40-60% at 2 hours ) .
Fran these results it is apparent that the secondary 
stimulatory effect of high concentrations of cyclic AMP , as 
produced by the combination of forskolin and IEMX , is dependent 
upon protein synthesis hut the initial inhibition occurs 
independently of protein synthesis . It is also apparent that the 
loss of the inhibitory effects of cyclic AMP at high 
concentrations is also due to protein synthesis presumably hprwn»* 
inhibition is masked by the greater mgnitude of the stimulatory 
effect .
It can be seen in figure 21 that each of the enzyme 
activities shown is affected in a similar way by preincubation 
with cycloheximide indicating that each of the enzymes is under 
identical control with regards to the mechanism of action of 
cyclic AMP . In sections 3.4(b) and 3.5 , therefore , only 
the activity of 7a hydroxylase will be illustrated in the 
figures and discussed , to allow comparison with control time 
courses . In each case all of the enzymes were affected in an 
identical manner by the addition of the agents .
3.4(b) Effects of cycloheximide upon the actions of cyclic 
AMP in electropermeabilised hepatocytes .
Figure 22 shows the effects of preincubation with 
cycloheximide (10"5M) on the actions of cyclic AMP 5 x 10~5M 
(panel A ) , 5 x 10”4M ( panel B ) and 5 x 10-3M ( panel C ) upon
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Figure 22 : Change in 7a-hydroxylase activity in electropermeabilised 
hepatocytes with time following the administration of 5 x 10_5M cyclic AMP 
( panel A ) , 5 x 10_4M cyclic AMP ( panel B ) and 5 x 10“ 3M cyclic AMP 
( panel C ) in the presence (-O- ) or absence (■♦•) of cycloheximide ( 10“5 M ). 
Results are expressed as percentage of relevant control ± S.D. for at least 
4 different cell samples ( * : p<0.05 ) . Control 7a-hydroxylase activities, 
expressed in pnoles of metabolite per minute per 106 cells , were as follows:
£ hour 1 hour 2 hour 3 hour
control 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0 58.5 ± 5.4
control (cycloheximide) 80.6 ± 6.6 86.4 ± 8.8 83.7 ± 5.9 60.6 ± 6.7
the metabolism of 4-androstene-3,17-dicne . it can be seen that 
when protein synthesis was blocked by cycloheximide the initial 
inhibitory effect of 5 x 10_5M cyclic AMP was unaffected but 
recovery from inhibition was scmewhat slower ( not complete by 2 
hours ) . In the presence of cycloheximide , 5 x 10-4M cyclic AMP 
produced much greater inhibition ( 57% of corresponding control 
activity ) than in the cells treated with cyclic AMP alone ( 80% 
of corresponding control activity ) and the inhibition was slower 
to reverse ( not recovered by 3 hours ) . When cells were treated 
with 5 x 10” 3M cyclic AMP following preincubation with 
cycloheximide , the stimulation of enzyme activity was abolished 
and marked inhibition of enzyme activity occurred ( maximum of 60% 
of corresponding control at 2 hours ) over the time course of i to 
3 hours .
These effects correlate with those seen in 3.4(a) above 
i.e. the stimulatory effect but not the inhibitory effect is 
dependent upon protein synthesis and the loss of the inhibitory 
effect at high concentrations of cyclic AMP is due to it being 
masked by the greater magnitude of the stimulatory effect . It is 
also apparent from the lower concentrations of cyclic AMP ( 5 x 
10" 5M ) that recovery from inhibition is also dependent upon 
protein synthesis and that cyclic AMP stimulated- protein 
synthesis occurs even at the lower concentrations hut is too weak 
to produce the secondary stimulation of enzyme activity .
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3.5 THE EFFECTS OF PROTEIN KINASE INHIBITORS UPON THE ACTIONS
OF CYCLIC AMP IN ALTERATION OF ANDROSTENEDIONE METABOLISM 
IN ELECTROPERMEABILISED HEPATOCYTES .
3.5(a) Effects of K-252a ( general protein kinase inhibitor )
Figure 23 shows the effects of preincubating with K-252a ( an 
inhibitor of all protein kinases ) (2 x 10~8M) upon the time 
course of the effect of 5 x 10- 5M cyclic AMP ( panel A ) and 5 x 
10” 3M cyclic AMP ( panel B ) on 7a hydroxylase activity . Both 
the primary inhibitory effect produced by 5 x 10~5M cyclic AMP 
and the secondary stimulation produced by 5 x 10~3M cyclic AMP 
were abolished by preincubation with K-252a indicating that both 
of these effects are produced by activation of a protein kinase 
by cyclic AMP .
3.5(b) Effects of KT5720 ( inhibitor of cyclic AMP-dependent 
protein kinase ) .
The effects of preincubating with KT5720 ( a specific 
inhibitor of PKa ) ( 6 x 10"8M) upon the actions of 5 x 10”5M 
cyclic AMP ( panel A ) and 5 x 10-3M cyclic AMP ( panel B ) are 
shown in figure 24 . As was seen following preincubation with the 
general protein kinase inhibitor , both the stimulatory and 
inhibitory effects of cyclic AMP were abolished in the presence of 
KT5720 indicating both these effects were due to the activation of
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Figure 23 : Change in 7a-hydroxylase activity in electropermeabilised 
hepatocytes with time following the administration of 5 x 10_5M cyclic AMP 
( panel A ) and 5 x 10- 3M cyclic AMP ( panel B ) in the presence (-o- ) and 
absence of K-252a ( 2 x 10_8M ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples. ( * : p<0.05 ). 
Control 7a-hydroxylase activities , stressed in pinole of metabolite pier 
minute per 106 cells , were as follows :
i hour 1 hour 2 hour
control 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0
control (K-252a) 52.2 ± 18.0 44.8 ± 13.1 41.5 ± 6.3
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Figure 24 : Change in 7 a-hydroxylase activity in electropermeabilised 
hepatocytes with time following the administration of 5 x 10-5M cyclic AMP 
( panel A ) and 5 x 10-3M ( panel B ) in the presence (~o~ ) and absence 
(*■«- ) of KT5720 ( 6 x 10~8M ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control 7a-hydroxylase activities , expressed as pinole of metabolite per 
minute per 106 cells , were as follows :
\ hour 1 hour 2 hour
control 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0
control (KT5720) 58.3 ± 18.0 47.3 ± 13.4 41.5 ± 12.4
EKa
3.5(c) Effects of K-252b ( inhibitor of protein kinase c )
Hie effects of preincubating with K-252b ( a specific 
inhibitor of PKc ) (2 x 10“8M) upon the actions of 5 x 10"5M 
cyclic AMP ( panel A ) and 5 x 10-3M cyclic AMP ( panel B ) are 
shewn in figure 25 . When PKc is inhibited by the presence of 
K-252b the primary inhibitory effect attributed to the initial 
activation of FKa by 5 x 10_5M cyclic AMP ( section 3.5(b) ) was 
abolished and the presence of K-252b revealed a slight stimulatory 
effect ( 110% of corresponding control activity ) which may 
otherwise have been masked by the predominant inhibition . Hie 
secondary stimulatory effects of 5 x 10-3M cyclic AMP in the 
presence of K-252b also occurred at an earlier time than in the 
corresponding cyclic AMP time course in untreated cells and showed 
a dose-dependent increase in magnitude above the stimulation seen 
with 5 x 10"5M cyclic AMP ( to 136% of corresponding control 
activity ) . This stimulation , however , was not maintained 
throughout the time course . At 2 hours the stimulation was less 
than that seen in the corresponding cyclic AMP time course in 
untreated cells .
It would appear that in the absence of PKc , therefore , 
cyclic AMP has no inhibitory effects at any concentration and 
dose dependent stimulation occurs at an earlier time period than 
seen in the presence of PKc .
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Figure 25 : Change in 7a-hydroxylase activity with time in electro­
permeabilised hepatocytes following administration of 5 x 10" 5M cyclic AMP 
( panel A ) and 5 X 10" 3M cyclic AMP ( panel B ) in the presence (-0 - ) or 
absence (•*) of K-252b ( 2 X 10~8M ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control 7a-hydroxylase activities , expressed in pinole of metabolite per 
minute per 106 cells , were as follows :
hour 1 hour 2 hour
control 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0
control (K-252b) 44.7 ± 10.3 35.7 ± 7.7 55.8 ± 10.6
3.5(d) Effects of a combination of K-252b and cycloheximide
The effects of cycloheximide upon the cyclic AMP mediated 
early stimulation of steroid metabolism in the presence of K-252b, 
were examined to ascertain if the stimulation produced by FKa 
activation in the absence of PKc was due to protein synthesis . 
Ulne results are shown in figure 26 for 5 x 10“ 5M cyclic AMP , 
K-252b (2 x 10-8M) and cycloheximide (10~5M) ( panel A) and 5 x 
10" 3M cyclic AMP , K-252b (2 x 10" 8M) and cycloheximide (10“5M)
( panel B ) . Effects in the presence of K-252b and cycloheximide 
alone are also shown for comparison . In the presence of 
cycloheximide the slight stimulation of enzyme activity produced 
by 5 x 10"5M cyclic AMP and K-252b alone was abolished and 
activity did not differ significantly from corresponding control 
activity . The greater stimulation of enzyme activity produced by 
5 x 10-3M cyclic AMP and K-252b was also inhibited by the presence 
of cycloheximide but unlike the lower concentration of cyclic AMP, 
slight inhibition of enzyme activity occurred ( 80% of 
corresponding control activity at 1 hour ) .
It would appear that the inhibitory effects of physiological 
concentrations of cyclic AMP ( 5 x 10-5M ) are produced only by 
activation of PKc and that PKa activation has no direct inhibitory 
effects upon enzyme activity . At pharmacological concentrations 
of cyclic AMP ( 5 x 10"3 M ) PKa activation does have a direct 
inhibitory action upon enzyme activity however the degree of 
inhibition produced by 5 x 10" 3M cyclic AMP in the presence of 
K-252b and cycloheximide was less marked than in the presence of
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Figure 26 : Change in 7a-hydroxylase activity in electropermeabilised 
hepatocytes with time following the administration of 5 x 10~5M cyclic AMP 
( panel A ) and 5 X 10" 3M cyclic AMP ( panel B ) in the presence of K-252b 
( 2 X 10_ 8M ) (-O- ) , cycloheximide ( 10_5M ) (-a- ) and a combination of 
cycloheximide and K-252b ( -*- ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control 7a-hydroxylase activities , expressed in prole of metabolite per 
minute per 106 cells , were as follows :
\ hour 1 hour 2 hour
control (K-252b) 44.7 ± 10.3 35.7 ± 7.7 55.8 ± 10.6
control (cycloheximide) 80.6 ± 6.6 86.4 ± 8.8 83.7 ± 5.9
control (cycloheximide + K-252b) 43.9 ± 5.0 40.6 ± 1.6 41.9 ± 10.4
cyclohexlmide alone ( section 3.4(b) ) which may indicate that 
both PKa and PKc activation are required for the full inhibitory 
effects of 5 x 10"3 M cyclic AMP . The early stimulatory effects of 
PKa activation in the absence of PKc are blocked by the presence 
of cycloheximide and so are mediated by an increase in protein 
synthesis .
3.5(e) Effects of KT5822 ( inhibitor of cyclic GMP-dependent 
protein kinase ) .
The effects of preincubating with KT5822 ( a specific 
inhibitor of PKg ) (2.5 X 10~9M) upon the actions of 5 x 10"5M 
cyclic AMP ( panel A ) and 5 x 10-3M cyclic AMP ( panel B ) are 
shown in figure 27 . No significant difference was apparent 
between the effects of cyclic AMP upon steroid metabolism in the 
presence or in the absence of PKg indicating that activation of 
this protein kinase has no role to play in the actions of cyclic 
AMP upon hepatic steroid metabolism .
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Figure 27 : Change in 7a-hydroxylase activity with time in electro- 
permeabilised hepatocytes following the administration of 5 X 10_5M cyclic 
AMP ( panel A ) and 5 X 10- 3M cyclic AMP ( panel B ) in the presence (-o- ) 
and absence (-a- ) of KT5822 ( 2.5 X 10-9M ) . Results are expressed as 
percentage of relevant control ± S.D. for at least 4 different cell samples 
( * : p<0.05 ) . Control 7a-hydroxylase activities , expressed as pinole of 
metabolite per minute per 106 cells , were as follows :
£ hour 1 hour 2 hour
control 55.3 ± 9.2 97.6 ± 8.8 66.9 ± 12.0
control (KT5822 ) 42.7 ± 5.7 50.8 ± 10.9 46.6 ± 11.0
3.6 EFFECTS OF ELEVATING CYCLIC AMP UPON CYTOCHRCME P450
LEVELS IN ISOLATED RAT HEPATOCYTES .
3.6(a) Effects of 8-brano-cyclic AMP , adrenaline , adrenaline 
and IEMX , forskolin and forskolin and IEMX in intact 
hepatocytes .
Basal levels of cytochrome P450 in freshly isolated , 
untreated hepatocytes were calculated to be approximately 50 
pnoles per 106 cells . Levels shewed a high degree of biological 
variation between animals and decreased by up to 33% over the 2 
hour incubation periods studied . Because of these variations in 
control levels , all cytochrome P450 measurements made in the 
treated cells were converted to percentage of mean control to 
allow comparison between the two groups .
Table 8 shows the effects of (a) 8-brcrro-cyclic AMP 10"4M ;
(b) adrenaline 10_7M ; (c) adrenaline 10“ 7M and IEMX 10-3M ; (d) 
forskolin 10-5M and (e) forskolin 10-5M and IEMX 10_3M , upon the 
levels of cytochrome P450 in hepatocytes for up to 2 hours 
following the addition of the agents . Elevation of cyclic AMP by 
agents (a)-(d) produced no significant variation between the 
levels of cytochrome P450 in treated cells and corresponding 
controls . Elevating cyclic AMP to a higher concent rat ion with 
Forskolin and IEMX , however , increased cytochrome P450 levels at 
i to 1 hour incubation times ( maximum of 137% of corresponding 
control following 1 hour incubation ) . This effect was transient 
and following 2 hour incubation cytochrome P450 levels did not
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Cyclic AMP-elevating 
agent
i hour 1 hour 2 hour
8-brano-cyclic AMP 99.88 ± 6.85 99.63 ± 8.86 93.61 ± 1.29
adrenaline 95.59 ± 10.65 100.55 ± 7.30 94.92 ± 3.44
adrenaline + IEMX 107.17 ± 7.49 114.82 ± 4.75 100.66 ± 20.34
forskolin 104.65 ± 3.19 103.64 ± 10.32 98.38 ± 4.50
forskolin + IEMX 120.24 ± 6.18 * 137.42 ± 9.64 * 104.65 ± 5.59
Table 8 . The effects of 8-brano-cyclic AMP (10_4M) , adrenaline (10_7M), 
isobutylmethylxanthine (IEMX )(10_3M), adrenaline and IEMX (10-7M/10_3M), 
forskolin (10-5M) and forskolin and IEMX (10_5M/10_3M) upon the levels of 
whole cell cytochrcme P450 in isolated rat hepatocytes over a 2hr period 
following the administration of the agent . Results are expressed as 
percentage of corresponding control cytochrcme P450 levels ± S.D. for at 
least 3 different cell samples . ( * : p<0.05 ) . Control cytochrcme P450 
levels expressed as pmoles per 106 cells at each time were as follows :
\ hour 1 hour 2 hour
44.8 ± 4.0 30.2 ± 2.3 30.8 ± 1.2
differ significantly frcm corresponding controls . The time course 
of the effect of forskolin and IEMX upon cytochrcme P450 levels is 
shewn in figure 28 .
3.6(b) Effects of cyclic AMP in electropermeabilised 
hepatocytes .
Table 9 shews the effects of 5 x 10-5M and 5 x 10~3M cyclic 
AMP upon the levels of cytochrcme P450 in permeabilised 
hepatocytes for 2 hours follcwing the addition of the cyclic 
AMP. The addition of 5 x 10_5M had no significant effect upon 
cytochrcme P450 levels which correlates well with the effects seen 
in the intact cells with agents which produce low concentrations 
of cyclic AMP . As was apparent with the combination of forskolin 
and IEMX , 5 x 10_3M cyclic AMP transiently elevated cytochrcme 
P450 levels to 120% of corresponding control at 1 hour and after 2 
hours levels had returned to control . The time course of the 
effects of 5 x 10“ 3M cyclic AMP upon cytochrcme P450 levels is 
shewn in figure 29 .
3.7 EFFECTS OF 5 X 1Q-5M CYCLIC AMP UPON CYTOCHRCME P450 
LEVELS IN HEPATOCYTES PRETREATED WITH CYCLQHEXIMIDE OR 
K-252b .
The effects of 5 x 10“ 5M cyclic AMP upon cytochrcme P450 
levels in cells pretreated with (a) cycloheximide and (b) K-252b 
are shown in table 10 . Neither of the pretreatments had any
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Figure 28 : Change in cytochrcme P450 content of isolated hepatocytes 
with time following the administration of forskolin ( 10"5 M ) and 
isobutylmethylxanthine ( 10"3 M ) . Results are expressed as percentage of 
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control cytochrcme P450 levels , expressed in pcnole per 106 cells , were as 
follows :
hour 1 hour 2 hour
45.7 ± 7.1 38.3 ± 12.9 30.8 ± 1.2
Cone.of 
cyclic AMP
•£- hour 1 hour 2 hour
5 x 10“5M 101.33 ± 10.18 106.30 ± 7.48 100.34 ± 2.64
5 x 10“3M 100.99 ± 3.37 120.16 ± 3.34 * 102.43 ± 7.84
Table 9 . The effects of 5 x 10"5 M cyclic AMP and 5 x 10~3M cyclic AMP 
upon the levels of whole cell cytochrcme P450 in isolated rat hepatocytes 
over a 2 hour period following the administration of cyclic AMP . Results 
are expressed as percentage of relevant cytochrcme P450 levels ± S.D. for 
at least 4 different cell samples . ( * : p<0.05 ) . Control cytochrcme 
P450 levels expressed in pmoles per 106 cells at each time were as 
follows:
4- hour 1 hour 2 hour
45.7 ± 7.1 38.3 ± 12.9 39.6 ± 10.2
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Figure 29 : Change in cytochrcme P450 content of electropermeabilised 
hepatocytes with time following the administration of 5 X 10-3M cyclic AMP. 
Results are expressed as percentage of relevant control ± S.D. for at least 
4 different cell samples ( * : p<0.05 ) . Control cytochrcme P450 levels , 
expressed as prole per 106 cells , were as follows :
\ hour 1 hour 2 hour
45.7 ± 7.1 38.3 ± 12.9 39.6 ± 10.2
£ hour 1 hour 2 hour
c-AMP 101.33 ± 10.18 106.30 ± 7.48 100.34 ± 2.64
c-AMP +
cyclohex 102.13 ± 5.60 101.72 ± 6.36 94.56 ± 1.31
c-AMP +
K-252b 108.18 ± 4.17 96.02 ± 5.39 105.68 ± 7.12
Table 10 . The effects of 5 x 10_5M cyclic AMP in non-pretreated rat 
hepatocytes and in rat hepatocytes pretreated with cycloheximide (10_5M) 
or K-252b (2 x 10"8M ) , upon the levels of whole cell cytochrcme P450 
over a 2 hour time period following the addition of cyclic AMP . Results 
are expressed as percentage of corresponding control cytochrcme P450 
levels ± S.D. for at least 4 different cell samples . Control cytochrcme 
P450 levels expressed in pmoles per 106 cells at each time were as 
follcws :
£ hour 1 hour 2 hour
control 45.7 ± 7.1 38.3 ± 12.9 39.6 ± 10.2
control (cyclohex) 47.0 ± 12.6 38.6 ± 4.3 36.8 ± 6.2
control (K-252b) 43.8 ± 9.7 38.1 ± 12.3 36.3 ± 8.4
effect upon cytochrcme P450 levels .
3.8 EFFECTS OF CTCD3HEXIMIDE UPON THE ACTIONS OF 5 X 10"3M 
CYCLIC AMP IN ALTERATION OF CYTOCHRCME P450 LEVELS .
Figure 30 shows the effects of 5 x 10_3M cyclic AMP upon 
cytochrane P450 levels in cells which had been preincubated with 
cycloheximide to block protein synthesis . The increase in 
cytochrcme P450 mediated by cyclic AMP in untreated cells was 
completely blocked in the presence of cycloheximide and instead 
marked decrease in the levels of cytochrcme P450 occurred . This 
loss of cytochrcme P450 was maintained throughout the time course 
( i to 2 hours ) and was maximally suppressed to 72% of 
corresponding control ( cycloheximide cxily ) levels . High 
concentrations of cyclic AMP , therefore , appear to have two 
effects upon cytochrcme P450 levels (a) protein synthesis 
independent degradation and (b) protein synthesis dependent 
synthesis of de novo cytochrcme P450 . In nan-pretreated cells 
cyclic AMP-mediated induction is the more marked of the two 
effects over the time period and thus an overall increase in 
cytochrane P450 levels occurs .
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Figure 30 : Change in cytochrane P450 content of electropermeabilised. 
hepatocytes with time following the administration of 5 X 10_3M cyclic AMP 
in the presence of cycloheximide ( 10"5 M ) . Results are expressed as 
percentage of relevant control ± S.D. for at least 4 different cell samples 
( * : p<0.05 ) . Control cytochrcme P450 levels , expressed as pinole of 
metabolite per 106 cells , were as follows :
% hour 1 hour 2 hour
control 45.7 ± 7.1 38.3 ± 12.9 39.6 ± 10.2
control (cycloheximide) 47.0 ± 12.6 38.6 ± 4.3 36.8 ± 6.2
3.9 EFFECTS OF PROTEIN KINASE INHIBITORS UPON IHE ACTIONS OF
CYCLIC AMP IN ALTERATION OF CYTOCHRCME P450 LEVELS .
3.9(a) Effects of KT5720 .
The effects of cyclic AMP in the presence of KT5720 ( a 
specific inhibitor of PKa ) upon cytochrane P450 levels are shewn 
in table 11 . The increase in cytochrane P450 levels mediated by 
cyclic AMP in the untreated cells was blocked by the presence of 
KT5720 and levels did not differ significantly fran control levels 
throughout the duration of the study . This indicates that the 
increase in cytochrane P450 content was due to cyclic AMP 
activation of PKa .
3.9(b) Effects of K-252b alone and in combination with 
cycloheximide .
Figure 31 shows the time course of the effect of 5 x 10" 3M 
cyclic AMP in hepatocytes pretreated with (a) K-252b ( a specific 
inhibitor of PKc ) or (b) K-252b and cycloheximide . In the 
presence of K-252b and cycloheximide the blocking of de novo 
protein synthesis with cycloheximide unmasked PKa mediated 
degradation of cytochrane P450 ( 82% of corresponding control 
levels at 1 hour ) . The loss of cytochrane P450 , however , was 
less marked than that observed following pretreatment with 
cycloheximide alone ( section 5.4 ) indicating that cyclic AMP 
mediated degradation is due , in part , to PKc activation .
■£■ hour 1 hour 2 hour
c-AMP 100.99 ± 3.37 120.16 ± 3.34 * 102.43 ± 7.84
c-AMP + 97.03 ± 1.98 105.77 ± 5.69 95.46 ± 0.72
KT5720
Table 11 . The effects of 5 x 10" 3 M cyclic AMP alone and in the presence 
of KT5720 (6 x 10" 8M) upon the whole cell levels of cytochrane P450 in 
isolated rat hepatocytes . Results are expressed as percentage of 
control cytochrane P450 levels ± S.D. for 4 different cell samples . 
Control cytochrane P450 levels expressed as pmoles per 106 cells.
i hour 1 hour 2 hour
control 45.7 ± 7.1 38.3 ± 12.9 39.6 ± 10.2
control ( KT5720 ) 42.9 ± 4.3 42.9 ± 2.7 43.5 ± 1.9
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Figure 31 : Change in cytochrcme P450 content of electropermeabilised 
hepatocytes with time following the administration of 5 X 10-3M cyclic AMP 
in the presence of K-252b ( 2 X 10_8M ) ( -•- ) or a ccmbination of K-252b and 
cycloheximide ( 10-5M ) ( ) . Results are expressed as percentage of
relevant control ± S.D. for at least 4 different cell samples ( * : p<0.05 ). 
Control cytochrcme P450 levels , expressed in pmole per 106 cells , were as 
follcws :
\ hour 1 hour 2 hour
control (K-252b) 43.8 ± 9.7 38.1 ± 12.3 36.3 ± 8.4
control (K-252b + cycloheximide) 46.3 ± 0.8 35.9 ± 1.6 28.3 ± 1.7
This implies that both PKc and PKa mediate protein synthesis 
-independent degradation of cytochrcme P450 and that cyclic AMP 
mediated degradation is due to a combination of PKa ( direct 
activation by cyclic AMP ) and PKc ( indirect activation by cyclic 
AMP secondary to activation of PKa) .
When K252b was used alcne , degradation of cytochrcme P450 was 
of a similar magnitude to that seen in the presence of K-252b and 
cycloheximide but the effect was delayed , and at ■£• hour , levels 
did not differ significantly fran control levels whereas in the 
K252b/cycloheximide treated cells levels were already suppressed 
to 86% of corresponding control levels at this time . This delay 
in the drop of cytochrcme P450 levels may be attributed to 
stimulation of protein synthesis by PKa , independent of PKc , 
which counteracts its degrading effects upon cytochrcme P450 .
This stimulation of protein synthesis appears to be transient in 
nature and so cytochrcme P450 levels decline to the reduced level 
corresponding to that observed in the K-252b/cycloheximide 
pretreated cells at 1-2 hours .
3.10 EFFECTS OF 5 x 10“ sm CYCLIC AMP UPON THE FH3SHCRYEATICIN 
OF PROTEINS IN ELECTROPEHMEABILISED HEPATOCYTES .
3.10(a) Whole cell proteins .
Figure 32 shows the effects of 5 x 10“5M cyclic AMP upon the 
phosphorylation of whole cell proteins following an incubation 
period of 30 minutes . Lane A shows molecular weight markers .
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Figure 32 : SDS-PAGE and autoradiogram of homogenised electro- 
permeabilised hepatocytes prelabelled with (32P) and incubated for 30 
minutes in the presence or absence ( control ) of 5 X 10“5 M cyclic AMP prior 
to hcmogenisation . Lane A shows the SDS-PAGE of molecular weight markers . 
Lane B shows the SDS-PAGE of homogenised hepatocyte proteins ( identical in 
control and cyclic AMP-treated cells ) . Lane C shews the autoradiogram of 
the SDS-PAGE of control hepatocytes . Lane D shews the autoradiogram of the 
SDS-PAGE of cyclic AMP-treated cells .
Lane B shews the separation of whole cell proteins by SDS-PAGE 
following staining of the protein bands with Coanassie Blue 
R-250. Lane C shews the autoradiogram of control hepatocytes and 
lane D shews the autoradiogram of cyclic AMP-treated hepatocytes . 
It is apparent that by the method used we are able to detect the 
labelling on cellular proteins in the whole cell extract . We were 
unable , however , to detect any difference between control and 
treated groups in the degree of labelling with 32P .
Figure 32 shows the results obtained following an incubation 
period of 30 minutes ( which correlates with the inhibitory effect 
of 5 x 10“5 M cyclic AMP upon the metabolism of androstenedicne ) . 
Hepatocytes incubated for 15 minutes , 45 minutes and 60 minutes 
in the presence or absence of 5 x 10~5M cyclic AMP yielded 
identical results to those shown in figure 32 in that 
3 2 P-labelling of proteins was detectable by the method used but we 
could detect no stimulation of phosphorylation by 5 x 10-5M cyclic 
AMP .
3.10(b) Inmunoprecipitated cytochromes P450 FB-2a , PB-3a and 
MC-lb .
Figure 33 shows the effects of 5 x 10_5M cyclic AMP upon the 
3 2 P-labelling of iirmuncprecipitated cytochromes P450 PB-2a , PB-3a 
and MC-lb following an incubation period of 30 minutes . It is 
apparent from figure 33 that although we were able to detect large 
amounts of protein of approximate Mr 45,000-50,000 which is 
assumed to correspond to the iirmunoprecipitated cytochrcme P450
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Figure 33 : SDS-PAGE and autoradiogram of cytochromes P450 PB-2a , PB-3a 
and MC-lb immunoprecipitated from electropermeabilised hepatocytes pre­
labelled with (32P) and incubated for 30 minutes in the presence or absence 
( control ) of 5 X 10"5 cyclic AMP prior to immunoprecipitation . Lane A 
shows the SDS-PAGE of molecular weight markers . Lanes B and C shew the SDS- 
PAGE of immunoprecipitated cytochrcme P450 PB-2a from control ( lane B ) and 
cyclic AMP treated ( lane C ) hepatocytes . Lanes D and E shew the auto­
radiogram of lane B ( control cells ) and lane C ( cyclic AMP-treated cells ) 
respectively . Lanes F and G show the SDS-PAGE ( lane F ) and autoradiogram 
( lane G ) of immunoprecipitated cytochrcme P450 PB-3a from cyclic AMP 
treated hepatocytes . Lanes H and I show the SDS-PAGE ( lane H ) and auto­
radiogram ( lane I ) of immunoprecipitated cytochrome P450 MG-lb frcm cyclic 
AMP-treated hepatocytes .
isozymes , following the irrmunoprecipitation of PB-2a fran control 
cells ( lane B ) , PB-2a fran cyclic AMP-treated cells ( lane C ) 
PB-3a fran cyclic AMP-treated cells ( lane F ) and MC-lb fran 
cyclic AMP-treated cells ( lane H ) , we were unable to detect 
any 3 2 P-labelling of PB-2a fran control cells ( lane D ) or any 
stimulation of 3 2 P-labelling of PB-2a ( lane E ) , PB-3a ( lane G) 
or MC-lb ( lane I ) . Although not illustrated in figure 33 , 
cytochromes P450 PB-3a and MC-lb iiiinunoprecipitated from control 
cells also shewed no incorporation of 32P following an incubation 
period of 30 minutes which correlates with the results illustrated 
in figure 33 for PB-2a .
Figure 33 shews only results obtained following an incubation 
period of 30 minutes ( which correlates with the inhibitory 
effects of 5 x 10~5M cyclic AMP upon androstenedione metabolism ). 
Hepatocytes incubated for 15 minutes , 45 minutes and 60 minutes 
in the presence and absence of 5 x 10“5 M cyclic AMP yielded 
identical results to those illustrated in figure 33 in that large 
amounts of protein of Mr 45,000-50,000 were precipitated by the 
specific antibodies but no 3 2 P-labelling was detectable either in 
control or cyclic AMP-mediated groups .
These results suggest that stimulation of phosphorylation of 
cytochrane P450 is not the mechanism by which 5 x 10“5M cyclic AMP 
mediates inhibitory effects upon the metabolism of 
androstenedione.
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DISCUSSION
4 DISCUSSION
4.1 CHOICE OF SUBSTRATE .
Much of the previous work concerning the mechanisms of action 
and the regulation of the hepatic monooxygenase system has 
utilised xenobiotic substrates . Kinetic studies have shown , 
however , that the apparent Km values for drug-metabolising 
enzymes e.g. 300-1400 pM for ethylmorphine-N-demethylase ( Castro 
and Gillette 1967 ) are generally higher than the corresponding 
values reported for steroid-metabolising enzymes ( Skett 1978 ) . 
This indicates that the hepatic monooxygenases exhibit low 
affinity for xenobiotic substrates . In this present study , 
therefore , we used the endogenous steroid , 4-androstene-
3,17-diane , as the substrate .
This steroid is widely available in both its unlabelled and 
(14C) labelled forms ( 4(4-14C)androstene-3/17-dione ) and is 
widely used in this laboratory . The metabolism of this steroid 
is well characterised ( section 1.5 ) . The metabolites have been 
separated by thin layer chromatography ( Gustafsson and Stenberg 
1974a) ( section 2.5 ) and also by radio-gas chromatography and 
gas chromatography-mass spectrophotometry ( Gustafsson and 
Stenberg 1974a ) .
Using thin layer chromatography in this present study we have 
been able to assess the activities of at least five different 
enzymes , three of which contain cytochrane P450 as an integral 
component , namely , 6{3 hydroxylase ( Waxman et al 1985 ) , 7a
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hydroxylase ( Waxman et al 1987 ; Nagata et al 1986 ) and 16a 
hydroxylase ( Waxman 1984 ) ( section 1.5 ) , and two of which do 
not contain cytochrane P450 as a component , namely , 17a/p 
hydroxysteroid dehydrogenase and 5a reductase ( Golf and Graef 
1978 ) ( section 1.5 ) . The activities of sane of these enzymes 
are sexually differentiated ( Gustafsson and Stenberg 1974a )
( table 2 ) .
The use of 4-androstene-3,17-dione as the substrate , 
therefore , allows the assessment of differential changes of 
enzyme activity such as occur during feminisaticn or 
masculinisaticn of hepatic enzyme profiles and also does not 
restrict assessment to cytochrcme P45 O-containing monooxygenases .
4.2 CHOICE OF EXPERIMENTAL MODEL .
Many of the early studies conducted to evaluate hormonal 
regulation of the hepatic monooxygenase system utilised "in vivo" 
models and involved injection of the hormone into the whole 
animal. The major drawback of such models is that additional 
actions of the hormones at sites other than directly at the level 
of the liver cannot be ruled out and it is well documented that 
many interactions exist between the components of the endocrine 
system . Many examples of such interactions have been discussed in 
the Introduction ( section 1.11 ) for each of the hormones 
reported to mediate effects upon hepatic monooxygenases . It would 
be erroneous to assume , therefore , that all of the effects of 
these hormones were being produced directly at the level of the
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liver rather than by the alteration of the synthesis , release and 
action of other hormones .
Other studies have been conducted "in vitro" utilising 
microscmes or reconstituted membrane systems however , although 
these models overcome problems of interactions , they cannot be 
used to study extracellular effects or the effects of 
intracellular pathways and their validity in the study of 
physiological processes is questionable .
We overcame these problems in this present study by using the 
isolated rat hepatocyte as our model and thereby overcame problems 
of hormone interaction whilst maintaining many of the 
physiological features of the system .
One of the major arguments against the use of isolated rat 
hepatocytes as a physiological model is that the highly structured 
arrangement of cells in intact liver is absent in homogenous 
suspensions or cultures of hepatocytes .
The intact liver contains three different cell types , namely, 
parenchymal cells ( hepatocytes ) , reticuloendothelial cells 
and Kupffer cells whereas modem techniques for the isolation of 
hepatocytes yield suspensions which are virtually free from 
contamination by these other cell types . In the intact liver , 
however , cooperation between the different cell types is known to 
occur e.g. cooperation between reticuloendothelial cells and 
parenchymal cells in the catabolism of haem by haem oxygenase 
( Maines and Anders 1973a ) . This effect will be lost when 
hepatocytes are isolated .
In addition , the parenchymal cells themselves are
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heterologous with regards to their content of cytochrane P450 and 
the ratios of the different cytochrane P450 isozymes . The 
variation in the content of the different cytochrome P450 isozymes 
is dependent upon the position of the parenchymal cells within the 
liver lobule e.g. phenobarbitone-inducible isozymes are located 
mainly in the centrilobular region of the lobule whereas
3-methylcholanthrene-inducible isozymes are located mainly in the 
periportal region ( Ioann ides and Park 1987 ) . The content of 
other enzymes also varies depending upon the location of the 
parenchymal cell populations . e.g. phase 2 conjugating enzymes 
are present at much higher concentrations in the centrilobular 
than in the periportal regions of the lobule ( Ioannides and Park 
1987 ) . In addition , different regions of the liver exhibit 
differences in glycolys is/gluccneogenesis in that hepatocytes of 
the perivenous region are involved mainly in glycolysis whereas 
the hepatocytes of the periportal region are involved mainly in 
gluccneogenes is . This heterologous distribution of parenchymal 
cells will be lost when the cells are isolated .
The loss of the structured arrangement of cells which occurs 
when hepatocytes are isolated , therefore , should be remembered 
when extrapolating data obtained in isolated rat hepatocytes to 
the physiological situation .
Another major problem that has previously been encountered 
when using isolated rat hepatocytes for the study of the hepatic 
monooxygenase system is that rapid loss of cytochrcme P450 occurs 
from hepatocytes during culture ( Stewart et al 1985 ) and during 
longer periods of culture loss of differentiated function occurs
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due to cell proliferation ( Bissell and Guzelian 1980 ) . The 
content of cytochrane P450 has been reported to fall to as little 
as 25% of the cytochrane P450 content of freshly isolated 
hepatocytes following 24 hours in culture ( Stewart et al 1985 ) 
and many attempts have been made to develop culture media which 
prevent this marked loss of cytochrane P450 .
Most cell lines require serum for growth in culture and it 
has been reported that the presence of fetal calf serum pranotes 
hepatocyte attachment to the culture dish , spreading and 
maintenance of viability over several days in culture . Stenberg 
et al ( 1978 ) , however , reported that the presence of fetal 
calf serum resulted in marked loss of androstenedicne- 
16a-hydroxylase and androstenedione-5a-reductase activities and it 
is new accepted that serum enriched culture media are unsuitable 
for the maintenance of isolated rat hepatocytes in the study of 
hepatic mcnooxygenases . Supplementing the medium with a variety 
of substances e.g. dexamethasone ( Michalopoulos and Pitot 1975 )
, adrenocorticosteroids ( Michalopoulos et al 1976 ) , ascorbic 
acid ( Bissell and Guzelian 1979 ) , 5-aminolaevulinic acid 
(Guzelian and Bissell 1976 ) , nicotinamide ( Paine et al 1979 ) 
or metyrapcne ( Lake and Paine 1982 ) , has been reported to 
maintain the levels of cytochrane P450 over short periods of 
culture . The drawback to maintenance of cytochrane P450 levels by 
these agents , however , is that sane cytochrane P450 isozymes are 
more susceptible to in vitro degradation than others ( Stewart et 
al 1985 ) and so the overall profile of the hepatocyte 
monooxygenases changes . This is particularly important when
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studying the hormonal regulation of steroid-metabolising enzymes 
which exhibit characteristic profiles in the male and female rat 
liver in vivo . Another drawback of using dexamethasone , 
adrenocorticosteroids or any other hormone supplement when 
examining the regulation of hepatic monooxygenases is that these 
hormones may themselves produce effects upon enzyme activities 
( section 1.11 ) .
In this laboratory , Hossin and Skett ( 1986 ) have 
characterised a system for primary culture of adult rat 
hepatocytes maintained in Hams F10 supplemented with 0.1% bovine 
serum albumin and 100IU penicillin/streptcmycin which overcomes 
some of these problems .
The absence of hormones in the medium allows the examination 
of the hormonal regulation of hepatic monooxygenases at both an 
extracellular and an intracellular level .
Hepatocytes were cultured at a cell density of 1 x 105 cells 
per an2 whereas it has been reported that proliferation of 
hepatocytes in culture occurs at lew cell densities hut is 
inhibited at these high cell densities ( Nakamura et al 1983a ) . 
It has been postulated that a growth-inhibiting factor is produced 
by the plasma membrane of mature rat hepatocytes which inhibits 
growth and promotes differentiation of the cells ( Nakamura et al 
1983b ) . This postulated factor , therefore , may prevent growth 
and promote differentiation of the hepatocytes when cultured at 
the high cell densities used in this present study .
In this present study we still noted a 33% loss of total 
cytochrome P450 content over a 3 hour period of culture ( section
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3.20 ) . At 24 hours the activities of all of the steroid- 
metabolising enzymes were markedly decreased in comparison to 
freshly isolated rat hepatocytes ( table 4 ) and this presumably 
represents corresponding decreases in the levels of both 
cytochrome P450-dependent and cytochrome P450-independent enzymes. 
Culture of the hepatocytes under these conditions did not result 
in significant change in the ratios of steroid-metabolising 
enzymes ( table 4 ) and sexual differentiation of these enzymes 
was maintained ( table 5 ) .
We therefore consider that the isolated rat hepatocyte 
maintained in Hams F10 supplemented with 0.1% bovine serum albumin 
and 100IU penicillin/streptcmycin is a valid , although not 
perfect , model for the study of the hormonal and intracellular 
regulation of hepatic steroid-metabolising monooxygenases over the 
time periods used in this present study .
4.3 EFFECTS OF ELEVATING CYCLIC AMP UPCN STEROID- 
METABOLISING ENZYMES .
The major drawback of examining the physiological regulation 
of any intracellular effect by cyclic AMP is that it does not 
readily penetrate the cell membrane and any that does gain access 
will be rapidly degraded by cyclic AMP phosphodiesterase for 
which it is a very good substrate ( Beebe et al 1986 ) . We 
overcame this problem in two ways .
In the first part of the study we examined the effects upon
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steroid metabolism of a number of agents which elevate cyclic AMP 
indirectly in intact hepatocytes i.e. 8-brcmo-cyclic AMP ( an 
analogue of cyclic AMP which readily penetrates the cell 
membrane), adrenaline ( receptor-mediated elevation of cyclic 
AMP), isabjtylmethylxanthine ( elevates cyclic AMP by 
inhibiting its degradation ) and forskolin ( elevates cyclic AMP 
by direct stimulation of adenylate cyclase ) .
In the second part of the study we overcame problems of 
cyclic AMP access to the interior of the cell by 
electropermeabilising the hepatocyte cell membrane . This allowed 
assessment of the effects of direct addition of different 
concentrations of cyclic AMP upon steroid-metabolising enzymes .
4.3(a) Effects of elevating cyclic AMP ( indirect ) in intact 
hepatocytes .
(i) Effects upon steroid-metabolising enzymes .
Incubation of isolated rat hepatocytes with 8-brano-cyclic 
AMP had a marked inhibitory effect upon the metabolism of
4-androstene-3,17-dicne in hepatocytes isolated fran male rats 
(figure 9 ) . This was not a feminising effect as all enzymes were 
inhibited to a similar degree whereas feminisation would have 
resulted in suppression of 16a- and 6{3- hydroxylase activities , 
little effect upon the activities of la hydroxylase and 17a/p 
hydroxysteroid dehydrogenase and stimulation of 5a reductase
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activity . This effect was also not sex-dependent as enzymes were 
inhibited to a similar degree in hepatocytes isolated fran female 
rats ( figure 10 ) .
The inability of 8-brcmo-cyclic AMP to feminise the male 
profile of steroid-metabolising enzyme activity may indicate that 
alteration of cyclic AMP levels has no role to play in mediating 
"in vivo" feminisaticn of hepatic monooxygenases . In addition , 
the identical effects of cyclic AMP in both male and female rats 
differs markedly from the effects of hormones postulated to 
mediate "in vivo" inhibition of hepatic monooxygenases by 
elevation of cyclic AMP levels . In these in vivo studies female 
hepatic monooxygenases were reported to be refractory to the 
inhibitory effects of thyroxine ( Kato and Gillette 1965a ; Kato 
et al 1970 ) ) ( section 1.11(h) ) ; diabetes ( Kato and Gillette 
1965a ; Kato et al 1971 ) ( section l.ll(i) ) ; adrenalectomy 
( Kato and Gillette 1965a ; Kato et al 1971 ) ( section l.ll(j) ) 
and adrenaline ( Kato and Gillette 1965a ) . Similarly the 
inhibitory effects of "in vivo" administration of dibutyryl cyclic 
AMP upon hepatic monooxygenase activity was also reported to occur 
in the male rat but not in the female rat ( Ross et al 1973 ) .
Postulated mechanisms for both the hormonal maintenance of 
sexually differentiated enzyme profiles and for mediating the 
production of "in vivo" refractoriness of female hepatic 
monooxygenases will be discussed in section 4.10(c) .
The inhibitory effect of 8-brcmo-cyclic AMP , hcwever , does 
indicate that the "in vivo" inhibition of hexobarbitone metabolism 
mediated by administration of dibutyryl-cyclic AMP to male rats
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( Weiner et al 1972a ; Ross et al 1973 ) is probably produced 
directly at the level of the liver rather than by the alteration 
of hormone release from components of the endocrine system . This 
correlates with the finding that the inhibitory effects of 
dibutyryl-cyclic AMP also occur in the isolated perfused liver and 
in liver slices ( Weiner et al 1972b ) .
Incubation of hepatocytes with adrenaline resulted in rapid , 
transient elevation of cyclic AMP levels which , after 10 minutes, 
had returned to the levels of corresponding control hepatocytes. 
This rapid rise and decline of cyclic AMP levels correlates 
with the findings of Exton et al ( 1971) in the perfused rat 
liver . The rapid rate of decline may be due to desensitisation 
of the adrenergic p2 receptor ( Bouvier et al 1987 ; Refnes et al 
1987 ) or to activation of cyclic AMP phosphodiesterase ( Corbin 
et al 1985 ) ( section 1.14(a) ) .
As shewn in figure 12 , the appearance of cyclic AMP-mediated 
inhibition of the metabolism of 4-androstene-3,17-dicne occurred 
1 to 2 hours following administration of adrenaline . The time 
lag between the effects of adrenaline upon cyclic AMP levels and 
its effects upon steroid-metabolising enzyme activity indicates 
that cyclic AMP probably produces its effects by activation of a 
cascade process . In 1971 , Exton et al postulated that the 
effects of adrenaline upon phosphorylase activation , an important 
step in the stimulation of glycogenolys is , were mediated by a 
similar cyclic AMP cascade process . The effects of adrenaline 
upon phosphorylase activation , however , are new thought to be
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mediated via the actions of adrenaline at the ax receptor which is 
linked to inositol phospholipid hydrolysis and mobilisation of 
calcium whereas p2-mediated generation of cyclic AMP is thought to 
be functionally unimportant for the activation of phosphorylase in 
the made rat ( Morgan et al 1983b ; Studer and Borle 1982 ; 
Bimbaum and Eain 1977 ; Studer et al 1984 ) .
The effects of adrenaline upon steroid-metabolising enzymes 
in the male rat , however , differ markedly fran its effects upon 
phosphorylase in that the inhibitory effects of adrenaline appear 
to be mediated only via p2 receptors and generation of cyclic AMP 
( as blocked by propranolol ) and the effects of adrenaline at ax 
receptors ( as blocked by prazocin ) do not appear to mediate its 
inhibitory effects upon, steroid-metabolising enzymes ( figure 13).
These findings are unusual in that receptors on the plasma 
membrane of male rat hepatocytes greatly outnumber p2 receptors. 
Seme other intracellular events , however , such as adrenaline- 
mediated induction of ornithine decarboxylase and its associated 
messenger RNA ( Evoniuk et al 1985 ) and adrenaline-stimulated 
phosphorylation and subsequent activation of fructose 
1,6-biphosphatase ( Nilsson-Ekdahl and Ekman 1987 ) have also 
been reported to be due to elevation of cyclic AMP and not due to 
calcium mobilisation . The results of this present study also 
correlate with the findings of Hussin et al ( 1988 ) who reported 
that incubation of male rat hepatocytes with the calcium 
icnophore, A23187 , had no effect upon the activity of the 
steroid-metabolising enzymes in hepatocytes isolated from male 
rats .
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Incubation of hepatocytes with iscfautylmethylxanthine ( IEMX ) 
resulted In a two phase elevation of cyclic AMP ( figure 14 ) . 
levels were elevated within 2 minutes and had returned to control 
levels after 5 minutes but this was followed by a secondary 
sustained rise in cyclic AMP levels which occurred after 30 
minutes .
IEMX was included in the study as a phosphodiesterase 
inhibitor and , therefore , would be expected to elevate cyclic 
AMP as a result of reduced cellular degradation of the cyclic 
nucleotide . The initial peak in cyclic AMP levels , however , is 
probably of too transient a duration to be accounted for by the 
phosphodiesterase-blocking action of the agent . IEMX is also 
known to mediate antagonistic effects at adenosine receptors as 
another of its actions ( Daly 1982 ) and this is thought to 
partially account for the stimulatory effects of this and other 
methylxanthines upon the central nervous system . This is unlikely 
to be the underlying mechanisms mediating the initial rise in 
cyclic AMP levels , however , because adenosine receptors present 
on the plasma membrane of hepatocytes have been reported to be Ag, 
linked via Ns to the stimulation of adenylate cyclase , as 
opposed to Ax , linked via Ni to the inhibition of adenylate 
cyclase ( Daly 1982 ) . The presence of IEMX , therefore , would 
be expected to decrease and not to increase cyclic AMP levels . In 
addition , the antagonistic activity of IEMX at A: or Ag receptors 
would be unlikely to result in any alteration in cyclic AMP levels 
in hepatocytes but would augment the effects of other hormones 
upon cyclic AMP generation in vivo . The precise mechanism by
which IEMX mediates this initial , transient elevation of cyclic 
AMP , therefore , is unknown .
The second gradual rise in cyclic AMP levels which occurs 
after 30 minutes has characteristics and time of onset which would 
be expected of phosphodiesterase-blocking activity .
As shewn in figure 14 , incubation of hepatocytes with IEMX 
resulted in inhibition of the metabolism of 4-androstene-
3,17-dione which occurred over a similar time course and was of a 
similar magnitude to that produced by adrenaline and in an 
analogous manner the increase in cyclic AMP levels produced by 
IEMX within 2 minutes also correlated with that produced by 
adrenaline .
It appears , therefore , that it is the initial transient 
elevation of cyclic AMP and not the secondary sustained rise 
attributed to phosphodiesterase-blocking activity , which mediates 
the inhibitory effects of IEMX upon steroid-metabolising enzyme 
activity .
Incubation of hepatocytes with the combination of adrenaline 
and IEMX resulted in much greater generation of cyclic AMP than 
mediated by either adrenaline or IEMX alone . Cyclic AMP levels 
were maximally elevated at 10 minutes and levels declined at a 
slower rate than those produced by adrenaline alone presumably due 
to the phosphodiesterase-blocking activity of IEMX . The 
combination of the two agents also had a correspondingly greater 
inhibitory effect upon the metabolism of 4-androstene-3,17-dicne 
( figure 15 ) .
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It is apparent , therefore , that the concentrations of cyclic 
AMP generated by adrenaline , IEMX and a combination of adrenaline 
and IEMX , mediate concentration-dependent inhibition of 
steroid-metabolising enzyme activity .
The concentrations of cyclic AMP generated by these agents in 
this present study may correlate with the concentrations of cyclic 
AMP which are generated by hormones in vivo . Elevation of cyclic 
AMP to these levels , therefore , may be cne mechanism by which 
some hormones e.g. thyroxine ( Muller and Seitz 1987 ) ( section 
1.16(g) ) ) , adrenaline ( Exton et al 1971 ) ( 1.16(b) ) and 
glucagon ( Exton et al 1971 ) ( 1.16(c) ) , mediate inhibitory 
effects upon hepatic monooxygenase ( see section 1.11 under 
separate hormones ) . Comparison between the inhibitory effects 
of elevating cyclic AMP in this present study , however , and the 
inhibitory effects of these hormones upon hepatic monooxygenase 
activity in vivo , is difficult because cyclic AMP levels were not 
measured in these in vivo studies . Subcutaneous injection of 
glucagon into rat pups , however , was reported to result in 4 
fold elevation of hepatic cyclic AMP levels 2.5 minutes following 
administration ( Evcniuk et al 1985 ) . In the same study , 
Evcniuk and co-workers reported that isoproterol ( a specific 
p-adrenergic agonist ) , administered in an identical manner , 
also produced a 3 to 4 fold elevation of hepatic cyclic AMP levels 
5 minutes after injection . These levels of cyclic AMP correlate 
with those generated by adrenaline , IEMX and a combination of 
adrenaline and IEMX in this present study . In addition both 
glucagon ( Weiner et al 1972a ) and adrenaline ( Pouts 1962 ; Kato
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and Gillette 1965a ) have been reported to have an inhibitory 
effect upon hepatic monooxygenase activity in vivo .
More direct evidence that correlation between the elevation of 
cyclic AMP ( 2 to 3 fold ) and inhibition of hepatic monooxygenase 
activity may be a physiological effect has been provided in a 
study by Olson and Weiner ( 1980 ) . These workers reported that 
the taxohormcnes secreted by the Walker 256 carcinsarccma had an 
inhibitory effec± upon the in vivo metabolism of 
p-chloro-N-methylaniline in male rats and this inhibitory effect 
was accompanied by a rise in hepatic cyclic AMP levels to 154% of 
sham operated controls . It was concluded by these workers that 
the inhibitory effects of the toxohormcnes upon hepatic 
monooxygenase activity may be mediated by alterations in the 
levels of hepatic cyclic AMP and this proposal correlates well 
with the findings of this present study .
The physiological implications of these findings will be 
discussed in more detail in section 4.10(a) .
Porskolin has been reported to elevate intracellular cyclic 
AMP levels by directly activating the catalytic subunit of 
adenylate cyclase ( Ruiz et al 1986 ) . Incubation of hepatocytes 
with forskolin alone ( figure 16 ) or a canbinaticn of forskolin 
and IEMX ( figures 18 and 19 ) generated concentrations of cyclic 
AMP which were far in excess of concentrations which are likely to 
be produced by in vivo hormonal stimulation .
At these higher concentrations of cyclic AMP a later , 
stimulatory effect upon the metabolism of 4-androstene-3,17-dione
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was apparent and led to progressive reduction in the degree of 
inhibition . As the cyclic AMP levels were increased further , the 
inhibitory effect was abolished and instead marked stimulation of 
enzyme activity occurred at this later time .
It is widely accepted that forskolin acts specifically upon 
adenylate cyclase to elevate cyclic AMP ( Seamon et al 1981 , Ruiz 
et al 1986 , Shi et al 1986 , Ho et al 1986 ) and its effects upon 
other intracellular systems have been little studied . It is 
conceivable , however , that the later stimulatory effects of 
forskolin , alone and in combination with IEMX , upon steroid 
metabolism occur independently of cyclic AMP generation but may be 
due to seme previously undocumented effect of forskolin upon other 
intracellular second messengers or alternatively due to a direct 
action of forskolin itself . These alternatives are unlikely 
because forskolin mediated-elevation of cyclic AMP levels to 488% 
of corresponding control levels ( figure 17 ) resulted in 
subsequent inhibition of steroid metabolism corresponding to that 
mediated by a combination of adrenaline and IEMX .
It is likely , therefore , that the loss of the inhibitory 
effects and the appearance of later stimulatory effects are due to 
the high concentrations of cyclic AMP generated by forskolin 
rather than any alternative mode of action . This may indicate 
that cyclic AMP has a second effect upon hepatic monooxygenase 
activity at these higher concentrations i.e. stimulation .
It is unlikely that concentrat ions of cyclic AMP correlating 
with those generated by forskolin and a combination of forskolin
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and IEMX in this present study can be generated by physiological 
concentrations of hormones . it is possible , however , that these 
high concentrations of cyclic AMP correlate with those which have 
been proposed to mediate the inductive effects of phenobarbitone , 
3-methylcholanthrene ( Byus et al 1976 ) and Anochlor-1254 ( Costa 
et al 1976 ) upon cytochrane P450 isozymes in vivo ( section 
1.17(b) ) . Byus et al ( 1976 ) , however , reported that 
following parental administration of phenobarbitone or 
3-methylcholanthrene , hepatic cyclic AMP levels were maximally 
elevated to 200% of corresponding control levels by 
3-methylcholanthrene and to 150% of corresponding control levels 
by phenabarbitone . These elevations of cyclic AMP were correlated 
to subsequent induction of hepatic monooxygenases which occurred 
24 hours following the administration of the agents .
These concentrations of cyclic AMP differ markedly from the 
high concentrations of cyclic AMP which we have found to be 
necessary to mediate stimulatory effects in this present study .
In addi tion , the time between maximum elevation of cyclic AMP and 
induction of hepatic monooxygenase activity mediated by in vivo 
administration of phenobarbitone and 3-methylcholanthrene appears 
to be much longer than that for cyclic AMP in this present study 
although comparison between the two studies is difficult because 
we did not examine the effects of forskolin or a combination of 
forskolin and IEMX following an incubation period of 24 hours .
A possible role for cyclic AMP in the effects of these 
inducing agents will be discussed in more detoil in section 4.11 .
-175-
Cyclic AMP , therefore appears to have a concentration- and 
time-dependent biphasic effect upon steroid metabolism which 
appears to reflect the relative magnitudes of two opposing effects 
i.e. inhibition which predominates at low concentrations and 
stimulation which predominates at high concentrations .
The mechanism by which cyclic AMP mediates these two opposing 
effects will be discussed in more detail in sections 4.4 to 4.8 .
(ii) Drawbacks of indirectly elevating cyclic AMP .
One of the drawbacks of using indirect mechanisms for 
elevating cyclic AMP is the possibility that the agents are 
producing effects by additional actions not related to cyclic AMP 
generation .
It is likely that the inhibitory effects of adrenaline are due 
to cyclic AMP generation and not to elevation of cytosolic calcium 
levels because the effects of adrenaline were inhibited by 
propranolol ( a p blocker ) but not by prazocin ( an ax blocker ).
Methylxanthines have been reported to mediate relaxation of 
smooth muscle by elevation of intracellular cyclic GMP levels ( 
Kukovetz et al 1980 ) . Elevation of hepatic cyclic GMP levels , 
therefore , may be an alternative mechanism by which IEMX mediates 
inhibition of steroid metabolism . Methylxanthines have also been 
reported to stimulate the release of calcium from the endoplasmic 
reticulum ( Exton 1980 ) . Mobilisation of calcium , however , is 
unlikely to mediate the inhibitory effects of IEMX upon steroid 
metabolism because neither the calcium icnophore , A23187 ( Hussin
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et al 1988 ) , nor adrenaline acting via ax receptors ( see above) 
had any effect upon steroid metabolism in isolated rat 
hepatocytes .
Additional actions of forskolin have been little studied . It 
is conceivable , however , that the effects of forskolin upon 
hepatic monooxygenase activity may be mediated by previously 
undocumented effects upon other intracellular second messengers or 
may be due to a direct action of forskolin itself .
IXie to these potential additional actions it would be 
erroneous to conclude that the effects upon steroid-metabolising 
enzymes mediated by these agents are attributable only to 
progressive rises in intracellular cyclic AMP level .
The problems of additional actions of the agents have been 
partially overcome in this present study by using the cyclic AMP 
analogue , 8-brcmo-cyclic AMP . Cyclic AMP is thought to mediate 
most , if not all , of its intracellular effects by activation of 
cyclic AMP-dependent protein kinase ( FKa ) . 8-brcmo-cyclic AMP 
has been reported to pass freely across the plasma membrane of the 
cell and directly activate PKa in an analogous manner to cyclic 
AMP ( Beebe et al 1985 ) . 8-Brcmo-cyclic AMP has not been 
reported to have any additional actions .
Quantitative assessment of the effects of 8-brcmo-cyclic AMP , 
however , is difficult as it has been reported to be much more 
potent in activating cyclic AMP-dependent processes than cyclic 
AMP itself e.g. in stimulating adipocyte lypolysis , the EC50 of 
8-brcmo-cyclic AMP has been reported to be 3.9M whereas the EC50
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for cyclic AMP has been reported to be in excess of 15mM ( Beebe 
et al 1986 ) . In addition , 8-brcmo-cyclic AMP is 15 times less 
susceptible to the degradative effects of cyclic AMP 
phosphodiesterase ( Beebe et al 1986 ) and the continuous
activation of PKa by this agent may , therefore , prolong a
response which is limited under physiological conditions . It has
recently been reported that PKa is not a single species but is a
family of closely related enzymes which have been classified into 
two groups , type 1 and type 2 ( Robinsan-Steiner et al 1984 ) . 
The liver has been reported to contain both type 1 and type 2 
protein kinases . Different cyclic AMP analogues appear to have 
different affinities for the two types of PKa e.g. 
8-thio-substituted analogues preferentially activate type 2 
enzymes whereas 8-amino-substituted analogues preferentially 
activate type 1 enzymes ( Beebe et al 1986 ) . It is possible , 
therefore , that the ratio of type 1/type 2 protein kinases 
activated by 8-brcmo-cyclic AMP differs frcm the activation of 
these two types of protein kinase by cyclic AMP . Although 
different physiological roles for the two types of protein kinase 
have not been elucidated , it is possible that differences between 
activation of type 1 and type 2 protein kinases by 8-brcmo-cyclic 
AMP and by cyclic AMP may result in qualitative and quantitative 
differences in cellular response .
Another drawback of using these indirect mechanisms to elevate 
cyclic AMP is that the cyclic AMP concentrations evaluated and 
used to establish a concentration/effect relationship in this
present study were determined in the whole cell and almost 
certainly do not reflect the concentrations of cyclic AMP at 
specific sites within the cell . This is due to the known 
ccmpartmentalisaticn of cyclic AMP within the cell which has been 
illustrated well in a study by Yamatani et al ( 1987 ) . This 
group postulated that glucagon was linked to two functionally 
separate types of adenylate cyclase , one mediating the effects of 
glucagon upon glycogenolys is and the other having no effect upon 
glycogenolysis . It was postulated that the cyclic AMP generated 
by activation of the two types of adenylate cyclase were separated 
by caipartmentalisaticn within the cell .
4.3(b) Direct addition of cyclic AMP to electropermeabilised 
hepatocytes .
(i) Problems of direct addition of cyclic AMP .
The problems associated with indirect elevation of cyclic AMP 
discussed in the previous section , could be overcome by using the 
direct addition of cyclic AMP . The major problem of this 
approach , however , is that cyclic AMP penetration of the 
plasma membrane is very poor and cyclic AMP that does penetrate 
the plasma membrane will be rapidly degraded within the cell by 
the action of cyclic AMP phosphodiesterase ( Beebe et al 1986 ) . 
The concentration of cyclic AMP within the cell , therefore , will 
be considerably lower than that in the extracellular medium .
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(ii) Theory of electropermeabilisation
The problems of access of small , non-permeant molecules 
across the cell membrane has been addressed previously and one 
method which has been used to permit entry of these molecules into 
the cell frcm the extracellular medium is electropenneabilisation 
of the plasma membrane .
In 1974 , Zimmerman et al reported that the application of 
potential difference of IV across a physiological membrane 
resulted in membrane breakdown . This process is known as 
electropenneabilisation and was used by Knight and Baker ( 1982 ) 
to allow access of calcium into bovine adrenal medullary cells .
A diagrammatic representation of a cell placed in an electric 
field is shown in figure 7 ( see Materials and Methods ) . Knight 
and Baker ( 1982 ) used the following formula to calculate the 
potential difference across the plasma membrane :
Vp = C b E cos 0
Where Vp is the potential difference at any point (p) around 
the circumference of the cell , b is the radius of the cell , E is 
the applied field strength , 0 is as shown in figure 7 and C is a 
constant which depends upon the relative conductivities of the 
extracellular fluid , the cytosol and the membrane with relation 
to cell size and membrane thickness . It can be assumed that the
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cxnductivities of the extracellular and intracellular fluids are 
much greater than that of the membrane and that the dimensions of 
the cell are much greater than the thickness of the membrane . 
Under these conditions C has been shown to be approximately 1.5 
( Knight and Baker 1982 ) .
Therefore : Vp = 1.5 b E cos 0
The potential difference across the cell membrane will be
maximum at the centre of the cell in line with the electric field
( A-B in figure 7 ) at which point cos 0 = ± 1 .
Therefore : V(A/B) = 1.5 b E
Using this formula , Knight and Baker calculated that an 
applied field strength of 1000-2000V/an across a bovine adrenal 
medullary cell ( b = 10pm ) would produce a transmembrane 
potential of 1.5V-3V at opposite poles of the cell in line with 
the electric field which is sufficient to mediate membrane 
breakdown .
One possible problem of this method is that potential 
differences occur across all of the cell membranes and so 
intracellular damage may occur . The radii of the intracellular
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organelles , hcwever , are much less than that of the whole cell 
e.g. mitochondria have a radius of approximately 0.5 pm ( Knight 
and Baker 1982 ) . Using the above formula , the potential 
difference across the membrane of the mitochondria in a field 
strength of 1000-2000V/cm is 75mV-150mV . This potential 
difference is theoretically much less than that required for 
membrane breakdown and so intracellular damage is minimal .
Since the work of Zirrmerman et al ( 1974 ) and Knight and 
Baker ( 1982 ) , the method of electropenneabilisation has been 
widely used in a number of different cell types e.g. NIH-3T3 cells 
( Mir et al 1988 ) , NHTK 3025 cells ( Melvik et al 1986 ) , 
medullary thyroid carcinoma cells ( Haller-Brem et al 1987 ) , 
neutrophils ( Grinstein and Furuya 1988 ) and Chinese hamster 
ovary cells ( Teisse and Rols 1986 ) and in 1982 , Gordon and 
Seglen first characterised a system for permeabilisaticn of 
isolated rat hepatocytes .
(iii) Histological characteristics of permeabilised cell 
membranes .
In the study of Knight and Baker ( 1982 ) it was postulated 
that the application of a strong electrical field across bovine 
adrenal medullary cells punctured two pores in the plasma membrane 
of the cell at opposite poles ( see previous section ) . Due to 
the random motion of the cells within the suspension the cells 
will rotate and the application of a second pulse will puncture 
another pair of pores at two more sites on the plasma membrane .
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The number of pores created , therefore , will increase in ratio 
to the number of pulses applied . if the face of the cell in line 
with the electric field contains a previously punctured pore close 
to the orientation of the electric field , however , the pore is 
of lcwer resistance that the surrounding membrane and the lines of 
the electric field will pass through the pore and no new pore will 
be created . The number of pores created by successive discharges, 
therefore , is limited by this effect .
In contradiction to the creation of pores in the membrane as 
proposed by Knight and Baker above , Gordon et al ( 1985 ) 
reported that electropenneabilisation of isolated rat hepatocytes 
resulted in the formation of protruberances or blebs on the plasma 
membrane of the cell . This was thought to indicate the sites of 
cell damage and similar blebs were noted on the cell membrane 
iumediately following isolation of the hepatocytes try collagenase 
perfusion . It was proposed by these workers , that stretching of 
the plasma membrane at the site of the blebs may be the reason for 
increased permeability .
TWo different models have been proposed for the mechanism of 
electropenneabilisation of cell membranes . These differences may 
be due to (a) tissue differences , (b) differences in the 
electropenneabilisation process or (c) differences in data 
interpretation .
-183-
(iv) Size of permeable areas and markers
Electropenneabilisation of bovine adrenal medullary cells has 
been reported to produce pores of radius 1 to 2 nm ( Knight and 
Baker 1982 ) whereas Gordon and Seglen ( 1982 ) reported that 
permeabilised areas of the hepatocytes cell membrane allowed free 
influx or efflux of molecules with a molecular weight of less than 
1000 but occluded larger molecules . In both of these cases 
electropenneabilisation of the membrane results in the free 
passage of small molecules such as cyclic AMP and calcium down a 
concentrations gradient but large molecules such as proteins will 
be retained within the cell .
A number of markers have been used to assess 
electropenneabilisation in different cell types . Most workers 
have measured the rate of influx of these markers in 
electropermeabilised compared to intact cells . Markers , 
therefore , are all snail molecules ( Mr < 1000 ) which are 
relatively poor at penetrating the intact cell . Markers tend to 
be either radiolabelled compounds e.g. (14C)sucrose ( Gordon and 
Seglen 1982 ; Gordon et al 1985 ) and 45Ca-EGEA ( Knight and Baker 
1982 ) which are detected by scintillation counting , or 
fluorescent dyes e.g. Lucifer Yellow ( Mir et al 1988 ) which are 
detected optically or fluoranetrically .
Trypan blue is unsuitable as a marker as its molecular weight 
is very close to the maximum for access . It can , however , be 
used for the assessment of cell viability following 
electropenneabilisation and its ability to differentiate between
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viable and ncn-viable cells will be minimally affected try the 
permeabilisaticn process .
(v) IXiraticn of permeability .
Reports on the length of time that the membrane remains 
permeable following electropenneabilisation vary . Knight and 
Baker ( 1982 ) reported that following electropenneabilisation of 
bovine adrenal medullary cells the membrane was permeable to 
Ca-ECTA for over 60 minutes ( the longest time period studied ) at 
both 0°C and 37°C . This was postulated to be due to the membrane 
proteins surrounding the "pore" ( see section 4.3(b)(iii) ) being 
denatured by the electropermeabilisaticn process . Teisse and Rols 
( 1986 ) , however , reported that following
electropenneabilisation of Chinese hamster ovary cells , the cell 
membranes had reverted to their non-permeable state after 20 
minutes at room temperature . Following electropenneabilisation of 
isolated rat hepatocytes , the cells have been reported to remain 
permeable to (14 C) sucrose for at least 2 hours at room temperature 
or below but become non-permeable to the marker after a 15 minute 
incubation period at 37° C ( Gordon and Seglen 1982 ) and this is 
accompanied by disappearance of the blebs thought to be associated 
with permeabilised areas of the membrane ( Gordon et al 1985 ) .
It is interesting to note that increased blebbing and 
permeabilisaticn of the bepatocyte plasma membrane to (14C)sucrose 
have also been reported to occur immediately following the 
isolation of hepatocytes by collagenase perfusion ( Gordon et al
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1985 ) tut the membranes revert to their intact , non-permeable 
state during the 30 minute incubation period at 37° C which is 
routinely used to allow the hepatocytes to recover from the 
isolation process .
These varying reports of the duration of permeability may be 
due to one or a combination of (a) tissue differences ,
(b) electropenneabilisation technique or (c) marker used .
(vii) Fermeabilisation media .
As discussed in section 4.3(b)(ii) , the ionic strength ( and 
therefore the conductivity ) of the extracellular medium is one of 
the factors which determines the potential difference across the 
plasma membrane of a cell placed in an electric field . The ionic 
strength of the medium determines the duration of the electric 
field to which the cells are exposed , i.e. the lower the ionic 
strength , the greater the resistivity and the longer the duration 
of the pulse .
The electropenneabilisation technique used by Gordon and 
Seglen ( 1982 ) for isolated rat hepatocytes was standardised 
using an electrolyte rich buffer which results in a very brief 
duration of the pulse . In the same study , Gordon and Seglen also 
examined the effects upon cellular structure of 
electropermeabilising hepatocytes in a 10% sucrose solution which 
has very high resistivity and therefore will result in very long 
exposure of cells to the electric field . They reported that one 
discharge of 2000V/an resulted in marked destruction of cellular
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structure and they termed this process electrodisrupticn .
Most studies upon the electropenneabilisation of cells have 
used media of intermediate ionic strengths e.g. Teisse and Rols 
( 1986 ) used a 10nM phosphate buffer containing sucrose ( 250RM ) 
and magnesium chloride ( lirM ) to effect permeabilisaticn of 
Chinese hamster ovary cells and a buffer of similar ionic strength 
and composition was used try Knight and Baker ( 1982 ) to effect 
electropenneabilisation of bovine adrenal medullary cells .
(vii) Standardisation of electropenneabilisation in this 
present study .
In this present study , electropenneabilisation was carried 
out in an extracellular medium of Hams F10 culture medium 
supplemented with 0.1% bovine serum albumin or phosphate-free 
incubation medium supplemented with 0.1% bovine serum albumin 
( section 2.19(f) ) . These media are of higher ionic strength 
than the sucrose buffers used by Knight and Baker ( 1982 ) or 
Teisse and Rols ( 1986 ) but of lcwer ionic strength than the 
electrolyte-rich saline buffer used to effect permeabilisaticn 
hepatocytes by Gordon and Seglen ( 1982 ) ( section 4.3(b)(vi) ) .
Cyclic AMP was used as a marker for the assessment of 
permeabilisaticn . This marker differs fran those discussed in 
section 4.3(b)(iv) in that it is not fluorescent and is not 
radiolabelled . Cyclic AMP levels were detected by 
radioirrmunoassay .
Using a range of electropenneabilisation parameters ( 2-10
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pulses , 1000-3000V/cm ) and increase in the intracellular 
concentrations of cyclic AMP as a measure of the degree of 
permeabilisaticn , we were able to show that 5 pulses of 1000V 
resulted in almost 100% permeabilisaticn subject to the assumption 
that (a) the hepatocyte is a sphere of volume 4/3ti3 , (b) the 
volume of the intracellular organelles impermeable to cyclic AMP 
is very small in comparison to the total volume of the cell and 
(c) that cyclic AMP degraded by cyclic AMP phosphodiesterase is 
replaced by cyclic AMP from the surrounding medium .
The strength of the applied field is lower than that routinely 
used by Gordon and Seglen ( 1982 ) to effect 
electropenneabilisation of isolated rat hepatocytes ( 2000V/an ) 
and lower than that used by Knight and Baker ( 1982 ) to effect 
permeabilisaticn of bovine adrenal medullary cells ( 2000V/cm ) 
which are of a similar diameter to rat hepatocytes ( 20pm ) . The 
field strength of lOOOV/an can be calculated by the formula shewn 
in section 4.3(b) (ii) to produced a potential difference across 
the cell membrane at opposite poles the cell in line with the 
electric field of 1.5V which is above the minimum voltage of IV 
reported to mediate membrane breakdown ( Zimmerman et al 1974 ) 
and use of this lower voltage will minimise damage to 
intracellular membranes . Minimising damage to intracellular 
membranes is of particular importance in this present study 
because the cytochrome P450-dependent monooxygenases and the 
5a-reductase enzyme complex are membrane bound .
Cell viability following electropenneabilisation was assessed 
by trypan blue exclusion which , as discussed in section
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4.3(b)(iv) , is too large to readily pass into the 
elect ropermeabilised cell . It ability to differentiate between 
viable and non-viable cells , therefore , is little affected by 
the electropermeabilisation process . Cell viability was reduced 
from >97% to 75%-80% following electropermeabilisation . This may 
be due to the electropermeabilisation process or due to the 
penetration of sane components of the external medium 
( standardised for intact cells ) into the interior of the cell .
Using this technique we were able to overcome the problems of 
cyclic AMP access across the cell membrane and examine the direct 
effects of different concentrations of cyclic AMP upon steroid 
metabolising enzyme activity . Cyclic AMP allowed access in this 
manner will still be subject to rapid degradation by cyclic AMP 
phosphodiesterase . The concentration gradient which results from 
cyclic AMP degradation , however , will replace that which is lost 
and so the overall effects of degradation by cyclic AMP 
phosphodiesterase will be negligible . The intracellular 
concentration , assumed to be homogenous throughout the hepatocyte 
, therefore , will be the same as that in the extracellular 
medium .
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4.3(c) Effects of elevating cyclic AMP ( direct ) in
elect ropermeabilised hepatocytes .
(i) Effects upon steroid-metabolising enzymes .
Using the electropermeabilised hepatocyte as our model we were 
able to demonstrate that the direct application of cyclic AMP has 
a concentration- and time-dependent biphasic effect upon steroid 
metabolism .
5 x 10"5M Cyclic AMP ( figure 20 , panel A ) had an 
non-specific inhibitory effect upon the metabolism of 
4-androstene-3,17-dicne in an analogous manner to adrenaline ,
IEMX and the combination of adrenaline and IEMX and this 
concentration may correlate with those produced by hormones in the 
physiological situation as discussed in section 4.3(a)(i) .
Incubation with 5 x 10~4M cyclic AMP had less of an inhibitory 
effect than did 5 x 10~5M cyclic AMP and this was followed by 
slight stimulation of all of the enzyme activities ( figure 20 , 
panel B ) . This intermediate concentration of cyclic AMP , 
therefore , produced identical effects to forskolin in that slight 
secondary stimulatory effects were apparent .
5 x 10-3M Cyclic AMP had only very slight inhibitory effects 
but this was followed by a much greater stimulatory effect than 
that produced by 5 x 10-4M cyclic AMP ( figure 20 , panel C ) . 
These effects , therefore , correlate with those produced by the 
combination of forskolin and IEMX and these high concentrations of 
cyclic AMP are unlikely to be generated by hormones under
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physiological conditions but may correlate with those generated in 
the liver by in vivo administration of phenobarbitcne ,
3-methylcholanthrene ( Byus et al 1976 ) and Arochlor-1254 ( Costa 
et al 1976 ) ( section 1.17(b) ) .As discussed previously in 
section 4.3(a)(i) , however , the concentrations of cyclic AMP 
generated by these agents in vivo were apparently considerably 
lower than those necessary to mediate stimulation of 
steroid-metabolising enzyme activity in this present study .
The concentrations of cyclic AMP which were required to 
produced identical effects upon steroid metabolism in the 
electropermeabilised hepatocytes and in intact hepatocytes were 
approximately 100-fold higher in the electropermeabilised 
hepatocytes and this may reflect the degree of 
cxirpartmentalisation of agent-generated cyclic AMP within the 
intact cell .
The mechanism by which cyclic AMP mediates both inhibition and 
stimulation of steroid-metabolising enzymes will be discussed in 
sections 4.4 to 4.8 .
(ii) Drawbacks of using electropermeabilised cells as a 
physiological model .
One drawback is the amount of time that cyclic AMP remains 
elevated within the cell . Knight and Baker ( 1982 ) reported that 
electropermeabilisation of bovine adrenal medullary cells produced 
pores which remained stable for in excess of 1 hour following 
electropermeabilisation . Gordon and Seglen ( 1982 ) , however ,
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reported that following electropermeabilisation of rat 
hepatocytes , the cell membrane remained permeable for 15 
minutes when incubated at 37° C . Intracellular cyclic AMP levels , 
therefore , may be expected to remain constant for at least 15 
minutes following its addition to the extracellular medium and 
this contrasts markedly with the transient elevation of cyclic AMP 
generated by indirect methods in intact hepatocytes . Hie constant 
elevation of cyclic AMP over this extended time period , 
therefore , may prolong a cellular event which is limited under 
physiological conditions . It is interesting , therefore , that 
the effects of cyclic AMP upon steroid metabolism in 
electropermeabilised hepatocytes correlate well with the effects 
of corresponding elevations of cyclic AMP in intact hepatocytes . 
This further suggests that it is the initial concentration of 
cyclic AMP within the cell which determines the later effects upon 
steroid-metabolising enzymes and that the rate of decline of 
cyclic AMP levels is functionally unimportant for regulation of 
steroid-metabolising enzymes .
Another drawback of the system is that the cell membrane 
becomes freely permeable to all molecules of molecular weight less 
than 1000 . The intracellular milieu equilibrates with the 
extracellular medium and this may result in efflux of important 
components from the cell and influx of unwanted components from 
the extracellular medium . Correlation between the effects of 
cyclic AMP upon steroid metabolism in intact cells and in 
electropermeabilised cells indicates that these possible changes 
in the cytosolic constituents have no apparent effect upon the
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activities of hepatic monooxygenases and their regulation by 
cyclic AMP .
It has previously been reported that electropermeabilisation 
of both Chinese hamster ovary cells ( Teisse and Rols 1986 ) and 
rat hepatocytes ( Gordon and Seglen 1982 ) may result in fusion of 
the cells and the production of multinucleated giant cells . This 
was thought to be due to changes in the plasma membrane and not 
the electric field ( Teisse and Rols 1986 ) . Fusion of the 
hepatocytes was reported to be increased if the cells were in 
tight contact ( Gordon and Seglen 1982 ) and Teisse and Rols (
1986 ) reported that sedimentation of Chinese hamster ovary cells 
by centrifugation was necessary to produce cell fusion . In this 
present study the hepatocytes were not centrifuged following 
electropermeabilisation and microscopic examination of the cells 
revealed no giant cells which would have indicated that fusion had 
occurred .
Another effect of electropermeabilisation noted by Gordon and 
Seglen ( 1982 ) was that the procedure resulted in decrease in 
hepatocyte protein synthesis and degradation . This may be an 
important consideration in this present study because stimulation 
of both the synthesis and degradation of cytochrane P450 is a 
mechanism by which high concentrations of cyclic AMP mediate their 
effects upon steroid-metabolising enzymes ( section 4.7 ) and 
these actions may be depressed in electropermeabilised 
hepatocytes . Gordon and Seglen ( 1982 ) , however , noted that 
protein synthesis and degradation were reduced by 15 to 20% 
following the application of 10 discharges of 2000V/cm . In this
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present study we have used 5 discharges of lOOOV/an to effect 
permeabilisaticn and the effect upon protein synthesis and 
degradation may be expected to be correspondingly less than that 
noted by Gordon and Seglen ( 1982 ) . In addition we noted little 
difference between the effects of a combination of forskolin and 
IEMX upon steroid metabolism and cytochrome P450 levels in intact 
hepatocytes and those of 5 x 10~3M cyclic AMP in 
electropermeabilised hepatocytes ( section 4.7 ) . This may 
indicate that the reduction of protein synthesis and degradation 
is minimal using these electropermeabilisation parameters and over 
the time periods used in this present study .
Problems of cell fusion and reduction of protein synthesis and 
degradation , therefore , may have been minimised in this present 
study by the protocol used whereas possible changes in the 
cytosolic constituents and extended elevation of cyclic AMP appear 
to have little effect upon steroid-metabolising enzyme activities 
and their regulation by cyclic AMP . We , therefore , consider 
that the electropermeabilised hepatocytes , although not perfect , 
is a valid model for examining the regulation of 
ateirH ising enzymes by cyclic AMP under the conditions
used in this present study .
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4.3(d) Conclusions to section 4.3
Vfe have shewn by both indirectly elevating cyclic AMP in 
intact rat hepatocytes and by directly elevating cyclic AMP in 
electropermeabilised hepatocytes that cyclic AMP has a time- and 
concentration-dependent biphasic effect upon the metabolism of
4-androstene-3,17-dicne . The effect upon steroid-metabolising 
enzyme activity occurring at ^ to 2 hours is related to the 
concentration of cyclic AMP present in the cell at 2 to 5 minutes. 
Lew ( physiological ) concentrations of cyclic AMP , generated by 
adrenaline , IEMX , and a combination of adrenaline and IEMX and 
simulated by 8-brano-cyclic AMP in intact cells , correlating with 
5 x 10-5M cyclic AMP in electropermeabilised cells , mediate early 
inhibition of enzyme activity .
Intermediate concentrations of cyclic AMP , generated by 
forskolin in intact cells and correlating with 5 x 10~4M cyclic 
AMP in electropermeabilised cells mediate weak early inhibitory 
effects possibly followed by weak stimulatory effects upon enzyme 
activity .
High ( supraphysiological ) concentrat ions of cyclic AMP , 
generated by a combination of forskolin and IEMX in intact 
hepatocytes and correlating with 5 x 10“3 M cyclic AMP in 
electropermeabilised cells mediate little or no early inhibitory 
effects but this is followed by marked later stimulatory effects 
upon enzyme activity .
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4.4 THE ROLE OF PROTEIN KINASES AND PROTEIN SYNTHESIS IN THE
ACTIONS OF CYCLIC AMP .
Cyclic AMP is thought to mediate most , if not all , of its 
effects in the cell by activation of cyclic AMP-dependent protein 
kinase ( PKa ) . In 1983 , Pyerin et al reported that the purified 
rabbit liver cytochrome P450 , P450 IM2 , in a reconstituted 
membrane system was phosphorylated by incubating with the 
catalytic subunit of PKa and this was accompanied by decrease in 
the metabolism of 7-ethoxycoumarin . Later work by Pyerin and 
co-workers ( 1987 ) indicated that the catalytic subunit of PKa 
could also phosphorylate many rat liver cytochrome P450 isozymes. 
Activation of PKa , therefore , may be a mechanism by which 
cyclic AMP mediates its inhibitory effects upon steroid 
metabolising enzymes in this present study . Pyerin and co-workers 
( 1987 ) also reported that many rat liver cytochrome P450 
isozymes were phosphorylated by protein kinase c ( PKc ) . Many 
interactions exist between PKa-activating and PKc-activating 
pathways ( section 1.14(b) ) and it is possible that some of the 
effects of cyclic AMP may be mediated by modulation of 
FKc-activating pathways .
Cyclic AMP activation of PKa has also been Implicated in the 
induction of hepatic monooxygenases mediated by Arochlor-1254 
(Costa et al 1976 ) , pbenobarbitone and 3-methylcholanthrene 
(Byus et al 1976 ) and the inductive effects of these agents are 
thought to be due , at least in part , to increase in protein 
synthesis ( section 1.9(b) ) • Activation of PKa and subsequent
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increase in protein synthesis , therefore , may be a mechanism by 
which cyclic AMP mediates stimulation of steroid-metabolising 
enzymes in this present study .
We , therefore , examined the roles of protein kinase and 
protein synthesis in the actions of cyclic AMP upon steroid 
metabolism in isolated rat hepatocytes .
4.4(a) Agents .
(i) Protein kinase inhibitors .
Hie role of protein kinases in the actions of cyclic AMP were 
assessed using the recently developed K-252 compounds . Hie first 
of these compounds to be characterised was K-252a which is a 
indole carbazole compound produced by the microbe , Nocard iops is 
species K-252 ( Kase et al 1986 ) . This compound was first 
characterised as a potent inhibitor of Protein kinase c ( PKc ) 
with an IC50 of 32.9nM ( Kase et al 1986 ) and a Ki of 25nM . It 
has been subsequently reported that K-252a has comparative 
inhibitory effects upon both cyclic AMP-dependent protein kinase 
(PKa ) and cyclic OiP-dependent protein kinase ( PKg ) with a Ki 
of 18nM and 20nM respectively ( Kase et al 1987 ) . K-252a , 
therefore , appears to a general protein kinase inhibitor of both 
PKc and cyclic nucleotide-dependent protein kinases .
K-252a is also an inhibitor of calmodulin and subsequently of 
calmodulin-dependent cyclic AMP phosphodiesterase ( Kase et al 
1986 ) and this may be an unwanted effect of the compound . Hie
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IC50 of K-252a for heart calmodulin-dependent cyclic AMP 
phosphodiesterase , however , is 1.3pM and so inhibitory effects 
against calmodulin-dependent phosphodiesterase will only occur at 
concentrations far in excess of those required to inhibit protein 
kinases .
A related species of Nocardiopsis ( species K-290 ) was also 
reported to produce compounds with PKc-blocking activity and 
these were termed K-252b , c and d ( Nakanishi et al 1976 ) , all 
of these compounds were found to possess PKc-blocking activity 
tut K-252b was found to be the most potent with an IC50 of 38.3nM 
compared with 214nM for K-252c and 337nM for K-252d . Structural 
analysis of the K-252b has revealed that it is the 9-carboxylic 
acid derivative of K-252a ( Kase et al 1987 ) . It differs from 
K-252a , however , in that it is relatively specific for PKc with 
a Ki of 20nM , whereas its Ki for PKa is 90nM and its Ki for PKg 
is lOOnM ( Kase et al 1987 ) . At a concentration of 20nM , as 
used in this present study , K-252b will be a selective inhibitor 
of PKc and will have minimal blocking activity against cyclic 
nucleotide-dependent protein kinases .
Chemical modification of K-252a yielded two more derivatives 
with protein kinase-blocking activity . KT5720 is the 9-n-bexyl 
ester derivative of K-252a and has been found to be a highly 
selective inhibitor of PKa with a Ki of 60nM whereas its Ki for 
PKc and PKg are in excess of 2pM ( Kase et al 1987 ) . KT5822 is 
the 9-methoxy derivative of K-252a and has been found to be a 
highly selective inhibitor of PKg with a Ki of 2. 4nM whereas its 
Ki for PKc and PKa are 79nM and 37.4nM respectively . ( Kase et
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al 1987 ) .
These protein kinase inhibitors are thought to act by 
competing with ATP for the active site of their respective protein 
kinases ( Kase et al 1987 ) . In this present study we used the 
K-252 compounds at concentrations correlating with the Ki for 
their respective protein kinases thereby eliminating problems of 
lack of selectivity at higher concent rat ions . None of the K-252 
compounds were found to adversely affect cell viability . In 
studies utilising these agents , test cell samples were compared 
to control cells which received the inhibitor alone to eliminate 
any possible direct effects of the protein kinase inhibitors 
against hepatic monooxygenase activity . Comparison between 
untreated control cells and control cells which received the 
inhibitor alone , however , indicated that the protein kinase 
inhibitors appear to have little or no direct effect against 
hepatic mcnooxygenases .
One of the major problems noted in preliminary experiments 
was that none of the protein kinase inhibitors ( K-252a# K-252b 
and KT5720 ) had any effect upon the actions of 8-brano-cyclic 
AMP in the intact cell but we have later shown that these agents 
have marked effect upon the actions of cyclic AMP in the 
electropermeabilised cell . This may indicate that 8-brano-cyclic 
AMP is mediating its inhibitory effects upon steroid metabolism by 
a protein kinase-independent mechanism . This explanation seems 
unlikely , however , because no protein kinase-independent effects 
of 8-brano-cyclic AMP have been reported and 8-brano-cyclic AMP is 
thought to simulate the effects of cyclic AMP . A more likely
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explanation , therefore , is that the protein kinase inhibitors 
are unable to penetrate the intact cell membrane . The assay 
procedure used by Kase et al ( 1987 ) to establish the inhibitory 
potencies of the K-252 compounds were carried out using in vitro 
models and no studies were carried out to establish the effects of 
these compounds in the intact cells . The inability of the 
compounds to penetrate into intact cells , as Implied by this 
study , may be a serious drawback to the use of these compounds in 
the investigation of physiological processes .
(ii) Cycloheximide .
Cycloheximide is a glutaramide antibiotic and inhibits protein 
synthesis at the level of translation . It is thought to inhibit 
both the initiation of protein synthesis and polypeptide chain 
elongation by interacting with the 60s riboscmal subunit ( Feshka 
1971 ) . In this present study cycloheximide was not found to 
adversely affect cell viability . One problem of using a protein 
synthesis inhibitor in studying hepatic monooxygenase activity is 
that the turnover of the proteinaceous components , e.g. 
cytochrome P450 , will be disrupted and so a decline in the levels 
of these components may be expected . This would result in 
decrease in the metabolising capacity of the hepatic 
monooxygenases . In studies utilising this agent , therefore , 
test samples were compared to controls which received 
cycloheximide alone thereby overcoming direct effects of
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cycloheximide perhaps due to disruption of enzyme turnover .
4.4(b) Identification of a multicomponent system .
(i) Effects of protein kinase inhibitors and cycloheximide .
As stated in the introduction , cyclic AMP is thought to 
produce most of its effects in the cell by activation of FKa . Hie 
inhibition of both the initial inhibitory effect and the later 
stimulatory effect of cyclic AMP upon enzyme activity in the 
presence of K-252a ( figure 23 ) and KT5720 ( figure 24 ) confirms 
both that cyclic AMP mediates these two effects by activation of a 
protein kinase and that the identity of the protein kinase appears 
to be PKa .
In the presence of KT5822 ( figure 27 ) the inhibitory and
stimulatory effects of cyclic AMP upon enzyme activity were
unaffected indicating that cyclic AMP does not produce any of its 
effects via activation of PKg .
In the presence of K-252b ( figure 25 ) the inhibitory effect
of 5 x 10"5 M cyclic AMP was completely inhibited and instead
slight stimulation of enzyme activity occurred . It appears , 
therefore , that the activation of PKc is necessary for cyclic 
AMP-mediated inhibition of steroid-metabolising enzymes at these 
physiological concentrations . This may indicate that the 
phosphorylation of PKa by PKc is necessary to activate PKa . This 
is unlikely , however , because cyclic AMP is not thought to 
directly activate PKc and it is more likely , therefore , that
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activation of PKc occurs secondary to activation of PKa by cyclic 
AMP . Another explanation may be that phosphorylation of proteins 
by both PKa and PKc is necessary for enzyme inhibition to occur . 
This is unlikely because activation of PKc by the phorbol ester , 
EMA , has been reported to inhibit the metabolism of 
androstenedicne to the same magnitude and over a similar time 
course as cyclic AMP-mediated inhibition ( Allan and Skett 1988) 
and the effects of FMA were unaffected by the presence of KT5720 
indicating that the inhibitory effects of PKc can occur 
independently of PKa activation ( C.J. Allan : personal 
catmunication ) . A more likely explanation is that the inhibitory 
effects of cyclic AMP are mediated by secondary activation of PKc 
by PKa and PKa has no direct inhibitory effects .
This interaction represents an unusual mode of intracellular 
regulation and the physiological implications of such an 
interactions will be discussed in more detail in section 4.10(b) .
As shown in figure 25 , in the presence of K-252b the weak 
initial inhibitory effects of 5 x 10-3M cyclic AMP were also 
inhibited indicating that PKc activation is also necessary for 
the inhibitory effects of high concentrations of cyclic AMP . The 
secondary stimulatory effects of 5 x 10" 3M upon steroid- 
metabolising enzymes , however , were of a similar magnitude to 
those produced in the absence of K-252b . The stimulatory effects 
of cyclic AMP , therefore , appear to occur independently of PKc 
activation . It is also apparent that when the PKc-dependent 
inhibitory effect is blocked by K-252b , concentration-dependent 
stimulation of enzyme activity occurs i.e. slight stimulation
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mediated by 5 x 10_5M cyclic AMP and narked stimulation mediated 
by 5 x 10_ 3 M cyclic AMP . This occurs at an earlier time point 
than the later stimulation produced in the presence of activated 
PKc and would be masked by the predominant inhibitory effect in 
the presence of activated PKc .
It appears , therefore , that both inhibition and stimulation 
occur at all concentrations of cyclic AMP but at low 
concentrations the predominant inhibitory effect masks the weak 
stimulatory effect whereas at high concentrations the predominant 
stimulatory effect masks the inhibitory effect .
As shown in figure 22 , cycloheximide blocks the stimulatory 
effects and enhances the inhibitory effects of all concentrations 
of cyclic AMP and this indicates that the stimulatory effects of 
all concentrations of cyclic AMP are mediated by increase in 
protein synthesis . Cycloheximide also blocked the early , 
concentration-dependent stimulatory effects of cyclic AMP , 
unmasked by inhibiting PKc activation with K-252b ( figure 26 ) , 
which indicates that these early stimulatory effects are also due 
to increase in protein synthesis . These results further imply 
that both inhibition and stimulation of steroid metabolism occur 
at all concentrations of cyclic AMP .
In the presence of both cycloheximide and K-252b , 5 x 10“5M 
cyclic AMP had no effect upon steroid metabolism which confirms 
the previous finding that activation of PKa by physiological 
concentrations of cyclic AMP has no direct inhibitory effects upon
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steroid metabolism . 5 x 10-3M Cyclic AMP , however , did mediate 
slight inhibition of steroid metabolism in the presence of 
cycloheximide and K-252b . This may be due to the high 
concentrations of cyclic AMP overcaning the inhibitory effects of 
K-252b . It has been reported , however , that PKa mediates 
inhibition of cytochnane P450-dependent monooxygenases in vitro 
( Pyerin et al 1983 ; Pyerin et al 1984 ) . It is possible , 
therefore , that another explanation for the inhibitory effects of 
5 x 10"3 M cyclic AMP in the presence of cycloheximide and K-252b 
is that these supraphysiological concentrations of cyclic AMP 
mediate seme inhibitory effects by a PKc-independent mechanism .
The finding that cycloheximide also blocks the stimulatory 
effects and prolongs and enhances the inhibitory effects of 
forskolin and a combination of forskolin and IEMX in intact 
hepatocytes , indicates that the stimulatory effects of these 
agents appear to be mediated by an increase in protein synthesis 
and the stimulatory effects of forskolin and a combination of 
forskolin and IEMX in intact hepatocytes appear to be mediated in 
an identical manner to those produced by high concentrations of 
cyclic AMP in electropermeabilised hepatocytes .
(iii) Components mediating the effects of physiological 
concentrations of cyclic AMP .
Low ( physiological ) concentrations of cyclic AMP ( 5 x 
10~ 5M ) , therefore , have a weak PKc-independent stimulatory
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effect upon protein synthesis which does not result in overall 
stimulation of enzyme activity due to the predominance of the 
inhibitory effect but does accelerate the recovery of the enzymes 
from inhibition . The weak stimulatory effects , however , can be 
unmasked by inhibiting the PKc-dependent inhibitory effects .
When the weak protein synthesis-dependent stimulation of enzyme 
activity , mediated by PKa in the absence of activated PKc , is 
inhibited by cycloheximide , PKa has no effect upon enzyme 
activity and this further illustrates that the inhibitory effects 
of physiological concentrations of cyclic AMP are mediated by 
indirect activation of PKc and PKa has no direct inhibitory 
effects .
The effects of physiological concentrations of cyclic AMP , 
therefore , appear to be mediated by two components (a) FKc- 
independent/protein synthesis-dependent stimulation and (b) FKc- 
dependent/protein synthesis-independent inhibition .
(iv) (^ proponents mediating the effects of supraphysiological 
concentrations of cyclic AMP .
High ( supraphysiological ) concentrations of cyclic AMP ( 5 
x 10" 3M ) have a much greater PKc-independent/protein synthesis- 
dependent stimulatory effect upon steroid-metabolising enzyme 
activity which masks the inhibitory effects . When protein 
synthesis is blocked by cycloheximide , inhibitory effects are 
unmasked . When PKc-dependent inhibition is blocked by K-252b and
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the protein synthesis-dependent effects of PKa are blocked by 
cycloheximide , PKa does appear to have sane PKc-independent 
inhibitory effects upon steroid-metabolising enzyme activity . Hie 
inhibitory effects unmasked by the presence of cycloheximide , 
therefore , may be mediated by a canbinaticn of PKc-dependent and 
PKc-independent mechanisms and this may indicate that PKa has a 
direct inhibitory effect upon steroid-metabolising enzymes at 
supraphysiological concent rat ions of cyclic AMP .
we have identified three components which contribute to the 
overall effects of supraphysiological concentrations of cyclic 
AMP , (a) PKc-independent/protein synthesis-dependent stimulation
(b) PKc-dependent /protein synthes is - independent inhibition and
(c) PKc- and protein synthesis-independent inhibition .
4.4(c) Conclusion to section 4.4 .
Using the selective protein kinase inhibitors and 
cycloheximide , we have shown that both physiological and 
supraphysiological concentrations of cyclic AMP mediate inhibitory 
and stimulatory effects upon steroid metabolism and that both of 
these effects appear to be mediated by cyclic AMP activation of 
PKa . The inhibitory effects of phys iological concentrations of 
cyclic AMP , however , do not appear to be mediated directly by 
PKa but may be due to secondary activation of PKc by PKa . 
Supraphysiological concentrations of cyclic AMP do appear to 
mediate seme inhibition of steroid metabolism by a PKc-independent
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mechanism which may indicate a direct effect of PKa at these 
concentrations . Inhibition of steroid metabolism by these 
supraphysiological concentrations of cyclic AMP , therefore , may 
be mediated by a combination of direct actions of PKa and indirect 
actions via secondary activation of PKc .
Stimulation of steroid metabolism occurs independently of PKc 
activation at all concentrations of cyclic AMP and is due to 
increase in protein synthesis .
4.5 MEDIATORS OF PROTEIN KINASE C-INDEPENDENT EFFECTS OF 
CYCLIC AMP .
Although the initial mediator of all of the separate effects 
of cyclic AMP is PKa , the exact nature of the mediator of PKc- 
independent effects is unclear . PKa is known to affect other 
intracellular pathways as documented in the Introduction ( section 
1.14(b) ) and the PKc-independent actions of cyclic AMP , 
therefore , could be mediated either by PKa directly or indirectly 
via alteration of the levels or activities of other intracellular 
mediators .
It is well documented that one of the effects of PKa 
activation is stimulation of calcium influx ( Mauger et al 1985 ; 
Staddon and Hansford ; Poggioli et al 1986 ) . The elevation of 
intracellular calcium , however , is unlikely to mediate the 
PKc-independent effects of PKa as the inhibitory effects of 
adrenaline were completely blocked by the presence of propranolol
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which blocks p2 receptor-mediated generation of cyclic AMP . This 
indicates that adrenaline-stimulated elevation of intracellular 
calcium levels does not mediate the inhibitory effects of 
adrenaline on steroid metabolism . It has also been reported that 
incubation of isolated rat hepatocytes with the calcium icncphore, 
A23187 , similarly has no effects upon the metabolism of 
androstenedicne ( Hussin et al 1988 ) .
PKa may alter the levels of other second messengers such as 
arachidonic acid and prostaglandins . The mechanism by which PKa 
may produce such effects , however , is unclear . The 
cyclooxygenase inhibitor , indcmethacin , has been reported to 
inhibit monooxygenase activity by mediating a selective loss of 
haem and one mechanism by which these effects may occur is by 
elevation of arachidonic acid levels which has also been reported 
to inhibit monooxygenase activity ( Burke et al 1983 ) . The 
inhibitory effects of another cyclooxygenase inhibitor , 
ibuprofen, upon hepatic monooxygenase activity , hcwever , are 
thought to be due to direct toxic effects upon cytochrome P450 
mediated by the drug itself and unrelated to its 
cyclooxygenase-inhibiting activity ( Reinicke and Klinger 1975 ) . 
Furthermore phenylbutazone is a known inducer of cytochrome P450 
and this effect is not related to its actions as a cyclooxygenase 
inhibitor ( Ccnney and Schneidman 1964 ) . In addition PKa has no 
known cyclooxygenase-inhibiting activity and so would be unlikely 
to be producing its effects by mediating a subsequent accumulation 
of intracellular arachidonic acid . It appears unlikely ,
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therefore , that alteration in the levels of arachidonic acid and 
prostaglandins would constitute a major PKa-mediated regulatory 
pathway .
It appears likely , therefore , that the PKc-independent 
effects of PKa are due to direct effects of PKa itself and 
subsequent results will be discussed in this context .
4.6 MECHANISMS OF ACTION ( PHYSIOLOGICAL CONCENTRATIONS OF 
CYCLIC AMP ) .
4.6(a) Effects upon cytochrome P450 levels .
One of the mechanisms by which physiological concentrations 
of cyclic AMP may mediate inhibitory effects is by decreasing 
levels of cytochrome P450 . The inhibitory effects of 5 x 10~5M 
cyclic AMP , however , were not accompanied by alteration in 
cytochrome P450 levels as determined by assessing whole cell 
cytochrome P450 levels ( table 8 ) . Furthermore we could detect 
no alteration in the levels of cytochrome P450 in the presence of 
cycloheximide or in the presence of K-252b . In addition , the 
inhibitory effects of 8-brcmo-cyclic AMP , adrenaline , IEMX , 
adrenaline in combination with IEMX , and forskolin in intact 
hepatocytes similarly did not appear to be mediated by alteration 
of cytochrome P450 assessed by the same assay procedure ( table 
7). One explanation may be that inhibitory effects are due to 
selective decrease in the levels of specific cytochrome P450
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isozymes fcut that the overall depletion of whole cell cytochrane 
P450 levels is negligible and undetectable by this assay 
procedure. This explanation seems unlikely due to the pronounced 
non-specific inhibitory effects of cyclic AMP upon steroid- 
metabolising enzymes . It is probable , therefore , that the 
inhibitory effects of cyclic AMP may be due , at least in part , 
to seme alternative mechanism of action which does not involve 
degradation of cytochrome P450 .
4.6(b) Effects upon phosphorylation of cytochrane P450 .
In 1983 , Pyerin et al reported that incubation of the 
purified rabbit liver cytochrane P450 , P450 IM2 / in a 
reconstituted membrane system , with the catalytic subunit of PKa 
resulted in phosphorylation of the cytochrane P450 . The identity 
of the phosphorylated residue has subsequently been shewn to be 
serine 128 ( Pyerin et al 1986a ) which is on the cytoplasmic side 
of the cytochrane P450 apoprotein ( Nelson and Strbbel 1988 ) and 
it has been proposed by Janssen et al ( 1987 ) that this residue 
may be at the site of interaction between cytochrane P450 and 
cytochrane bg ( section 1.3(b) ). Phosphorylation was shew to 
result in the conversion of the cytochrane P450 to the 
corresponding cytochrane P420 ( Taniguchi et al 1985 ) with a 
concomitant decrease in the metabolism of benzphetamine and 
7-ethoxycoumarin ( Pyerin et al 1984 ) .
In a later study ( 1987 ) Pyerin and co-workers reported that
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the phosphorylation of cytochrane P450 by PKa was not restricted 
to rabbit liver isozymes , but that PKa could also phosphorylate 
a number of rat liver cytochrane P450 isozymes . In the same 
study , these workers also examined the effects of incubating 
rabbit or rat liver cytochrane P450 isozymes with PKC and 
reported that many of these isozymes could also be phosphorylated 
by PKc . The susceptibility of each of the isozymes to 
phosphorylation by either PKa or PKc , however , varied . Rat 
cytochrane P450 PB-3a ( the major phenobarbitone-inducible 
isozyme : table 1 ) was reported to be phosphorylated by both PKa 
and PKc . Rat cytochrane P450 PB-3b ( phenobarbitone-inducible : 
table 1 ) was reported to be phosphorylated by PKa but not by PKC. 
Rat cytochromes P450 FB-2a ( steroid-16a-hydroxylase : table 1) 
and MC-la ( the major isosafrole-inducible isozyme : table 1 ) 
were reported to be phosphorylated by PKc but not by PKa . Rat 
cytochromes P450 MC-lb ( the major 3-met±ylcbolanthrene-inducible 
isozyme : table 1 ) and UT-1 ( steroid-7 a-hydroxylase : table 1 ) 
were reported to be refractory to phosphorylation by both PKa and 
PKc .
These reports Imply that phosphorylation of cytochrome P450 
by secondary activation of PKc by PKa may be a mechanism by which 
physiological concentrations of cyclic AMP may inhibit steroid 
metabolism in isolated rat hepatocytes .
To investigate if secondary activation of PKc by PKa mediated 
phosphorylation of cytochrome P450 , we examined the incorporation 
of 32P into cytochrome P450 PB-2a ( table 1 ) which is thought to
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mediate up to 90% of the hydroxylat ion of androstenedicne at the 
16a position ( Waxman 1984 ) ( section 1.5 ) . We were unable to 
detect any incorporation of 32P into irrrnunoprecipitated cytochrane 
P450 PB-2a either in control hepatocytes or in hepatocytes 
incubated for up to 1 hour with 5 x 10_5M cyclic AMP ( figure 33). 
Vfe also examined the incorporation of 32P into two other isozymes 
which represent the major cytochrane P450 isozymes induced by the 
two major classes of inducing agent ( section 1.9(a) ) .
Cytochrome P450 PB-3a is the major phenabarbitcne-inducible 
isozyme ( table 1 ) and cytochrome P450 MC-lb is the major 
polycyclic aromatic hydrocarbon-inducible isozyme ( table 1 ) . We 
waere unable to detect the incorporation of 32P into either of 
these isozymes following incubation of hepatocytes for up to 1 
hour vdth 5 x 10-5 M cyclic AMP and subsequent inmunoprecipitaticn 
with specific antibodies ( figure 33 ) .
The above findings may indicate that direct phosphorylation 
of cytochrome P450 isozymes is not a physiological effect . This 
proposed remains to be clarified , however , because although we 
were able to demonstrate that the phosphorylation of 
intracellular proteins occurred in the whole cell extract ( figure 
32 ) , we did not assess the cytochrome P450 content of the 
inmunoprecipitates . We cannot be certain , therefore , that the 
isolation of the specific cytochrome P450 isozymes by this method 
was successful . The presence of a large protein band of Mr 
45,000-50,000 , however , indicates that the inmunoprecipitaticn 
process has resulted in the isolation of a protein with similar
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molecular weight to cytochrane P450 . In addition , it has 
recently been reported that the imminoprecipitate contains haem 
(C.J. Allan : personal ccmnunication ) . Both of these findings 
imply that the iirmunoprecipitation of cytochrane P450 isozymes has 
been successful by the method used . Additional evidence also 
exists that implies that phosphorylation of cytochrane P450 may 
not be the underlying mechanism of cyclic AMP-mediated , 
PKc-dependent inhibition of steroid-metabolising enzymes :
(1) Cytochrane P450 17T-1 ( table 1 ) is thought to mediate , 
almost exclusively , the hydroxylation of androstenedicne at the 
7a position ( Waxman et al 1987 ; Nagata et al 1986 ) ( section 
1.5 ) and Pyerin et al ( 1987 ) reported that this isozyme was 
refractory to phosphoryaticn by both PKa and PKc . We have 
previously reported , however , that both 5 x 10~5M cyclic AMP 
and agents acting physiologically to elevate cyclic AMP in intact 
cells have a marked inhibitory effect upcn the activity of this 
enzyme .
(2) We have reported that the activities of 5a-reductase and 
17a/p hydroxysteroid dehydrogenase are also inhibited following 
Incubation with physiological concentrations of cyclic AMP .
These enzymes do not contain cytochrane P450 ( Golf and Graef 
1978 ) ( section 1.5 ) and so inhibition cannot be attributed to 
phosphorylation of cytochrane P450 .
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(3) Taniguchi et al ( 1985 ) reported that phosphorylation of 
cytochrome P450 resulted in its conversion to cytochrome P420 .
As discussed previously ( section 4.6(a) ) , however , we were 
unable to detect any increase in the levels of cytochrome P420 
when we assessed whole cell cytochrome P450 levels nor were we 
able to detect any decrease in cytochrome P450 levels which would 
be the ultimate result of the conversion of cytochrome P450 to 
cytochrome P420 and its rapid degradation by haem oxygenase 
(Maines and Anders 1973b ; Kutty et al 1988 ) ( section 1.8(b) ) .
One of the mechanism by which cyclic AMP may be producing its 
effects is by depletion of the cofactors for the electron 
transport chain of hepatic monooxygenases . Homogenisation of 
hepatocytes following incubation with 8-brano-cyclic AMP and the 
readdition of excess cofactors using a NADFH-generating system , 
however , had no effect upon the 8-brano-cyclic AMP-mediated 
inhibition of steroid metabolism ( figure 11 ) . This indicates 
that the inhibitory effects of cyclic AMP at physiological 
concentrations are not due to depletion of cofactors .
The possibility exists that the phosphorylation of other 
enzymes in the electron transport chain of hepatic monooxygenases 
may mediate cyclic AMP-mediated , PKc-dependent Inhibition of 
enzyme activity . In this context both NADFH-cytochrcme P450 
reductase and NAEH-cytochrcme bs reductase have been reported to 
be weak substrates for phosphorylation by PKc although cytochrome 
bs appears to be a very poor substrate for PKc ( Pyerin et al
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1987 ) .
Phosphorylation of these additional components may explain 
the cyclic AMP-mediated inhibition of 5a reductase which although 
a ncn-cytochrctne P45 O-dependent enzyme , is the terminal enzyme 
of an electron transport chain which exhibits many similarities 
to the cytochrome P450 monooxygenases ( Golf and Graef 1978 )
( section 1.5 ) .
Another mechanism by which cyclic AMP may mediate enzyme 
inhibition is by activation of phosphatases which have been shown 
to mediate inhibition of cytochrome P450 monooxygenases in a 
reconstituted system ( Pyerin et al 1986b ) . This effect appears 
to be mediated at the level of NADFH-cytochrcme P450 reductase 
and may be due to the conversion of FMN to riboflavin ( Taniguchi 
and Pyerin 1987 ) . This would result in disruption of the trans­
fer of electrons from the reductase to the cytochrome P450 
(Backes and Reker-Backes 1988 ; Iyanagi et al 1981 ; Vermilion et 
al 1981 ) ( section 1.2(d) ) and subsequent inhibition of the 
activity of the enzyme .
One of the mechanism by which phosphatase activation may 
occur is by PKa-mediated elevation of intracellular calciun levels 
( Aitkin et al 1984 ; Tcnks and Cohen 1983 ) . This does not 
explain the dependence of inhibition of steroid metabolism upon 
PKc activation , however , and PKc has not been reported to have 
any effect upon intracellular calcium levels . In addition , as 
stated previously ( section 4.8 ) , agents which directly elevate 
intracellular calcium levels ( A23187 and adrenaline acting at ax
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receptors ) have been reported to be without effect upon 
steroid-metabolising enzymes . This suggests that the activation 
of phosphatases by secondary elevation of calcium is unlikely to 
mediate the inhibitory effects of cyclic AMP .
More recently Yang et al ( 1987 ) have reported the existence 
of a directly-acting activator of the membrane-bound protein 
phosphatase-1 in the liver which appears to be a membrane-bound 
protein kinase and has been termed Fa . The endogenous ligand for 
Fa was not elucidated by Yang and co-workers but it is possible 
that activation of Fa may be a mechanism by which PKa-mediated 
activation of PKc may directly activate protein phosphatase-1 
independently of any alteration in the levels of cytosolic free 
calcium . Alternatively , PKc may directly phosphorylate protein 
phosphatase-1 in an analogous manner to Fa .
4.6(c) Conclusion to section 4.6 .
In this present study we have been able to shew that the 
inhibition of steroid-metabolising enzymes mediated by 
physiological concentrations of cyclic AMP do not appear to be 
mediated by changes in the levels of whole cell cytochrome P450 , 
direct phosphorylaticn of cytochrome P450 or by depletion of 
cofactors for the electron transport chain . The precise cellular 
mechanisms of cyclic AMP-mediated effects , therefore , still 
remains to be clarified but they may involve some reversible 
inactivation of the enzyme complex .
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4.7 MECHANISMS OF ACTION ( SUPRAFHYSIOLOGICAL (XNCENTRATICNS
OF CYCLIC AMP ) .
4.7 (a) Effects upcn. cytochrane P450 levels .
As stated in the previous section , one of the mechanisms by 
which supraphysiological concentrations of cyclic AMP ( 5 x 10~3M) 
may mediate their effects upon steroid-metabolising enzyme 
activity is by altering levels of cytochrane P450 . The effects 
of 5 x 10-3M cyclic AMP and the effects of the canpcnents which 
have been postulated to mediate the overall effects of 5 x 10~3M 
cyclic AMP upon both steroid-metabolising enzyme activity ( 7a 
hydroxylase ) and whole cell cytochrane P450 are illustrated in 
figure 34 . This figure is composed of the results previously 
illustrated in figures 20 ( panel c ) ; 22 ( panel c ) ; 25 
(panel b ) ; 26 ( panel b ) ; 29 ; 30 and 31 and is included to 
illustrate more clearly the effects of the different components 
in producing the overall response to high concentrations of 
cyclic AMP .
(i) Effects of cyclic AMP .
Measurement of the whole cell cytochrome P450 levels following
incubation with both 5 x 10“ 3M cyclic AMP in electropermeabilised 
hepatocytes and a combination of forskolin and IEMX in intact 
hepatocytes , indicated that the protein synthesis-dependent
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Figure 34 : Changes in steroid metabolism ( 7a-hydroxylase activity ) and 
cytochrane P450 levels with time in electropermeabilised hepatocytes 
following addition of 5 X 10-3M cyclic AMP ( ) , 5 X 10-3M cyclic AMP and
cycloheximide ( 10"5M )(•»•), 5 X 10"3M cyclic AMP and K-252b ( 2 X 10“8M) 
(*o* ) and 5 X 10~ 3M cyclic AMP with a combination of cycloheximide and 
K-252b(-A- ) . Results are expressed as percentage of relevant control ± S.D. 
for at least 4 different cell samples . Control activities and cytochrane 
P-450 levels at all time points are as listed previously ( figures : 20 , 22, 
25, 26 , 29 , 30 , and 31 ) .
stimulatory effects upon steroid metabolism are due , at least in 
part , to induction of cytochrane P450 .
The hypothesis that the induction of cytochrane P450 is 
mediated by cyclic AMP activation of PKa was confirmed by the fact 
that cyclic AMP-mediated increase in cytochrane P450 levels was 
inhibited by the presence of the PKa blocker , KT5720 ( table 10). 
The percentage increase in the levels of whole cell cytochrane 
P450 , however , was not as great as the stimulatory effects of 
high concentrations of cyclic AMP upon steroid metabolism . This 
may be due to the induction of other protein factors which act in 
a stimulatory manner upon steroid-metabolising enzymes . It is 
more probable , however , that cyclic AMP is acting in a selective 
manner to induce steroid-metabolising cytochrane P450 isozymes but 
having little effect upon other constitutive cytochrane P450 
isozymes and the overall increase in whole cell cytochrane P450 
does not reflect this selective induction .
The development of specific antibodies raised against 
individual cytochrane P450 isozymes should help to clarify this 
matter using the technique of Western blotting and will give a 
clearer indication of the induction profile of high concentrations 
of cyclic AMP .
(ii) Effects of cyclic AMP in the presence of cycloheximide .
In the presence of cycloheximide , supraphysiological 
concentrations of cyclic AMP ( 5 x 10_3M ) mediated a marked 
decrease in the levels of whole cell cytochrane P450 . The
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inhibitory effects of these concentrations of cyclic AMP upon 
steroid metabolism , therefore , appear to be due , at least in 
part , to degradation of cytochrome P450 . This differs markedly 
from the inhibitory effects of physiological concentrations of 
cyclic AMP which did not appear to be mediated by degradation of 
cytochrane P450 and were postulated to be due to seme reversible 
inhibitory effect upon steroid-metabolising enzymes ( section 
4.9). The percentage decrease in whole cell cytochrome P450 
levels is not as great as its effects upon steroid-metabolising 
enzymes . This may indicate that cyclic AMP has a selective 
degradative effect upon sane cytochrane P450 isozymes which is not 
detected by determining whole cell cytochrane P450 content . It is 
more likely , however , that , in addition to degradation of 
cytochrane P450 , the non-degraded cytochrane P450 is further 
inactivated by the same mechanisms postulated to mediate 
physiological inhibition of enzyme activity ( section 4.9 ) .
It seems probable , therefore , that at least two mechanisms 
mediate the inhibitory effects of cyclic AMP upon cytochrome P450 
monooxygenases (a) inactivation of cytochrome P450 by a direct or 
indirect mechanism which occurs at all concentrations of cyclic 
AMP and (b) degradation of cytochrome P450 which occurs at high 
concentrations of cyclic AMP .
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(iii) Effects of cyclic AMP in the presence of a examination
of cycloheximide and K-252b .
In the presence of both cycloheximide and K-252b , the 
degradative effects of supraphys iological concentrations of cyclic 
AMP were weaker than in the presence of cycloheximide alone . This 
indicates that secondary activation of PKc by PKa mediates at 
least seme of the degradative effects of cyclic AMP at these 
concentrations . The levels of cytochrane P450 were still 
decreased over the whole time course of ^ to 2 hours , however , 
although to a lesser degree than in the presence of PKc , and it 
appears , therefore , that the degradative effects of 
pharmacological concentrations of cyclic AMP upon cytochrane P450 
are mediated by a combination of direct degradation by PKa and 
indirect degradation due to secondary activation of PKc .
These findings correlate with the inhibitory effects of 
supraphys iological concentrations of cyclic AMP upon steroid- 
metabolising enzyme activity which were also proposed to be 
mediated by a combination of PKa and PKc ( section 4.8 ) .
(iv) Effects of cyclic AMP in the presence of K-252b .
In section 4.4(b) it was shewn that in the absence of 
activated PKc , activation of PKa by supraphys iological 
concentrations of cyclic AMP mediated marked stimulation of 
steroid metabolising enzyme activity . When the effects of 
supraphys iological concentrations of cyclic AMP upon cytochrane
- 220-
P450 levels were examined in the presence of K-252b to inhibit the 
secondary activation of PKc , however , we were unable to detect 
any corresponding increase in the levels of whole cell cytochrane 
P450 . This may imply that the early protein synthesis-dependent 
stimulatory effects of PKa upon steroid-metabolising enzymes are 
not due to synthesis of cytochrome P450 . This differs from the 
mechanism proposed to mediate the later stimulatory effects of 
high concentrations of cyclic AMP upon steroid metabolism in the 
control cyclic AMP time course ( as discussed in section 
4.7(a)(i)).
The ability of PKa to stimulate protein synthesis , however , 
did delay the PKa-mediated degradation of cytochrane P450 which 
occurred when protein synthesis was blocked by the presence of 
cycloheximide . Thus , as shown in figure 34 , following an 
incubation period of £ hour with 5 x 10- 3M cyclic AMP in the 
presence of K-252b , the levels of cytochrane P450 did not differ 
significantly from corresponding controls . When cycloheximide was 
included , however , ( as discussed in section 4.7(a)(ii) ) 
cytochrane P450 levels were decreased to 84% of corresponding 
controls following an identical time period . The difference 
between these two levels is due to PKa-mediated protein synthesis. 
The time course of the early stimulatory effects upon steroid 
metabolism correlates well with the delay of PKa-mediated 
degradation of cytochrane P450 . It is possible , therefore , that 
the direct degradative effects of PKa are relatively non-specific 
for cytochrome P450 isozymes whereas its inductive effects are 
relatively specific for steroid-metabolising cytochrane P450
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isozymes and so no overall increase in the whole cell cytochrane 
P450 levels occurs over this early time period .
This was also thought to be a likely explanation for the 
discrepancy between steroid-metabolising enzyme activity and 
cytochrane P450 levels in the control cyclic AMP time course 
( section 4.7(a)(i) ) .
(v) Components mediating the effects of supraphysiological 
conoentraticns of cyclic AMP upon cytochrome P450 levels.
In section 4.4 it was postulated that the effects of high 
concentrations of cyclic AMP upon steroid-metabolising enzyme 
activity were mediated by a number of separate components and the 
sum of the effects of these components at any one time determined 
the overall effect upon enzyme activity .
We have subsequently shown that the overall effects of cyclic 
AMP upon the cytochrane P45O-dependent steroid-metabolising 
enzymes and the separate components which determine the overall 
effect are due , at least in part , to alterations in the levels 
of cytochrome P450 .
Using the PKc inhibitor , K-252b , and cycloheximide we have 
identified three of these components , namely , (a) PKa-mediated, 
protein synthes is-dependent induction of cytochrane P450 and 
concomitant stimulation of steroid metabolism , (b) PKa-mediated, 
protein synthesis-independent degradation of cytochrome P450 
and concomitant inhibition of steroid metabolism and (c) FKc- 
mediated , protein synthesis-independent degradation of cytochrome
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P450 and concomitant inhibition of steroid metabolism.
4.7(b) Proposed mechanisms mediating the effects of cyclic AMP 
upon cytochrane P450 levels .
(i) Induction .
The PKa-mediated , protein synthesis-dependent stimulatory 
effects upon steroid-metabolising enzyme activities have been 
proposed to be due to selective Increase in the levels of steroid 
metabolising cytochrome P450 isozymes . One of the mechanisms by 
which this may occur is by PKa-mediated phosphorylation of acidic 
nuclear proteins ( Johnson and Allfrey 1972 ) . This is thought 
to stimulate gene transcription as correlation exists between 
the decrease in the binding of these proteins to specific 
initiation sites when phosphorylated by PKa and the subsequent 
enhancement of messenger RNA synthesis ( Teng et al 1971 ) . In 
addition , increase in messenger RNA has been reported to occur in 
the liver 1 hour following the "in vivo" administration of cyclic 
AMP ( Ddkas and Kleinsmith 1971 ) . It is interesting to note that 
phenbbarbitcne , which has been reported to elevate cyclic AMP 
levels and/or activate PKa ( Byus et al 1976 ) , has also been 
reported to increase the phosphorylation states of acidic nuclear 
proteins ( Blankenship and Bresnick 1974 ) .
It has been proposed that an alternative mechanism by which 
phenbbarbitone and 3-methylcholanthrene may mediate induction is 
by stabilisation of seme extranuclear event which occurs beyond
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the level of gene transcription ( Iversen et al 1987 ) perhaps by 
stabilising messenger RNA or by stimulating messenger RNA 
translation at the level of the ribosome . Although Dokas and 
Kleinsmith ( 1971 ) noted an increase in the levels of messenger 
RNAs in the liver following injection of cyclic AMP , as we have 
previously discussed ( section 4.5 ) , cyclic AMP penetration of 
the intact plasma membrane is very poor and cyclic AMP which does 
penetrate the plasma membrane will be rapidly degraded by cyclic 
AMP phosphodiesterases ( Beebe et al 1986 ) . The mechanism by 
which cyclic AMP may mediate this elevation of messenger RNA 
levels in the liver , therefore , is unknown . It is possible , 
therefore , that the inductive effects of PKa upon cytochrane P450 
levels may be mediated , at least in part , by stabilisation of 
post-transcriptional events in an analogous manner to the effects 
reported for phenobarbitcne and 3-methylcholanthrene .
Using cycloheximide , which blocks the translation of 
messenger RNA at the level of the ribosomes ( Peshka 1971 ) , we 
were unable to determine if the increase in the levels of 
steroid-metabolising cytochrane P450 isozymes was due to an 
increase in gene transcription or due to extranuclear effects .
The development of complementary ENA probes for cytochrane 
P450 genes and Northern blotting will allow the effects of cyclic 
AMP upon the levels of messenger RNA corresponding to the isozymes 
which are induced by cyclic AMP , to be determined , and so will 
give an indication of whether the effects of cyclic AMP are 
mediated by an increase in gene transcription or by stabilisation 
of post-transcriptional events .
-224-
Other workers , in attempting to elucidate the mechanisms 
by which the classic inducing agents mediate their effects , have 
proposed that induction of apoprotein occurs secondary to 
induction of ALA-synthase . The subsequent elevation of haem 
levels in the cytosolic haem pool has been postulated to induce 
cytochrane P450 apoproteins ( Ewarki et al 1987 ; Satyabhama et al 
1986 ; Jayarama-Bhat and Padmanaban 1988 ; ) ( section 1.9(c) ) . 
The possibility exists , therefore , that the inductive effects of 
PKa upon cytochrane P450 apoprotein synthesis are not mediated 
directly by PKa but that induction of cytochrome P450 occurs 
secondary to the induction of ALA-synthase as has been proposed 
for the classic inducing agents above .
The possibility that the effects of cyclic AMP cure mediated
secondary to induction of ALA-synthase may be evaluated by using 
cobalt chloride which inhibits ALA-synthase as one of its actions
( Drunmond and Kappas 1982 ) ( section 1.10(c) ) .
(ii) Degradation .
The mechanisms of the degradative effects of PKa and PKc upon 
cytochrome P450 isozymes are unknown .
We did not determine the effects of supraphysiological 
concentrations of cyclic AMP ( 5 x 10'3 M ) upon the 
phosphorylation states of cytochrane P450 isozymes because cyclic 
AMP-mediated alteration of the levels of the cytochrane P450
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isozymes would have made comparison between control and treated 
groups difficult due to the limitations of the assay procedure 
used . This problem may be overcome in future studies by 
qualitative assessment of the levels of individual cytochrome P450 
isozymes by Western blotting . Any increase in the phosphorylation 
of the cytochrome P450 isozyme mediated by supraphys iological 
concentrations of cyclic AMP may , therefore , be correlated to 
the level of that particular isozyme .
It is conceivable that although we did not detect any 
increase in the phosphorylation of cytochrane P450-2a ( table 1 ) 
mediated by physiological concentrations of cyclic AMP ( section 
4.9 ) , phosphorylation may occur at these high concentrations of 
cyclic AMP . The subsequent conversion of cytochrome P450 to the 
corresponding cytochrome P420 ( Taniguchi et al 1985 ) and 
degradation by haem oxygenase ( Maines and Anders 1973b ; Kutty et 
sd 1988 ) may , therefore , be the underlying mechanism mediating 
degradation of cytochrane P450 . It has been reported , however , 
that haem oxygenase is located predominantly in the 
reticuloendothelial cells of the liver ( Guengerich 1977 ) and 
although carrier proteins have been postulated to convey 
cytochrane P450 ( or the corresponding cytochrome P420 ) to the 
site of haem oxygenase in the intact liver ( Maines and Anders 
1973b ) this cannot occur in the isolated rat hepatocyte model 
which we have utilised in our studies .
Another mechanism which has been postulated to mediate 
degradation of cytochrome P450 and which does not rely on the
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postulated transportation of cytochrane P450/P420 to the 
reticuloendothelial cells , is by an increase in lipid 
peroxidation ( Schacter et al 1973 ) . Lipid peroxidation is 
mediated by NADFH-cytochrane P450 reductase in the presence of 
NADFH and molecular oxygen . Subsequent increase in the generation 
of hydrogen peroxide in the vicinity of the haem mediates lipid 
peroxidation and degradation of cytochrane P450 ( Guengerich 1977) 
( section 1.8(c) ) . This is the mechanism by which carbon 
tetrachloride has been postulated to mediate its degradative 
effects upon cytochrome P450 ( Davies et al 1985 ) . In addition , 
3-methylcholanthrene , which has been postulated to mediate its 
inductive effects upon cytochrane P450 by elevation of cyclic AMP 
( Byus et al 1976 ) , also mediates degradation of cytochrome P450 
by uncoupling the components of the electron transport chain which 
results in the accumulation of hydrogen peroxide ( De Mattheis 
1988 ) . PKa- and PKc-mediated degradation of cytochrome P450 , 
therefore , m y  also be due to increase in lipid peroxidation 
perhaps by uncoupling the electron transport chain and subsequent 
increase in hydrogen peroxide generation .
It is possible that phosphorylation of additional components 
of the cytochrane P450 electron transport chain e.g. NADFH- 
cytochrane P450 reductase , which has been reported to be weakly 
phosphorylated by both PKa ( Pyerin et al 1983 ) and PKc ( Pyerin 
et al 1987 ) , m y  lead to uncoupling of the electron transport 
chain , an increase in the production of hydrogen peroxide and 
degradation in this manner .
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Cyclic AMP has also been postulated to mediate the effects of 
glucagon upon cellular autophagy i.e. lysosanal breakdown of 
intracellular proteins by proteolytic enzymes ( Ballard 1980 ) . 
Phenobarbitcne has been postulated to mediate its inductive 
effects upon cytochrane P450 isozymes by elevation of cyclic AMP 
( Byus et ed 1976 ) and has also been reported to increase 
cellular autophagy . This effect has been proposed to mediate the 
rapid removal of the induced proteins following cessation of 
phenobarbitcne treatment ( Bolender and Weibel 1973 ) . Increase 
in the proteolytic breakdown of cytochrane P450 apoprotein , 
therefore , m y  be an alternative mechanism by which PKa and PKc 
m y  mediate the degradative effects of cyclic AMP . The effects of 
glucagon upon cellular autophagy , however , occur at 
physiological concentrations ( Ballard 1980 ) and as discussed in 
section 4.6(a) , physiological concentrations of cyclic AMP do not 
appear to mediate any detectable degradation of cytochrane P450 . 
It seems unlikely , therefore , that an increase in the 
proteolytic breakdown of cytochrane P450 apoprotein would be a 
"first line" mechanism of PKa- and PKc-mediated degradation . It 
is conceivable , however , that sane other mechanism of action of 
these supraphys iological concentrations of cyclic AMP m y  mediate 
a conformational change in the cytochrane P450 molecule which does 
not occur at physiological concentrations and which results in an 
increase in the susceptibility of the apoprotein to proteolytic 
breakdown . This effect has been reported for 
2dlylisopropylacetamide- and 3,5-dicarbethoxy-2,6-dimethyl 
-4-ethyl-l, 4-dihydropyridine-mediated degradation of cytochrane
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P450p ( Bomheim et al 1987 ; Correia et al 1987 ) ( section 
1.10(a) ) and is thought to occur subsequent to breakdown of haem 
by either haem oxygenase or lipid peroxidation in the 
physiological situation ( Abraham et al 1988 ) ( section 1.8(c) ).
The assay procedure used to determine the whole cell content 
of cytochrome P450 did not enable us to determine if the 
degradation of cytochrome P450 was due to the proteolytic 
breakdown of the cytochrome P450 apoprotein or due to loss of haem 
from the apoprotein active site . The possible role of proteolytic 
breakdown of the apoprotein in the PKa- and PKc-mediated 
degradation of cytochrome P450 , therefore , remains to be 
elucidated .
4.7(c) Conclusion to section 4.7
Measurement of whole cell cytochrome P450 levels has shown 
that the effects of supraphys iological concentrations of cyclic 
AMP and the components which determine the overall effect are 
mediated , at least in part , by alteration in the levels of 
cytochrome P450 . It is proposed that the inductive effects of 
cyclic AMP are mediated directly by PKa and are relatively 
specific for steroid-metabolising cytochrome P450 isozymes . The 
degradative effects of supraphys iological concentrations of cyclic 
AMP appear to be less specific than the inductive effects and are 
mediated by a combination of PKa acting directly and secondary 
activation of PKc .
In addition to degradation of cytochrane P450 , cytochrome
-229-
P450 may also be inactivated by the same mechanism that mediates 
the inhibitory effects of physiological concentrations of cyclic 
AMP. The overall inhibitory effects of supraphys iological 
concentrations of cyclic AMP upon steroid metabolism , therefore , 
may be due to both degradation and reversible inactivation of 
cytochrane P450 .
The precise cellular mechanisms by which cyclic AMP mediates 
induction and degradation of cytochrome P450 have not been 
elucidated by this study .
4.8 OTHER POSSIBLE CCMPCNENTS MEDIATING THE EFFECTS OF 
SUPRAPHYSIOLOGICAL OCNCENTRATICNS OF CYCLIC AMP .
It has been shown in previous sections that the effects of 
physiological concentrations of cyclic AMP upon steroid 
metabolising enzymes occur as a result of two canpcnents , namely,
(a) PKa-mediated , protein synthesis-dependent stimulation and
(b) PKc-mediated , protein synthesis-independent inhibition . The 
overall effect upon steroid metabolism appears to reflect the 
changes in the relative magnitudes of these two components with 
time .
We have also identified three canpcnents of the effects of 
supraphys iological concentrations of cyclic AMP upon steroid- 
metabolising enzymes . The overall effect of cyclic AMP and the 
separate components all reflect , at least in part , changes in 
the levels of whole cell cytochrane P450 and the three components 
are (a) PKa-mediated , protein synthesis-dependent induction and
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concomitant stimulation of steroid metabolism , (b) PKa-mediated 
/ protein synthesis-independent degradation of cytochrane P450 
and concomitant inhibition of steroid metabolism and (c) PKc- 
mediated , protein synthesis-independent degradation of cytochrane 
P450 and concomitant inhibition of steroid metabolism . It is 
apparent from figure 34 , however , that the overall effects of 
supraphysiological concentrations of cyclic AMP upon both steroid 
metabolism and cytochrane P450 levels do not appear to be fully 
explained numerically by these three components and this m y  Imply 
that one or more , as yet unidentified , components are necessary 
to explain the overall effect .
One possible discrepancy which arises when assessing the 
effects of supraphys iological concentrations of cyclic AMP upon 
steroid-metabolising enzyme activity is that the early PKa- 
mediated , protein synthesis-dependent stimulation of enzyme 
activity , unmasked by inhibiting PKc activation with K-252b , is 
of too transient a duration to account for the pronounced 
secondary stimulatory effects of 5 x 10'3M cyclic AMP in the 
control cyclic AMP time course . This discrepancy is more apparent 
when assessing effects upon cytochrane P450 levels and the 
PKa-mediated , protein-synthesis-dependent induction of cytochrome 
P450 is too weak to mediate any overall increase in whole cell 
cytochrome P450 levels whereas 5 x 10“ 3M cyclic AMP mediates a 
marked increase in the levels of cytochrome P450 in the control 
cyclic AMP time course .
It is possible that this discrepancy may be due either to
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another unidentified component , which we propose to be PKc- and 
protein synthesis-dependent , mediating the secondary stimulatory 
effects , or that the PKa-mediated , protein synthesis-dependent 
stimulatory effects upon steroid metabolism are prematurely 
terminated in the presence of K-252b .
As discussed previously , phenbbarbitone has been reported to 
stimulate cellular autophagy and one of the mechanism by which 
phenobarbitcne has been postulated to produce this effect is by 
mediating general proliferation of liver membranes and then this 
increase in membrane proteins triggers cellular autophagy 
(Bolender and Weibel 1973 ) . The effects of phenbbarbitone upon 
cellular autophagy , therefore , appear not to be due to a direct 
effect of phenobarbitcne itself but to be due to sane secondary 
cellular event . Cyclic AMP has been reported to mediate the 
autophagic effects of glucagon ( Ballard 1980 ) and to mediate 
the effects of phenobarbitcne upon cytochrome P450 isozymes 
(Byus et al 1976 ) and it may be that when cyclic AMP-mediated 
inhibition of enzyme activity is partially blocked by the presence 
of K-252b the early increase in steroid-metabolising enzyme 
activity , which we have postulated to be due to early induction 
of cytochrome P450 , triggers cellular autophagy in an analogous 
manner to phenbbarbitone . This increase in cellular autophagy may 
result in premature termination of the increase in steroid- 
metabolising enzyme activity due to proteolytic breakdown of 
cytochrome P450 . We proposed in section 4.7(a)(iv) , however , 
that these early stimulatory effects of cyclic AMP , unmasked by
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inhibition of the FKc-mediated inhibitory effects are due to 
selective induction of steroid-metabolising cytochrane P450 
isozymes and we could not detect any increase in whole cell 
cytochrane P450 levels which correlated with the early stimulation 
of enzyme activity . It seems unlikely , therefore , that the 
premature termination of enzyme activity occurs as a result of 
selective increase in the levels of steroid-metabolising 
cytochrane P450 isozymes triggering cellular autophagy .
The possibility exists that the secondary stimulatory effects 
of supraphysiological concentrations of cyclic AMP upon cytochrane 
P450 levels and subsequent stimulation of steroid-metabolising 
enzyme activity are due to another component which is PKc- and 
protein synthes is-dependent and may be due to FKc-mediated 
stimulation of gene transcription or extranuclear effect in an 
analogous manner to that proposed for PKa ( section 4.7(b)(i) ) . 
However , although Allan and Skett ( 1988 ) reported that direct 
activation of PKc by FMA and 1,2-dioleoylglycerol mediated 
inhibition of steroid-metabolising enzyme activity , they did not 
report any secondary stimulatory effects upon enzyme activity . In 
addition , Hussin et al ( 1988 ) examined the effects of a range 
of concentrations of glucagon and TH-glucagon upon 
steroid-metabolising enzyme activity in isolated rat hepatocytes 
and showed that physiological concentrations of glucagon inhibited 
enzyme activity but that this effect of glucagon was lost at 
supraphysiological concentrations . TH-glucagon had an analogous 
inhibitory effect upon enzyme activity at concentrations
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corresponding to physiological concentrations of glucagon but this 
effect was not diminished as the concentration increased . As 
TH-glucagon stimulates hydrolysis of inositol phospholipids but 
has no effect upon cyclic AMP generation , it was postulated that 
glucagon mediates its inhibitory effects upon steroid metabolism 
by stimulation of PIP2 hydrolysis and subsequent PKc activation . 
The results of this present study suggest that the loss of enzyme 
inhibition at supraphysiological concentrations of glucagon are 
due to the high concentrations of cyclic AMP generated by the 
glucagon mediating stimulatory effects upon steroid metabolism 
which opposes the inhibitory effects . The absence of this effect 
in the TH-glucagon treated cells implies that PKc activation does 
not mediate any stimulatory effects upon steroid-metabolising 
enzyme activity even at these very high concentrations .
These results imply that PKc alone is unable to mediate the 
secondary stimulatory effects of cyclic AMP upon steroid- 
metabolising enzymes . They may indicate , however , that both 
PKa and PKc are necessary for the sustained stimulatory effects 
upon steroid-metabolising enzymes and correspondingly upon the 
induction of cytochrome P450 and that neither of these protein 
kinases is capable of mediating sustained induction by itself .
It may be possible to differentiate between these two 
postulated mechanisms by comparing the time course of the effect 
of cyclic AMP in the presence of K-252b upon protein synthesis 
with the time course of the effect of the same combination on 
cytochrome P450 levels . If the time course of the effect of
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cyclic AMP upon messenger KNAs are also prematurely terminated in 
the presence of K-252b this would imply that PKc activation is 
necessary for sustained induction of cytochrome P450 . However , 
if the effect of cyclic AMP upon messenger RNA remains stable 
throughout the time course whilst the effects of cyclic AMP upon 
cytochrome P450 levels are suppressed then this would imply that 
seme additional effect , not involving termination of protein 
synthesis , was mediating isozyme degradation perhaps mediated by 
an increase in proteolysis .
4.9 CYTOCHRCME P45O-INDEPENDENT ENZYMES .
The mechanisms of action of the separate components proposed 
to mediate the actions of supraphys iological concentrations of 
cyclic AMP upon steroid-metabolising enzyme activity , have been 
examined and discussed only with regards to cytochrome 
P450-dependent enzymes . The mechanisms which mediate the 
analogous effects of supraphysiological concentrations of cyclic 
AMP upon the activities of the ncn-cytochrane P45O-dependent 
enzymes , 5a reductase and 17a/p hydroxysteroid dehydrogenase , 
have not been examined . The mechanism of action of cyclic AMP 
control over the activities of these enzymes and the possibility 
that the activities of these enzymes also reflect changes in the 
levels of constitutive enzymes , therefore , have not been 
elucidated .
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4.10 PHYSIOLOGICAL IMPLICATIONS .
4.10(a) Hormonal control of hepatic monooxygenase activity .
We have shewn in this study that physiological concentrations 
of cyclic AMP have a concentration-dependent inhibitory effect 
upon hepatic monooxygenases in isolated rat hepatocytes . The in 
vivo inhibitory effects of adrenaline ( Pouts 1962 ; Kato and 
Gillette 1965a ) ( section 1.11(1) ) , glucagon ( Weiner et al 
1972a ) ( section l.ll(k) ) and thyroxine ( Kato and Gillette 
1965a ; Kato et al 1970 ) ( section 1.11(h) ) , therefore , are 
all likely to be mediated , at least in part , by elevation of 
hepatic cyclic AMP levels either by direct receptor-mediated 
mechanisms in the case of adrenaline ( Exton et al 1971 ) ( 
section 1.16(b) ) and glucagon ( Exton et al 1971 ) ( section 
1.16(c) ) or by indirectly altering the sensitivity of the 
hepatocytes to the cyclic AMP-elevating effects of glucagon and 
catecholamines in the case of thyroxine ( Muller and Seitz 1987 )
( section 1.16(g) ) . Similarly the hormone deficiency states , 
diabetes ( Kato and Gillette 1965a ; Kato et al 1971 ; Weiner et 
al 1972 ; Reinke et al 1978 ) ( section l.ll(i) ) and 
adrenalectomy ( Kato and Gillette 1965a ; Kato et al 1971 ) 
(section l.ll(j) ) , may also mediate inhibitory effects upon 
hepatic monooxygenases by elevating hepatic cyclic AMP levels . 
This occurs by derepression of the inhibitory effects of their 
respective hormones upon either intracellular cyclic AMP levels 
and effects in the case of diabetes ( Heyworth et al 1985 ;
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O'Brien et al 1987 ; Malchoff et al 1987 ; Thanas et al 1985 ) 
(section 1.16(d) ) or p2 adrenergic receptor responsiveness in the 
case of adrenalectomy ( Studer and Borle 1984 ; Kunos and Ishac 
1987 ; Kunos et al 1984 ) ( section 1.16(f) ) .
In this present study we have not examined the possibility 
that a decrease in the intracellular levels of cyclic AMP has the 
reverse effect upon the activities of steroid-metabolising 
enzymes i.e. stimulation . It is conceivable , however , that the 
stimulation of hepatic steroid metabolism that occurs £ hour 
after the addition of physiological concentrations of insulin to 
isolated rat hepatocytes ( Hussin and Skett 1987 ) is also due , 
at least in part , to a decrease in the intracellular 
concentration of cyclic AMP ( Heyworth et al 1985 ; O'Brien et al 
1987 ; ( section 1.16(d) ) .
4.10(b) Protein kinase c as a mediator of the effects of 
cyclic AMP .
One of the most interesting findings of this present study 
has been that , although the cyclic AMP-mediated inhibition of 
hepatic monooxygenase activity is attributable to cyclic AMP- 
mediated activation of PKa , PKa appears to have no direct 
inhibitory effects upon hepatic monooxygenases but inhibitory 
effects appear to be due to secondary activation of PKc . This 
interaction between the two protein kinases may represent a novel 
mode of intracellular regulation because , although many 
interactions exists between the cyclic AMP-generating and inositol
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phospholipid-hydrolysing pathways ( section 1.14(b) ) , activation 
of PKc by FKa has not previously been reported to be a mechanism 
by which cyclic AMP mediates its physiological effects .
One of the mechanisms by which this interaction may occur is 
by FKa-mediated stimulation of inositol phospholipid hydrolysis . 
Hcwever , reports on the ability of FKa to stimulate inositol 
phospholipid hydrolysis in isolated rat hepatocytes vary . FKa 
has been reported to stimulate PIP2 hydrolysis by phosphorylating 
and subsequently stimulating the activity of the putative CTP- 
binding protein linking the hormone receptor to phospholipase c 
(section 1.12(c) ) ( Blackmore and Exton 1986 ) . These workers , 
hcwever , were attempting to elucidate the mechanisms by which 
glucagon elevates intracellular calcium levels and the effects of 
FKa-mediated PIP2 hydrolysis upon activation of PKc were not 
examined . In contradiction to the above report , Kaibuchi et al 
( 1982 ) reported that cyclic AMP had no effect upon hydrolysis 
of inositol phospholipids in hepatocytes and O'Shea et al ( 1987) 
reported that cyclic AMP inhibits hormonal stimulation of PIP2 
hydrolysis by inhibition of PI kinase ( section 1.12(c) ) and 
depletion of PIP2 in the plasma membrane .
In this present study we have shewn that the inhibitory 
effects of adrenaline upon steroid-metabolising enzyme activity 
are mediated only by activity at the p2 adrenergic receptor and 
that adrenaline activity at a: adrenergic receptors , which are 
directly linked to hydrolysis of inositol phospholipids , has no 
role to play in the regulation of steroid-metabolising enzymes .
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This finding implies that PKa-mediated activation of PKc is not 
mediated by stimulation of hydrolysis of inositol phospholipids .
In contradiction to the mechanisms proposed for adrenaline in 
this present study , Hussin et al ( 1988 ) reported that the 
inhibitory effects of physiological concentrations of glucagon 
upon steroid metabolism could be mimicked by TH-glucagcn which 
stimulates PIP2 hydrolysis but has no effect upon cyclic AMP 
levels . It was postulated , therefore , that the inhibitory 
effects of glucagon upon hepatic monooxygenase activity were 
mediated by stimulation of inositol phospholipid hydrolysis and 
not by cyclic AMP generation . This finding implies that 
glucagon-mediated stimulation of PIP2 hydrolysis can result in 
sufficient activation of PKc to mediate the inhibitory effects of 
the hormone upon steroid metabolism . FKa may be acting in a 
similar way , therefore , to stimulate inositol phospholipid 
hydrolysis and activate PKc which then mediates subsequent 
inhibition of steroid-metabolising enzyme activity .
In view of these contradictory reports , the possibility that 
PKa-mediated activation of PKc is mediated via stimulation of 
inositol phospholipid hydrolysis still remains to be clarified. 
Similarly the possibility that in vivo hormonally-mediated 
inhibition of enzyme activity proceeds , at least in part , by 
direct stimulation of inositol phospholipid hydrolysis , as has 
been postulated for glucagon , cannot be overlooked .
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An alternative mechanism by which FKa may activate PKc is via 
direct interaction between the two protein kinases , presumably 
involving phosphorylation by FKa . Such a positive interaction 
has not previously been reported but interaction between the two 
protein kinases has been reported to occur in skeletal muscle 
myoblasts which results in PKa-mediated inhibition of PKc ( 
Narindrasorasak et al 1987 ) . In the GH* pituitary cell line 
cyclic AMP has been postulated to mediate scroe of its nuclear 
effects by stimulating the activity of a calcium-dependent protein 
kinase ( Waterman et al 1985 ) . Although the identity of this 
protein kinase and the mechanisms by which cyclic AMP m y  
stimulate its activity are unclear , the possibility exists that 
this represents another example of PKa-mediated activation of a 
second protein kinase , which m y  or m y  not be PKc , and which 
mediates a physiological effect of cyclic AMP .
The possibility that FKa mediates direct activation of PKC in 
hepatocytes remains to be clarified .
4.10(c) Sex differences in hepatic monooxygenase activity and 
the response of these enzymes to hormones .
Another interesting finding fran this present study is that 
cyclic AMP has no effect upon the sexually differentiated enzyme 
profiles from either male or female rats and had a non-specific 
inhibitory effect upon all steroid-metabolising enzymes in rats 
regardless of sex . The inability of cyclic AMP to feminise male
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steroid-metabolising enzymes may indicate that alteration of 
cyclic AMP levels or alteration of the levels of other 
intracellular mediators that directly activate PKc , are not 
mechanisms by which the postulated in vivo feminising factor , now 
thought to be growth hormone ( Mode et al 1983 ; Kramer and Colby 
1976 ) ( sections 1.11(f) and 1.11(g) ) , mediates its effects . 
Growth hormone , however , has been reported to have no effect 
upon steroid-metabolising enzymes when added directly to isolated 
rat hepatocytes cultured under the same conditions as those used 
in this study ( P. Gulati : personal ccrmunication ) . It appears, 
therefore , that feminisation of hepatic monooxygenases is a 
much more complicated process than first thought and may involve 
many components of the endocrine system . It is conceivable , 
therefore , that although we have detected no feminisation of 
enzyme activity in this present study , one of the additional 
unidentified hormonal components which has been shewn to be 
necessary for the feminising effect of growth hormone , may be 
mediating effects by elevation of cyclic AMP and inhibition of the 
activities of 6p hydroxylase and 16a hydroxylase . Protection 
against the inhibitory effects of cyclic AMP upon 7a hydroxylase 
and 17a/p hydroxysteroid dehydrogenase and stimulation of the 
activity of 5a reductase , however , may be due to yet another 
hormonal factor .
Hie identical non-specific inhibitory effect of cyclic AMP 
upon steroid-metabolising hepatic monooxygenases in rats 
regardless of sex also differs markedly from the findings of in
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vivo studies which compared the effects of hormones postulated to 
mediate their effects , at least in part , by alteration of cyclic 
AMP in male and female rats . In these studies female hepatic 
monooxygenases were reported to be refractory to the in vivo 
inhibitory effects of thyroxine ( Kato and Gillette 1965a ; Kato 
et al 1970 ) ( section 1.11(h) ) , diabetes ( Kato and Gillette 
1965a ; Kato et al 1971 ) ( section l.ll(i) ) , adrenalectomy 
(Kato and Gillette 1965a ; Kato et al 1971 ) ( section l.ll(j) ) 
and adrenaline ( Kato and Gillette 1965a ) . The inhibitory 
effects of "in vivo" administration of dibutyryl cyclic AMP also 
do not occur in the female rat ( Ross et al 1973 ) . This implies 
that the refractoriness is due to seme extracellular effect which 
does not involve a decrease in hormonally-mediated generation of 
intracellular cyclic AMP in the female rat and may be due to seme 
hormonal influence which is absent in this present study .
It is conceivable that the hormonal factor which mediates the 
proposed protective effect against the inhibitory effects of 
cyclic AMP and/or PKc activation in the female rat is identical 
to that which we have postulated to mediated selective protection 
against the inhibitory effects of cyclic AMP upon 7a hydroxylase, 
17a/p hydroxysteroid dehydrogenase and 5a reductase in 
feminising male hepatic monooxygenases .
The nature of this postulated hormonal factor is unknown.
Kato et al ( 1971 ) , however , reported that the inhibitory 
effects of adrenalectomy and diabetes upon hepatic monooxygenase 
activity in the male rat did not occur in castrated male rats .
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This implies that one of the unidentified factors may be 
testosterone and its absence in the female may confer the 
protective effect . If testosterone is postulated to be the 
missing factor , however , its absence in the isolated rat 
hepatocyte model used in this present study would result in 
refractoriness of hepatic monooxygenases to the inhibitory effects 
of cyclic AMP in hepatocytes from both male and female rats and we 
have shewn that this does not occur . The loss of the protective 
effect in hepatocytes isolated fran female rats indicates that the 
protective effect is conferred by a hormonal factor which is 
present in the intact female but absent in the intact male and 
this differs from the role postulated for testosterone above .
One obvious possibility is that the identity of the missing 
factor is oestrogen . Oestrogen , however , is thought to have 
little effect upon hepatic monooxygenase activity at the level of 
the liver ( Gustafsson and Stenberg 1976 ) and hepatic oestrogen 
receptors are thought to be non-functional at physiological 
concentrations of the hormone ( Lax 1987 ) . It appears unlikely , 
therefore , that the postulated missing hormonal factor is of 
ovarian origin although Ross and Oppelt ( 1973 ) reported that 
pretreatment of castrated male rats with oestradiol reduced the 
inhibitory effects of dibutyryl cyclic AMP upon hepatic 
monooxygenase activity in comparison to the inhibitory effects of 
the cyclic AMP analogue in ncn-pretreated castrates .
It has recently been reported that the combination of growth 
hormone , thyroxine and a glucocorticosteroid ( dexamethascne ) 
when added directly to cultures of hepatocytes isolated fran male
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rats mediated feminisation of steroid-metabolising enzymes ( P. 
Gulati : personal ccnmunicaticn ) . It is conceivable , therefore 
/ that the identity of the missing hormonal factor is one or a 
combination of these three hormones .
The hormonal influences mediating "in vivo" refractoriness of 
female hepatic monooxygenases to the inhibitory effects of cyclic 
AMP and those mediating "in vivo" feminisation of rale hepatic 
enzyme profiles in addition to a possible role of cyclic AMP ,
FKa activation and PKc activation in the production of the latter, 
remain to be elucidated .
4.11 PHARMACOLOGICAL IMPLICATIONS .
In 1976 it was postulated that the inductive effects of 
Arochlor-1254 ( Costa et al 1976 ) , 3-methylcbolanthrene and 
phenobarbitone ( Byus et al 1976 ) were mediated by elevation of 
cyclic AMP and/or activation of FKa . The results of this present 
study have indicated that supraphys iological concentrations of 
cyclic AMP are able to mediate stimulation of steroid- 
metabolising enzyme activity by induction of cytochrome P450 and 
so correlate with the above report that the effects of the classic 
inducing agents ray be mediated by elevation of cyclic AMP and 
subsequent activation of FKa . The concentrations of hepatic 
cyclic AMP generated by in vivo administration of phenobarbitone 
and 3-methylcholanthrene , however , were reported to be only 150% 
to 200% of corresponding control levels ( Byus et al 1976 ) and
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these levels differ markedly fran the concentrations of cyclic AMP 
which we have found necessary to mediate induction of cytochrome 
P450 and associated stimulation of steroid metabolism in this 
present study .
Despite these discrepancies in concentrations , however , the 
effects of supraphysiological concentrations of cyclic AMP also 
exhibit other similarities with those of the classic inducing 
agents . Both phenobarbitone and 3-nethylcbolanthrene have been 
reported to increase the degradation of cytochrome P450 either by 
induction of haem oxygenase ( Lincoln et al 1988 ; Shedlovsky et 
al 1987 ) or by uncoupling the cytochrome P450 electron transport 
chain which mediates degradation of cytochrome P450 by increasing 
peroxide generation ( De Mattheis 1988 ) . The ultimate result of 
increase in degradation of cytochrome P450 by either of these two 
mechanisms in conjunction with induction of specific cytochrome 
P450 isozymes is an increase in the rate of turnover of cytochrome 
P450 ( Sadano and Qonura 1983 ) ( section 1.9(d) ) . We have noted 
a similar combination of inhibitory and stimulatory effects upon 
steroid-metabolising enzymes and cytochrome P450 levels mediated 
by supraphysiological concentrations of cyclic AMP in this present 
study .
One discrepancy which does arise between the effects of high 
concentrations of cyclic AMP and the effects of phenobarbitone 
and 3-methylcholanthrene , however , is that no inhibitory 
effects of low concentrations of either phenobarbitone or 
3-methylcholanthrene have been reported which would be expected if 
the effects of these inducing agents were mediated only by
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elevation of cyclic AMP . In an early study by Kato et al ( 1964 ) 
, however , a time-dependent biphasic effect upon the metabolism 
of xenchiotics was reported for a wide range of different inducing 
agents which would be expected if cyclic AMP was mediating the 
effects of these agents . In addition , low doses of 
phenobarbitone have been reported to have different effects in 
male and female rats in that females appeared to be refractory to 
the inductive effects of low doses of phenobarbitone whereas 
higher doses of phenobarbitone had the same inductive effect in 
rats of both sexes ( Shapiro 1986 ) . This may indicate that low 
doses of phenobarbitone mediate different effects to high doses . 
More recently it has been reported that phenobarbitone inhibits 
PKC activation in rat brain ( Chauhan and Brockerhoff 1986 ) and 
so a possible explanation for the lack of an inhibitory effect of 
phenobarbitone upon hepatic monooxygenases at low concentrations 
is that the FKc-dependent inhibitory effects are blocked by the 
presence of phenobarbitone and so only PKa-mediated induction 
occurs .
It is possible , therefore , that the effects of 
phenobarbitone , 3-methylcholanthrene and Arochlor-1254 upon 
hepatic monooxygenases are mediated , at least in part , by 
elevation of cyclic AMP and activation of FKa and perhaps also by 
concomitant inhibition of PKc . It will be necessary to examine 
the effects of phenobarbitone , 3-methylcholanthrene and 
Arochlor-1254 upon the levels of cyclic AMP in isolated rat 
hepatocytes and to determine if the inductive effects of these 
agents are inhibited by KT5720 ( FKa inhibitor ) to verify this
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proposal . in addition the fact that these agents induce different 
cytochrome P450 isozymes indicates that the inducing agents must 
have sane additional cyclic AMP-independent effects which confer 
isozyme specificity .
4.12 GENERAL OCNCLUSICNS .
We have shown by both Indirect methods in intact hepatocytes 
and by direct methods in electropermeabilised hepatocytes that 
cyclic AMP has a concentration- and time-dependent biphasic 
effect upon steroid-metabolising enzymes . The overall effect 
produced is the sun of the effects of a number of stimulatory and 
inhibitory components mediated either by FKa directly or by 
secondary activation of FKC by FKa . The changes in the relative 
magnitudes of these components with time results in the biphasic 
nature of the response .
Low ( physiological ) concentrations of cyclic AMP mediate 
predominant inhibition of steroid-metabolising enzymes and these 
concentrations correlate with those produced by hormones which 
have an inhibitory effect upon hepatic monooxygenases in vivo .
High ( supraphysiological ) concentrations of cyclic AMP 
mediate predominant stimulation of steroid-metabolising enzyme 
activity which we have shown may be due to induction of cytochrome 
P450 . Elevation of cyclic AMP , therefore , may be one mechanism 
by which phenobarbitone , 3-methylcholanthrene and Arochlor-1254
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mediate their inductive effects upon hepatic monooxygenases in 
vivo.
It Is proposed , therefore , that elevation of cyclic AMP has 
a role in both the homonally-mediated inhibition of hepatic 
monooxygenase activity and In the actions of xenohiotics in 
hepatic monooxygenase induction .
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